QUARTERLY REPORT
Q1 2026 — Quarterly report (10-Q)
Q1 2026PDF · 156 pages1.3 MB
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_____________________________________________
FORM 10-Q
_____________________________________________
(Mark One)
☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the quarterly period ended March 31, 2026
OR
☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from________ to________.
____________________________________________
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, New York 10036
(212) 345-5000
_____________________________________________
Commission file number 1-5998
State of Incorporation: Delaware
I.R.S. Employer Identification No. 36-2668272
_____________________________________________
Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading symbol(s) Name of exchange on which registered
Common Stock, par value $1.00 per share MRSH New York Stock Exchange
NYSE Texas
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the
past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted and posted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such
files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an
emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule
12b-2 of the Exchange Act.
Large Accelerated Filer ☒ Accelerated Filer ☐
Non-Accelerated Filer ☐ (Do not check if a smaller reporting company) Smaller Reporting Company ☐
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of April 13, 2026, there were outstanding 481,794,501 shares of common stock, par value $1.00 per share, of the registrant.
-- 1 of 156 --
INFORMATION CONCERNING FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains "forward-looking statements," as defined in the Private Securities Litigation Reform Act of 1995.
These statements, which express management's current views concerning future events or results, use words like "anticipate," "assume," "believe,"
"continue," "estimate," "expect," "intend," "plan," "project" and similar terms, and future or conditional tense verbs like "could," "may," "might,"
"should," "will" and "would".
Forward-looking statements are subject to inherent risks and uncertainties that could cause actual results to differ materially from those expressed
or implied in our forward-looking statements. Factors that could materially affect our future results include, among other things:
• the impact of geopolitical or macroeconomic conditions on us, our clients and the countries and industries in which we operate, including
from the conflict in the Middle East and other wars and global conflicts, social unrest, tariffs or changes in trade policies, slower GDP
growth or recession, fluctuations in foreign exchange rates, lower interest rates, capital markets volatility, inflation and changes in insurance
premium rates;
• the impact from lawsuits or investigations arising from errors and omissions, breaches of fiduciary duty or other claims against us in our
capacity as a broker or investment advisor, including claims related to our investment business’ ability to execute timely trades;
• the increasing prevalence of ransomware, supply chain and other forms of cyber attacks, and their potential to disrupt our operations, or the
operations of our third party vendors, and result in the disclosure of confidential client or company information;
• the financial and operational impact of complying with laws and regulations, including domestic and international sanctions regimes, anti-
corruption laws such as the U.S. Foreign Corrupt Practices Act, U.K. Anti Bribery Act and cybersecurity, data privacy and artificial
intelligence regulations;
• our ability to attract, retain and develop industry leading talent;
• our ability to compete effectively and adapt to competitive pressures and market changes in each of our businesses, including from
disintermediation as well as technological change, digital disruption and other types of innovation such as artificial intelligence;
• our ability to manage potential conflicts of interest, including where our services to a client conflict, or are perceived to conflict, with the
interests of another client or our own interests;
• our ability to fully realize the opportunities and efficiencies from the Thrive program, which focuses on our brand strategy, delivering greater
value to clients, accelerating growth and improving efficiency;
• the regulatory, contractual and reputational risks that arise based on insurance placement activities and insurer revenue streams; and
• the impact of changes in tax laws, guidance and interpretations, such as the implementation of the Organization for Economic Cooperation
and Development international tax framework, or the increasing number of challenges by tax authorities in the current global tax
environment.
The factors identified above are not exhaustive. Marsh and its consolidated subsidiaries (collectively, the "Company") operate in a dynamic
business environment in which new risks emerge frequently. Accordingly, we caution readers not to place undue reliance on any forward-looking
statements, which are based only on information currently available to us and speak only as of the dates on which they are made. The Company
undertakes no obligation to update or revise any forward-looking statement to reflect events or circumstances arising after the date on which it is
made.
Further information concerning the Company, including information about factors that could materially affect our results of operations and financial
condition, is contained in the Company's filings with the Securities and Exchange Commission, including the "Risk Factors" section and the
"Management’s Discussion and Analysis of Financial Condition and Results of Operations" section of this Quarterly Report on Form 10-Q and our
most recently filed Annual Report on Form 10-K.
2
-- 2 of 156 --
TABLE OF CONTENTS
PART I. FINANCIAL INFORMATION 4
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED) 4
CONSOLIDATED STATEMENTS OF INCOME 4
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME 5
CONSOLIDATED BALANCE SHEETS 6
CONSOLIDATED STATEMENTS OF CASH FLOWS 8
CONSOLIDATED STATEMENTS OF EQUITY 9
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 10
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS 38
OF OPERATIONS
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 52
ITEM 4. CONTROLS & PROCEDURES 53
PART II. OTHER INFORMATION 54
ITEM 1. LEGAL PROCEEDINGS 54
ITEM 1A. RISK FACTORS 54
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 54
ITEM 3. DEFAULTS UPON SENIOR SECURITIES 54
ITEM 4. MINE SAFETY DISCLOSURE 54
ITEM 5. OTHER INFORMATION 54
ITEM 6. EXHIBITS 54
3
-- 3 of 156 --
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements.
MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
Three Months Ended
March 31,
(In millions, except per share data) 2026 2025
Revenue $ 7,597 $ 7,061
Expense:
Compensation and benefits 4,130 3,850
Other operating expenses 1,713 1,206
Operating expenses 5,843 5,056
Operating income 1,754 2,005
Other net benefit credits 50 43
Interest income 11 19
Interest expense (240) (245)
Investment income 6 5
Income before income taxes 1,581 1,827
Income tax expense 395 415
Net income before non-controlling interests 1,186 1,412
Less: Net income attributable to non-controlling interests 40 31
Net income attributable to the Company $ 1,146 $ 1,381
Net income per share attributable to the Company:
– Basic $ 2.37 $ 2.81
– Diluted $ 2.36 $ 2.79
Average number of shares outstanding:
– Basic 484 492
– Diluted 486 495
Shares outstanding at March 31, 482 493
The accompanying notes are an integral part of these unaudited consolidated statements.
4
-- 4 of 156 --
MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
Three Months Ended
March 31,
(In millions) 2026 2025
Net income before non-controlling interests $ 1,186 $ 1,412
Other comprehensive income (loss), before tax:
Foreign currency translation adjustments (198) 402
Gain (Loss) related to pension/post-retirement plans 98 (88)
Other comprehensive (loss) income, before tax (100) 314
Income tax expense (benefit) on other comprehensive loss 31 (30)
Other comprehensive (loss) income, net of tax (131) 344
Comprehensive income 1,055 1,756
Less: comprehensive income attributable to non-controlling interest 40 31
Comprehensive income attributable to the Company $ 1,015 $ 1,725
The accompanying notes are an integral part of these unaudited consolidated statements.
5
-- 5 of 156 --
MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS
(In millions, except share data)
(Unaudited) March
31, 2026 December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents $ 1,611 $ 2,687
Cash and cash equivalents held in a fiduciary capacity 11,744 11,473
Receivables
Commissions and fees 7,777 7,015
Advanced premiums and claims 60 67
Other 749 750
8,586 7,832
Less-allowance for credit losses (159) (162)
Net receivables 8,427 7,670
Other current assets 1,454 1,370
Total current assets 23,236 23,200
Goodwill 24,273 24,337
Other intangible assets 4,607 4,746
Fixed assets (net of accumulated depreciation and amortization of $1,695 at March 31, 2026 and
$1,669 at December 31, 2025) 814 829
Pension related assets 2,168 2,140
Right of use assets 1,460 1,460
Deferred tax assets 193 212
Other assets 1,801 1,786
$ 58,552 $ 58,710
The accompanying notes are an integral part of these unaudited consolidated statements.
6
-- 6 of 156 --
MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED BALANCE SHEETS (Continued)
(In millions, except share data)
(Unaudited) March
31, 2026 December 31, 2025
LIABILITIES AND EQUITY
Current liabilities:
Short-term debt $ 1,702 $ 1,267
Accounts payable and accrued liabilities 4,180 3,652
Accrued compensation and employee benefits 1,945 3,962
Current lease liabilities 326 333
Accrued income taxes 572 373
Dividends payable 436 —
Fiduciary liabilities 11,744 11,473
Total current liabilities 20,905 21,060
Long-term debt 18,900 18,320
Pension, post-retirement and post-employment benefits 752 786
Long-term lease liabilities 1,523 1,529
Liabilities for errors and omissions 286 288
Other liabilities 1,380 1,412
Commitments and contingencies — —
Equity:
Preferred stock, $1 par value, authorized 6,000,000 shares, none issued — —
Common stock, $1 par value, authorized 1,600,000,000 shares, issued 560,641,640 shares at
March 31, 2026 and December 31, 2025 561 561
Additional paid-in capital 1,474 1,547
Retained earnings 28,037 27,767
Accumulated other comprehensive loss (5,560) (5,429)
Non-controlling interests 237 215
24,749 24,661
Less – treasury shares, at cost, 78,467,942 shares at March 31, 2026
and 75,783,063 shares at December 31, 2025 (9,943) (9,346)
Total equity 14,806 15,315
$ 58,552 $ 58,710
The accompanying notes are an integral part of these unaudited consolidated statements.
7
-- 7 of 156 --
MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
For the Three Months Ended March 31,
(In millions) 2026 2025
Operating cash flows:
Net income before non-controlling interests $ 1,186 $ 1,412
Adjustments to reconcile net income provided by operations:
Depreciation and amortization of fixed assets and capitalized software 89 88
Amortization of intangible assets 138 139
Non-cash lease expense 76 73
Adjustments and payments related to contingent consideration assets and liabilities 10 (5)
Net (gain) on investments (6) (5)
Net (gain) on consolidation of business and disposition of assets (7) (29)
Share-based compensation expense 139 112
Changes in assets and liabilities:
Net receivables (784) (599)
Other assets (122) (121)
Accrued compensation and employee benefits (2,004) (1,858)
Provision for taxes, net of payments and refunds 157 178
Contributions to pension and other benefit plans in excess of current year credit (61) (55)
Other liabilities 587 130
Operating lease liabilities (86) (82)
Net cash provided by (used for) operations (688) (622)
Financing cash flows:
Purchase of treasury shares (755) (300)
Net proceeds from issuance of commercial paper 1,049 1,048
Proceeds from issuance of debt 595 —
Repayments of debt (605) (505)
Shares withheld for taxes on vested units – treasury shares (118) (137)
Issuance of common stock from treasury shares 63 128
Payments of deferred and contingent consideration for acquisitions (31) (32)
Receipts of deferred and contingent consideration for dispositions 12 —
Distributions of non-controlling interests (17) (21)
Dividends paid (440) (405)
Change in fiduciary liabilities 361 86
Net cash provided by (used for) financing activities 114 (138)
Investing cash flows:
Capital expenditures (62) (55)
Purchases of long-term investments (8) (10)
Sales of long-term investments 1 84
Dispositions 12 25
Acquisitions, net of cash and cash held in a fiduciary capacity acquired (41) (18)
Other, net (6) —
Net cash provided by (used for) investing activities (104) 26
Effect of exchange rate changes on cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity (127) 243
Increase (Decrease) in cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity (805) (491)
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at beginning of period 14,160 13,674
Cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity at end of period $ 13,355 $ 13,183
Reconciliation of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity to the Consolidated Balance Sheets
Balance at March 31, 2026 2025
(In millions)
Cash and cash equivalents $ 1,611 $ 1,604
Cash and cash equivalents held in a fiduciary capacity 11,744 11,579
Total cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity $ 13,355 $ 13,183
The accompanying notes are an integral part of these unaudited consolidated statements.
8
-- 8 of 156 --
MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES
CONSOLIDATED STATEMENTS OF EQUITY
(Unaudited)
Three Months Ended
March 31,
(In millions, except per share data) 2026 2025
COMMON STOCK
Balance, beginning and end of period $ 561 $ 561
ADDITIONAL PAID-IN CAPITAL
Balance, beginning of period $ 1,547 $ 1,370
Change in accrued stock compensation costs (194) (226)
Issuance of shares under stock compensation and employee stock purchase plans 121 109
Balance, end of period $ 1,474 $ 1,253
RETAINED EARNINGS
Balance, beginning of period $ 27,767 $ 25,306
Net income attributable to the Company 1,146 1,381
Dividends declared (872) (801)
Dividend equivalents declared (4) (5)
Balance, end of period $ 28,037 $ 25,881
ACCUMULATED OTHER COMPREHENSIVE LOSS
Balance, beginning of period $ (5,429) $ (6,240)
Other comprehensive (loss) income, net of tax (131) 344
Balance, end of period $ (5,560) $ (5,896)
TREASURY SHARES
Balance, beginning of period $ (9,346) $ (7,655)
Issuance of shares under stock compensation and employee stock purchase plans 158 221
Purchase of treasury shares (755) (300)
Balance, end of period $ (9,943) $ (7,734)
NON-CONTROLLING INTERESTS
Balance, beginning of period $ 215 $ 193
Net income attributable to non-controlling interests 40 31
Distributions and other changes (18) (21)
Balance, end of period $ 237 $ 203
TOTAL EQUITY $ 14,806 $ 14,268
Dividends declared per share $ 1.80 $ 1.63
The accompanying notes are an integral part of these unaudited consolidated statements.
9
-- 9 of 156 --
MARSH & McLENNAN COMPANIES, INC. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
1. Nature of Operations
Marsh & McLennan Companies, Inc., and its consolidated subsidiaries (the "Company" or "Marsh") is a global professional services firm in the
areas of risk, reinsurance and capital, people and investments, and management consulting.
Effective January 14, 2026, the Company updated its brand name from Marsh McLennan to Marsh and the brand names of Marsh and Oliver
Wyman Group businesses to Marsh Risk and Marsh Management Consulting, respectively. References to the Company and its businesses in the
consolidated financial statements reflect these changes. Mercer and Guy Carpenter will continue to report under their current brands through a
transition period.
The changes to the brand names had no impact on the Company's operating and reporting segments.
The Company is organized based on the different services that it offers. Under this structure, the Company’s two business segments are Risk and
Insurance Services and Consulting.
The Risk and Insurance Services segment ("RIS") includes risk management activities and insurance/reinsurance broking and services conducted
through Marsh Risk and Guy Carpenter. Marsh Risk is an insurance broker and risk advisor, offering risk management, insurance broking,
insurance program management, risk consulting, analytical modeling and alternative risk financing services, to a wide range of businesses,
government entities, professional service organizations and individuals. Guy Carpenter, the Company's reinsurance intermediary and advisor,
provides specialized reinsurance broking, strategic advisory and actuarial services, and analytics solutions.
The Consulting segment includes health, wealth and career advice, solutions and products, and specialized management, strategic, economic and
brand consulting services conducted through Mercer and Marsh Management Consulting. Mercer delivers advice, solutions and products that help
organizations meet the health, wealth and career needs of a changing workforce. Marsh Management Consulting offers management consulting
and advisory services across various industries.
2. Principles of Consolidation and Other Matters
The Company prepared the consolidated financial statements included herein pursuant to the rules and regulations of the Securities and Exchange
Commission. For interim filings, certain information and disclosures normally included in financial statements prepared in accordance with
accounting principles generally accepted in the United States of America (U.S.) have been omitted pursuant to such rules and regulations. The
Company believes that the information and disclosures presented are adequate to make such information and disclosures not misleading. These
consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the
Company’s Annual Report on Form 10-K for the year ended December 31, 2025 (the "2025 Form 10-K").
The accompanied consolidated financial statements include all wholly-owned and majority-owned subsidiaries. All significant inter-company
transactions and balances have been eliminated. The financial information contained herein reflects all normal recurring adjustments which are, in
the opinion of management, necessary for a fair presentation of the Company’s consolidated financial statements as of and for the three months
ended March 31, 2026 and 2025.
The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities and disclosures of assets and liabilities at the date of the financial statements, and the reported amounts of
revenue and expense during the reporting period. On an ongoing basis, the Company evaluates its estimates, judgments and methodologies. The
estimates are based on historical experience and on various other assumptions that the Company believes are reasonable.
Such matters include:
• estimates of revenue;
• impairment assessments and charges;
• recoverability of long-lived assets;
10
-- 10 of 156 --
• liabilities for errors and omissions;
• deferred tax assets, uncertain tax positions and income tax expense;
• share-based and incentive compensation expense;
• the allowance for current expected credit losses on receivables;
• useful lives assigned to long-lived assets, and depreciation and amortization; and
• fair value estimates of contingent consideration receivable or payable, related to acquisitions or dispositions.
The Company believes these estimates are reasonable based on information currently available at the time they are made. The Company also
considered the potential impact of macroeconomic factors including from the conflict in the Middle East and other wars and global conflicts, social
unrest, tariffs or changes in trade policies, slower GDP growth or recession, fluctuations in foreign exchange rates, lower interest rates, capital
markets volatility, inflation and changes in insurance premium rates to its customer base in various industries and geographies. Insurance
exposures subject to variable factors are subject to mid-term and end of term adjustments, as well as policy audits, which may reduce premiums
and corresponding commissions. Estimates were updated based on internal and industry specific economic data. Actual results may differ from
these estimates.
Cash and Cash Equivalents
Cash and cash equivalents primarily consist of certificates of deposit and time deposits, with original maturities of three months or less, and money
market funds. The estimated fair value of the Company's cash and cash equivalents approximates their carrying value.
The Company is required to maintain operating funds primarily related to regulatory requirements outside of the U.S., or as collateral under captive
insurance arrangements. At March 31, 2026, the Company maintained $540 million, compared to $553 million at December 31, 2025 related to
these regulatory requirements.
Allowance for Credit Losses on Accounts Receivable
The Company’s policy for providing an allowance for credit losses on its accounts receivable is based on a combination of factors, including
historical write-offs, aging of balances, and other qualitative and quantitative analyses. The charge related to expected credit losses was not
material to the consolidated statements of income for the three months ended March 31, 2026 and 2025, respectively.
Investments
The caption "Investment income" in the consolidated statements of income comprises of realized and unrealized gains and losses from investments
recognized in earnings. It includes, when applicable, other than temporary declines in the value of securities, mark-to-market increases or
decreases in equity investments with readily determinable fair values and equity method gains or losses on the Company's investments in private
equity funds.
The Company holds investments in certain private equity funds. Investments in private equity funds are accounted for in accordance with the equity
method of accounting using a consistently applied three-month lag period adjusted for any known significant changes from the lag period to the
reporting date of the Company. The underlying private equity funds follow investment company accounting, where investments within the fund are
carried at fair value. Investment gains or losses for its proportionate share of the change in fair value of the funds are recorded in earnings.
Investments accounted for in accordance with the equity method of accounting are included in other assets in the consolidated balance sheets.
The Company recorded net investment income of $6 million and $5 million for the three months ended March 31, 2026 and 2025, respectively.
Income Taxes
The Company's effective tax rate for the three months ended March 31, 2026 was 25.0%, compared with 22.7% for the corresponding period of
2025.
The tax rate in each period reflects the impact of discrete tax items such as excess tax benefits related to share-based compensation, enacted tax
legislation, changes in uncertain tax positions, deferred tax adjustments, non-taxable adjustments related to contingent consideration for
acquisitions, and valuation allowances for certain tax credits and attributes.
11
-- 11 of 156 --
Purchases of U.S. tax credits are the most significant discrete item for the three months ended March 31, 2026, reducing the effective tax rate by
0.3%. For the three months ended March 31, 2025, the most significant discrete item was the excess tax benefit related to share-based payments,
which reduced the effective tax rate by 2.1%.
The Company's tax rate reflects its income, statutory tax rates, and tax planning in the various jurisdictions in which it operates. Significant
judgment is required in determining the annual effective tax rate and in evaluating uncertain tax positions. Losses in one jurisdiction generally
cannot offset earnings in another, and within certain jurisdictions profits and losses may not offset between entities. Consequently, losses in certain
jurisdictions may require valuation allowances affecting the effective tax rate, depending on estimates of the realizability of associated deferred tax
assets. The tax rate is also sensitive to changes in unrecognized tax benefits, including the impact of settled tax audits and expired statutes of
limitations.
The Company reports a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in tax returns. The
Company's gross unrecognized tax benefits were $114 million at March 31, 2026, and $109 million at December 31, 2025.
In 2024, the Company received closure notices and assessments from the United Kingdom (U.K.) tax authority in relation to its 2016-2020
examinations which disallowed certain interest expense deductions. The Company has appealed the assessments and resolving this matter
through litigation or alternative dispute resolution may take several years.
The Company has established liabilities for uncertain tax positions in relation to potential assessments in the jurisdictions in which it operates. The
Company believes the resolution of tax matters will not have a material effect on the consolidated financial position of the Company. However, an
adverse resolution of tax matters could have a material impact on the Company's net income or cash flows and on its effective tax rate in a
particular future period.
Changes in tax laws, rulings, policies, or related legal and regulatory interpretations occur frequently and may have significant favorable or adverse
impacts on our effective tax rate.
On July 4, 2025, U.S tax legislation was signed into law (known as the "One Big Beautiful Bill Act" or "OBBBA") which made permanent many of the
tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act. In addition, the OBBBA made changes to certain U.S. corporate tax
provisions, which are effective beginning in 2026. The enactment of the OBBBA does not have a material impact on the results from operations for
the current year or future years.
The Organization for Economic Cooperation and Development ("OECD") provided model rules for a 15% global minimum tax, known as Pillar Two.
Pillar Two has now been enacted by most key non-U.S. jurisdictions where the Company operates, including the U.K. and Ireland. Parts of the
minimum tax rules were applicable for 2024, with the remaining provisions becoming fully effective for 2025. This minimum tax is treated as a
period cost and does not have a material impact on the Company's financial results of operations for the current period.
While the U.S. has negotiated a "side-by-side" arrangement for the existing U.S. minimum taxes with the intent to exempt U.S. multinational
companies from certain of the Pillar Two provisions, uncertainty remains related to the implementation of this arrangement.
The Company continues to monitor legislative developments, as well as additional guidance from countries that have enacted Pillar Two legislation,
and will ensure it complies with any changes.
Restructuring Costs
Charges associated with restructuring activities are recognized in accordance with applicable accounting guidance which includes accounting for
disposal or exit activities, guidance related to impairment of right-of-use ("ROU") assets related to real estate leases, as well as other costs
resulting from accelerated depreciation or amortization of leasehold improvements and other property and equipment.
Severance and related costs are recognized based on amounts due under established severance plans or estimates of one-time benefits that will
be provided. Typically, severance benefits are recognized when the impacted colleagues are notified of their expected termination and such
termination is expected to occur within the legally required notification period. These costs are included in compensation and benefits in the
consolidated statements of income.
12
-- 12 of 156 --
Costs for real estate consolidation are recognized based on the type of cost, and the expected future use of the facility. For locations where the
Company does not expect to sub-lease the property, the amortization of any ROU asset is accelerated from the decision date to the cease use
date. For locations where the Company expects to sub-lease the properties subsequent to vacating the property, the ROU asset is reviewed for
potential impairment at the earlier of the cease use date or the date a sub-lease is signed. To determine the amount of impairment, the fair value of
the ROU asset is determined based on the present value of the estimated net cash flows related to the property. Contractual costs outside of the
ROU asset are recognized based on the net present value of expected future cash outflows for which the Company will not receive any benefit.
Such amounts are reliant on estimates of future sub-lease income to be received and future contractual costs to be incurred. These costs are
included in other operating expenses in the consolidated statements of income.
Other costs related to restructuring such as moving, legal or consulting costs are recognized as incurred. These costs are included in other
operating expenses in the consolidated statements of income.
Foreign Currency
The financial statements of international subsidiaries are translated from functional currency to U.S. dollars using month-end exchange rates for
assets and liabilities, and average monthly exchange rates during the period for revenues and expenses. Translation adjustments are recorded in
accumulated other comprehensive income (loss) ("AOCI") within the consolidated statements of equity. Foreign exchange transaction gains and
losses resulting from the conversion of the transaction currency to functional currency are included in operating income in the consolidated
statements of income.
13
-- 13 of 156 --
3. Revenue
The core principle of the revenue recognition guidance is that an entity should recognize revenue to depict the transfer of promised goods or
services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or
services.
To achieve this principle, the entity applies the following steps: identify the contract(s) with the customer, identify the performance obligations in the
contract(s), determine the transaction price, allocate the transaction price to the performance obligations in the contract, and recognize revenue
when (or as) the entity satisfies a performance obligation. In accordance with the accounting guidance, a performance obligation is satisfied either
at a "point in time" or "over time", depending on the nature of the product or service provided, and the specific terms of the contract with customers.
Other revenue included in the consolidated statements of income that is not from contracts with customers is less than 1% of total revenue and is
not presented as a separate line item.
The Company's revenue policies are provided in more detail in Note 2, Revenue, in the 2025 Form 10-K.
The following table disaggregates various components of the Company's revenue:
Three Months Ended
March 31,
(In millions) 2026 2025
Marsh Risk:
EMEA $ 1,208 $ 1,059
Asia Pacific 369 335
Latin America 136 124
Total International 1,713 1,518
U.S./Canada 2,013 1,935
Total Marsh Risk 3,726 3,453
Guy Carpenter 1,240 1,206
Subtotal 4,966 4,659
Fiduciary interest income 85 103
Total Risk and Insurance Services $ 5,051 $ 4,762
Mercer:
Wealth $ 752 $ 670
Health 661 608
Career 248 218
Total Mercer 1,661 1,496
Marsh Management Consulting 897 818
Total Consulting $ 2,558 $ 2,314
Total Segments $ 7,609 $ 7,076
Corporate/Eliminations (12) (15)
Total $ 7,597 $ 7,061
The following table provides contract assets and contract liabilities information from contracts with customers:
(In millions) March 31, 2026 December 31, 2025
Contract assets $ 577 $ 540
Contract liabilities $ 1,043 $ 927
14
-- 14 of 156 --
The Company records accounts receivable when the right to consideration is unconditional, subject only to the passage of time. Contract assets
primarily relate to quota share reinsurance brokerage and contingent insurer revenue. The Company does not have the right to bill and collect
revenue for quota share brokerage until the underlying policies written by the ceding insurer attach to the treaty. Estimated revenue related to the
achievement of volume or loss ratio metrics cannot be billed or collected until all related policy placements are completed and the contingency is
resolved. Contract assets are included in other current assets in the Company's consolidated balance sheets.
Contract liabilities primarily relate to the advance consideration received from customers. Contract liabilities are included in current liabilities in the
Company's consolidated balance sheets.
Revenue recognized for the three months ended March 31, 2026 and 2025, that was included in the contract liability balance at the beginning of
each of those periods was $380 million and $340 million, respectively.
The amount of revenue recognized for the three months ended March 31, 2026 and 2025 from performance obligations satisfied in previous
periods, mainly due to variable consideration from contracts with insurers, quota share business and consulting contracts previously considered
constrained was $25 million and $27 million, respectively.
The Company applies the practical expedient and does not disclose the value of unsatisfied performance obligations for (1) contracts with original
contract terms of one year or less and (2) contracts where the Company has the right to invoice for services performed.
15
-- 15 of 156 --
4. Fiduciary Assets and Liabilities
The Company, in its capacity as an insurance broker or agent, generally collects premiums from insureds and after deducting its commissions,
remits the premiums to the respective insurance underwriters. The Company also collects claims or refunds from underwriters on behalf of
insureds. Unremitted insurance premiums and claims proceeds are held by the Company in a fiduciary capacity. The Company's fiduciary assets
primarily include bank or short-term time deposits and liquid money market funds, classified as cash and cash equivalents. Since cash and cash
equivalents held in a fiduciary capacity are not available for corporate use, they are shown separately in the consolidated balance sheets as cash
and cash equivalents held in a fiduciary capacity, with a corresponding amount in current liabilities.
Risk and Insurance Services revenue includes interest on fiduciary funds of $85 million and $103 million for the three months ended March 31,
2026 and 2025, respectively.
Net uncollected premiums and claims and the related payables were $16.2 billion at March 31, 2026 and $14.6 billion at December 31, 2025. The
Company is not a principal to the contracts under which the right to receive premiums or the right to receive reimbursement of insured losses
arises. Accordingly, net uncollected premiums and claims and the related payables are not assets and liabilities of the Company and are not
included in the accompanying consolidated balance sheets.
In certain instances, the Company advances premiums, refunds or claims to insurance underwriters or insureds prior to collection. These advances
are made from corporate funds and are reflected in the accompanying consolidated balance sheets as receivables.
5. Per Share Data
Basic net income per share attributable to the Company is calculated by dividing the after-tax income attributable to the Company by the weighted
average number of outstanding shares of the Company’s common stock.
Diluted net income per share attributable to the Company is calculated by dividing the after-tax income attributable to the Company by the weighted
average number of outstanding shares of the Company’s common stock, which have been adjusted for the dilutive effect of potentially issuable
common shares.
Basic and Diluted EPS Calculation
Three Months Ended
March 31,
(In millions, except per share data) 2026 2025
Net income before non-controlling interests $ 1,186 $ 1,412
Less: Net income attributable to non-controlling interests 40 31
Net income attributable to the Company $ 1,146 $ 1,381
Basic weighted average common shares outstanding 484 492
Dilutive effect of potentially issuable common shares 2 3
Diluted weighted average common shares outstanding 486 495
Average stock price used to calculate common stock equivalents $ 179.92 $ 226.78
16
-- 16 of 156 --
6. Supplemental Disclosures to the Consolidated Statements of Cash Flows
The following table provides additional information concerning acquisitions, interest and income taxes paid for the three months ended March 31,
2026 and 2025:
(In millions) 2026 2025
Assets acquired, excluding cash, cash equivalents, and cash and cash equivalents held in a fiduciary
capacity $ 48 $ 65
Fiduciary liabilities assumed (1) (15)
Liabilities assumed (4) (7)
Fair value of previously-held equity investment — (15)
Contingent/deferred purchase consideration (2) (10)
Net cash outflow for acquisitions $ 41 $ 18
(In millions) 2026 2025
Interest paid $ 343 $ 317
Income taxes paid, net of refunds $ 238 $ 237
The classification of contingent consideration in the consolidated statements of cash flows is dependent upon whether the receipt or payment was
part of the initial liability established on the acquisition date (financing) or an adjustment to the acquisition date liability (operating).
The following amounts are included in the consolidated statements of cash flows as operating and financing activities:
For the Three Months Ended March 31,
(In millions) 2026 2025
Operating:
Contingent consideration payments for prior year acquisitions $ (1) $ (14)
Acquisition/disposition related net charges for adjustments 11 9
Adjustments and payments related to contingent consideration $ 10 $ (5)
Financing:
Contingent consideration for prior year acquisitions $ (17) $ (5)
Deferred consideration for prior year acquisitions (14) (27)
Payments of deferred and contingent consideration for acquisitions $ (31) $ (32)
Receipts of deferred and contingent consideration for dispositions $ 12 $ —
The Company had non-cash issuances of common stock in accordance with its share-based payment plan of $335 million and $339 million for the
three months ended March 31, 2026 and 2025, respectively.
The Company recorded share-based compensation expense related to restricted stock units, performance stock units and stock options of $139
million and $112 million for the three months ended March 31, 2026 and 2025, respectively.
17
-- 17 of 156 --
7. Other Comprehensive (Loss) Income
The changes, net of tax, in the balances of each component of AOCI for the three months ended March 31, 2026 and 2025, including amounts
reclassified out of AOCI, are as follows:
(In millions)
Pension/Post-
Retirement Plans
Gains (Losses)
Foreign Currency
Translation
Adjustments Total
Balance at January 1, 2026 $ (3,707) $ (1,722) $ (5,429)
Other comprehensive income (loss) before reclassifications 58 (206) (148)
Amounts reclassified from accumulated other comprehensive income 17 — 17
Net current period other comprehensive income (loss) 75 (206) (131)
Balance at March 31, 2026 (a) $ (3,632) $ (1,928) $ (5,560)
(In millions)
Pension/Post-
Retirement Plans
Gains (Losses)
Foreign Currency
Translation
Adjustments Total
Balance at January 1, 2025 $ (3,408) $ (2,832) $ (6,240)
Other comprehensive (loss) income before reclassifications (74) 411 337
Amounts reclassified from accumulated other comprehensive income 7 — 7
Net current period other comprehensive (loss) income (67) 411 344
Balance at March 31, 2025 (a) $ (3,475) $ (2,421) $ (5,896)
(a) At each March 31, 2026 and 2025, balances are net of deferred tax assets in pension and post-retirement plans gains (losses) of $1.6 billion.
The components of other comprehensive (loss) income for the three months ended March 31, 2026 and 2025 are as follows:
Three Months Ended March 31, 2026 2025
(In millions) Pre-Tax Tax (Credit) Net of Tax Pre-Tax Tax (Credit) Net of Tax
Foreign currency translation adjustments $ (198) $ 8 $ (206) $ 402 $ (9) $ 411
Pension/post-retirement plans:
Amortization of losses (gains) included in net benefit
(credit) cost:
Net actuarial losses (a) 23 6 17 10 3 7
Subtotal 23 6 17 10 3 7
Foreign currency translation adjustments 73 17 56 (100) (24) (76)
Effect of remeasurement — — — (3) (1) (2)
Effect of settlement 2 — 2 5 1 4
Pension/post-retirement plans gains (losses) 98 23 75 (88) (21) (67)
Other comprehensive (loss) income $ (100) $ 31 $ (131) $ 314 $ (30) $ 344
(a) Included in other net benefit credits in the consolidated statements of income. Income tax expense on net actuarial losses are included in income tax expense.
18
-- 18 of 156 --
8. Acquisitions and Dispositions
The Company’s acquisitions have been accounted for as business combinations. Net assets and results of operations are included in the
Company’s consolidated financial statements commencing at the respective purchase closing dates. In connection with acquisitions, the Company
records the estimated values of the net tangible assets and the identifiable intangible assets purchased, which typically consist of customer
relationships, developed technology, trademarks and non-compete agreements. The valuation of purchased intangible assets involves significant
estimates and assumptions. The Company estimates the fair value of purchased intangible assets, primarily using the income approach, by
determining the present value of future cash flows over the remaining economic life of the respective assets. The significant estimates and
assumptions used in this approach include the determination of the discount rate, economic life, future revenue growth rates, expected account
attrition rates and earnings margins. Refinement and completion of final valuation of net assets acquired could affect the carrying value of tangible
assets, goodwill and identifiable intangible assets.
The Risk and Insurance Services segment completed one acquisition for the three months ended March 31, 2026:
• January – Marsh McLennan Agency ("MMA") acquired Robinson & Son, LLC., a New York-based insurance broker that provides property
and casualty insurance solutions to businesses and individuals with a specialization in maritime insurance.
The Consulting segment completed one acquisition for the three months ended March 31, 2026:
• January – Mercer acquired Profil M Beratung für Human Resources Management GmbH & Co. KG., a Germany-based provider of
consulting services in the areas of leadership assessment, executive development, leadership culture and transformation.
Total purchase consideration for acquisitions made for the three months ended March 31, 2026 was $45 million, which consisted of cash paid of
$43 million and deferred and estimated contingent purchase consideration of $2 million. Contingent purchase consideration arrangements are
generally based on earnings before interest, tax, depreciation and amortization ("EBITDA") or revenue targets over a period of 2 to 4 years. The fair
value of contingent purchase consideration was based on projected revenue and earnings of the acquired entities.
For the three months ended March 31, 2026, the Company also paid $14 million of deferred purchase consideration and $18 million of contingent
purchase consideration related to prior year acquisitions. Estimated fair values of assets acquired and liabilities assumed are subject to adjustment
until purchase accounting is finalized.
The following table presents the preliminary allocation of purchase consideration to the assets acquired and liabilities assumed in 2026, based on
the estimated fair values for the acquisitions as of their respective acquisition dates.
Acquisitions through March 31, 2026
(In millions) Total
Cash $ 43
Estimated fair value of deferred/contingent purchase consideration 2
Total consideration $ 45
Allocation of purchase price:
Cash and cash equivalents $ 1
Cash and cash equivalents held in a fiduciary capacity 1
Net receivables 6
Goodwill 26
Other intangible assets 15
Other assets 1
Total assets acquired 50
Fiduciary liabilities 1
Other liabilities 4
Total liabilities assumed 5
Net assets acquired $ 45
19
-- 19 of 156 --
The purchase price allocation for assets acquired and liabilities assumed is based on estimates that are preliminary in nature and subject to
adjustments, which could be material. Any necessary adjustments must be finalized during the measurement period, which for a particular asset,
liability, or non-controlling interest ends once the acquirer determines that either (1) the necessary information has been obtained or (2) the
information is not available. However, the measurement period for all items is limited to one year from the acquisition date.
Items subject to change include:
• amounts of intangible assets, fixed assets, capitalized software assets and right-of-use assets, subject to finalization of valuation efforts;
• amounts for contingencies, pending the finalization of the Company’s assessment of the portfolio of contingencies;
• amounts for deferred tax assets and liabilities, pending the finalization of valuations of the assets acquired, liabilities assumed and
associated goodwill; and
• amounts for income tax assets, receivables and liabilities, pending the filing of the acquired companies' pre-acquisition income tax returns
and receipt of information from taxing authorities which may change certain estimates and assumptions used.
The estimation of fair value requires numerous judgments, assumptions and estimates about future events and uncertainties, which could materially
impact these values, and the related amortization, where applicable, in the Company’s results of operations.
The following table provides information about other intangible assets acquired in 2026:
Other intangible assets through March 31, 2026
(In millions) Amount
Weighted Average
Amortization Period
Client relationships $ 14 10.5 years
Other 1 2.6 years
Total other intangible assets $ 15
The consolidated statements of income include the results of operations of acquired companies since their respective acquisition dates. The
following table provides information about the consolidated statements of income for each respective period:
Three Months Ended
March 31,
(In millions) 2026 2025
Revenue $ 6 $ 3
Operating income $ — $ 1
The Company incurred acquisition related expenses of approximately $48 million and $78 million for the three months ended March 31, 2026 and
2025, respectively. These costs included approximately $42 million and $69 million of integration and retention related costs in connection with the
acquisition of McGriff Insurance Services in 2026 and 2025, respectively. Acquisition related expenses are included in compensation and benefits
or other operating expenses in the Company's consolidated statements of income, depending on the nature of the items.
Prior year acquisitions
The Risk and Insurance Services segment completed 14 acquisitions in 2025:
• January – Guy Carpenter acquired the remaining 51.5% ownership share in Carpenter Turner Cyprus Ltd., a Greece-based insurance
broker that provides reinsurance and advisory services, including treaty and facultative reinsurance, data and analytics, strategic advisory,
and capital markets solutions.
• February – Marsh Risk acquired Fontana Rava-Toscano & Partners S.r.l., an Italy-based insurance broker that offers property and casualty
insurance brokerage and risk consulting.
• March – Marsh Risk acquired the business of Cohere Insurance Solutions, an Australia-based insurance broker that specializes in life
sciences, start-up and professional services businesses.
20
-- 20 of 156 --
• April – MMA acquired Arthur C. Hall Insurance, Inc., a Pennsylvania-based insurance broker that provides commercial and personal lines
solutions to clients, with specialties in life sciences, information management, non-profit, craft beverage manufacturing and municipal
industries.
• May – Marsh Risk acquired Thornton Harvey Group, LLC (d/b/a ProWriters), a Pennsylvania-based wholesale insurance broker that
provides solutions for cyber, management and professional liability insurance to a network of retail brokers in the U.S.
• July – MMA acquired Excel Insurance LLC, a Florida-based insurance broker that provides property and casualty insurance solutions to
small businesses and individuals in South Florida, with specialties in watercraft and motor vehicle protection; and Donald S. Barberie
Insurance Agency, Inc. (d/b/a Olympic Insurance Agency), a California-based insurance broker that provides business insurance, employee
benefits, and personal asset protection expertise to clients in Southern California, serving real estate investors, property managers, and
manufacturing businesses.
• August – MMA acquired Robins Insurance Agency Inc., a Tennessee-based insurance broker that provides business insurance and
personal lines solutions, with expertise in real estate, construction, hospitality, community associations and manufacturing.
• October – MMA acquired Robison Insurance Services Inc., a North Carolina-based insurance broker that provides life, health, disability and
long term care insurance services to businesses and individuals; and Hayden Wood Insurance Agency, a Massachusetts-based insurance
broker that provides personal lines insurance solutions to clients nationally, with a specialty in collector auto and motorsports products.
• November – Marsh Risk acquired Mitsubishi Electric Insurance Service Co, Ltd., a Japan-based insurance broker offering clients access to
high-value, cost-effective insurance solutions across a broad range of commercial lines, including liability, property, cargo, workers
compensation, commercial auto, commercial umbrella, directors and officers, and cyber, as well as non-life/life insurance, medical care,
and nursing care; and Jointly – il Welfare Condiviso S.r.l., an Italy-based provider of integrated corporate well-being solutions for
organizations and their employees, including parenting and family care support programs, mental and physical well-being initiatives, and
flexible benefits.
• December – MMA acquired three insurance brokers, Atlas Insurance Agency, Inc., Pyramid Insurance Centre, Ltd., and NMF Insurance,
Inc. d/b/a IC International, a collective group of Hawaii-based insurance brokers offering insurance solutions to businesses and individuals
throughout Hawaii with a niche industry specialization in municipality, transportation and hospitality; and Marsh Risk acquired Finassur, a
France-based insurance broker offering tailored insurance solutions in Northern France, specializing in property and casualty, and health
and life insurance risk management.
The Consulting segment completed 6 acquisitions in 2025:
• April – Mercer acquired the business of Cerebrus Consultants Private Limited., an India-based provider of human resources consulting and
advisory services.
• May – Mercer acquired SECOR Asset Management, L.P., a U.S. and United Kingdom based global provider of bespoke strategic and
portfolio solutions to institutional investors, including investment advisory and implementation, fiduciary and asset liability management.
• August – Marsh Management Consulting acquired Validate Health Inc., an Illinois-based healthcare analytics consultancy that provides
analytics solutions to healthcare providers and accountable care organizations to help clients to better manage costs, risk and
performance. Mercer acquired ConvictionsRH, a France-based consulting firm specializing in Human Resources transformation, supporting
companies of all sizes in their strategic, organizational, digital, technological and cultural changes.
• October – Mercer acquired Fundhouse Limited and Fundhouse Bespoke Limited, a United Kingdom-based provider of investment advisory
and model portfolio services to financial advisors and institutional wealth investors.
• November – Mercer acquired Hexarem Inc., a Canada-based human resources consulting firm specializing in executive compensation and
governance advisory services.
21
-- 21 of 156 --
Total purchase consideration for acquisitions made for the three months ended March 31, 2025 was $62 million, which consisted of cash paid of
$37 million, deferred and estimated contingent purchase consideration of $10 million, and the remeasurement to fair value of a previously held
equity method investment upon consolidation of $15 million. Contingent purchase consideration arrangements are generally based primarily on
EBITDA or revenue targets over a period of 2 to 4 years. The fair value of the contingent purchase consideration was based on projected revenue
and earnings of the acquired entities.
For the three months ended March 31, 2025, the Company also paid $27 million of deferred purchase consideration and $19 million of contingent
purchase consideration related acquisitions made in prior years. Estimated fair values of assets acquired and liabilities assumed are subject to
adjustment when purchase accounting is finalized.
In the first quarter of 2025, in connection with its increased investment in Carpenter Turner Cyprus Ltd., the Company recorded a gain of $13 million
related to the remeasurement of its previously held equity method investment to fair value upon consolidation. The fair value of the pre-existing
equity method investment was calculated considering both an income approach based on discounted future cash flows and market approach.
Prior year dispositions
In the first quarter of 2025, the Company sold MMA's Technology Consulting and Administrative Solutions ("TCAS") business for approximately $25
million, and recorded a gain of $15 million, which is included in revenue in the consolidated statements of income.
Pro-Forma Information
The following unaudited pro-forma financial data gives effect to the acquisitions made by the Company in 2026 and 2025. In accordance with
accounting guidance related to pro-forma disclosures, the information presented for acquisitions made in 2026 is as if they occurred on January 1,
2025, and reflects acquisitions made in 2025, as if they occurred on January 1, 2024. The unaudited pro-forma financial data includes the effects of
amortization of acquired intangibles and acquisition related costs in all years.
The unaudited pro-forma financial data is presented for illustrative purposes only and is not necessarily indicative of the operating results that would
have been achieved if such acquisitions had occurred on the dates indicated, nor is it necessarily indicative of future consolidated results.
Three Months Ended
March 31,
(In millions, except per share data) 2026 2025
Revenue $ 7,599 $ 7,125
Net income attributable to the Company $ 1,146 $ 1,391
Basic net income per share attributable to the Company $ 2.37 $ 2.83
Diluted net income per share attributable to the Company $ 2.36 $ 2.81
22
-- 22 of 156 --
9. Goodwill and Other Intangibles
The Company is required to assess goodwill and any indefinite-lived intangible assets for impairment annually, or more frequently if circumstances
indicate an impairment may have occurred. The Company performs the annual impairment assessment for each of its reporting units during the
third quarter of each year. The reporting unit level is defined at the same level as the Company's operating segments. A company can assess
qualitative factors to determine whether it is necessary to perform a quantitative goodwill impairment test. Alternatively, a company may elect to
proceed directly to the quantitative goodwill impairment test. In the third quarter of 2025, the Company completed a qualitative impairment
assessment and concluded that goodwill was not impaired. As part of its assessment, the Company considered numerous factors, including:
• that the fair value of each reporting unit exceeds its carrying value by a substantial margin based on its most recent quantitative
assessment in 2023;
• whether significant acquisitions or dispositions occurred which might alter the fair value of its reporting units;
• macroeconomic conditions and their potential impact on reporting unit fair values;
• actual performance compared with budget and prior projections used in its estimation of reporting unit fair values;
• industry and market conditions; and
• the year-over-year change in the Company’s share price.
Other intangible assets that are not deemed to have an indefinite life are amortized over their estimated lives and assessed for impairment upon the
occurrence of certain triggering events in accordance with applicable accounting literature. Based on its assessment, the Company concluded that
other intangible assets were not impaired. The Company had no indefinite-lived intangible assets at March 31, 2026 and December 31, 2025.
Changes in the carrying amount of goodwill are as follows:
(In millions) 2026 2025
Balance at January 1, $ 24,337 $ 23,306
Goodwill acquired 26 33
Other adjustments (a) (90) 199
Balance at March 31, $ 24,273 $ 23,538
(a) Primarily reflects the impact of foreign exchange.
The goodwill from acquisitions in 2026 and 2025 consists largely of the synergies and economies of scale expected from combining the operations
of the Company and the acquired entities and the trained and assembled workforce acquired.
The goodwill acquired in 2026 included approximately $3 million in the Risk and Insurance Services segments which is deductible for tax purposes.
Goodwill allocated to the Company’s reportable segments at March 31, 2026 is $19.5 billion for Risk and Insurance Services and $4.7 billion for
Consulting.
The gross cost and accumulated amortization of other identified intangible assets at March 31, 2026 and December 31, 2025 are as follows:
March 31, 2026 December 31, 2025
(In millions)
Gross
Cost Accumulated
Amortization
Net
Carrying
Amount Gross
Cost Accumulated
Amortization
Net
Carrying
Amount
Client relationships $ 7,025 $ 2,483 $ 4,542 $ 7,091 $ 2,422 $ 4,669
Other (a) 460 395 65 476 399 77
Other intangible assets $ 7,485 $ 2,878 $ 4,607 $ 7,567 $ 2,821 $ 4,746
(a) Primarily reflects non-compete agreements, trade names and developed technology.
23
-- 23 of 156 --
Aggregate amortization expense for the three months ended March 31, 2026 and 2025, was $138 million and $139 million, respectively.
The estimated future aggregate amortization expense is as follows:
For the Years Ending December 31,
(In millions) Estimated Expense
2026 (excludes amortization through March 31, 2026) $ 411
2027 502
2028 477
2029 445
2030 447
Subsequent years 2,325
Total future amortization $ 4,607
10. Fair Value Measurements
Fair Value Hierarchy
The Company has categorized its assets and liabilities that are valued at fair value on a recurring basis into a three-level fair value hierarchy. The
fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets and liabilities (Level 1) and lowest priority to
unobservable inputs (Level 3). In some cases, the inputs used to measure fair value might fall into different levels of the fair value hierarchy. In such
cases, the level in the fair value hierarchy, for disclosure purposes, is determined based on the lowest level input that is significant to the fair value
measurement. Assets and liabilities recorded in the consolidated balance sheets at fair value are categorized based on the inputs in the valuation
techniques as follows:
Level 1. Assets and liabilities whose values are based on unadjusted quoted prices for identical assets or liabilities in an active market
(examples include active exchange-traded equity securities and exchange-traded money market mutual funds).
Assets and liabilities measured using Level 1 inputs include exchange-traded equity securities, exchange-traded mutual funds and money market
funds.
Level 2. Assets and liabilities whose values are based on the following:
a) quoted prices for similar assets or liabilities in active markets;
b) quoted prices for identical or similar assets or liabilities in non-active markets (examples include corporate and municipal
bonds, which trade infrequently);
c) pricing models whose inputs are observable for substantially the full term of the asset or liability (examples include most
over-the-counter derivatives, including interest rate and currency swaps); and
d) pricing models whose inputs are derived principally from or corroborated by observable market data through correlation or
other means for substantially the full asset or liability (for example, certain mortgage loans).
Level 3. Assets and liabilities whose values are based on prices or valuation techniques that require inputs that are both unobservable and
significant to the overall fair value measurement. These inputs reflect management’s own assumptions about the assumptions a
market participant would use in pricing the asset or liability.
Assets and liabilities measured using Level 3 inputs relate to assets and liabilities for contingent purchase consideration.
24
-- 24 of 156 --
Valuation Techniques
Equity Securities, Money Market Funds and Mutual Funds – Level 1
Investments for which market quotations are readily available are valued at the sale price on their principal exchange or, for certain markets, official
closing bid price. Money market funds are valued at a readily determinable price.
Contingent Purchase Consideration Assets and Liabilities – Level 3
Purchase consideration for some acquisitions and dispositions made by the Company includes contingent consideration arrangements. Contingent
consideration arrangements are based primarily on EBITDA or revenue targets over a period of 2 to 4 years. The fair value of the contingent
purchase consideration asset and liability is estimated as the present value of future cash flows to be paid, based on projections of revenue and
earnings and related targets of the acquired and disposed entities.
The following fair value hierarchy table presents information about the Company’s assets and liabilities measured at fair value on a recurring basis
at March 31, 2026 and December 31, 2025:
Identical Assets
(Level 1)
Observable Inputs
(Level 2)
Unobservable Inputs
(Level 3) Total
(In millions) 03/31/26 12/31/25 03/31/26 12/31/25 03/31/26 12/31/25 03/31/26 12/31/25
Assets:
Financial instruments owned:
Exchange traded equity securities (a) $ 13 $ 12 $ — $ — $ — $ — $ 13 $ 12
Mutual funds (a) 197 202 — — — — 197 202
Money market funds (b) 138 633 — — — — 138 633
Total assets measured at fair value $ 348 $ 847 $ — $ — $ — $ — $ 348 $ 847
Fiduciary Assets:
Money market funds $ 301 $ 322 $ — $ — $ — $ — $ 301 $ 322
Total fiduciary assets measured
at fair value $ 301 $ 322 $ — $ — $ — $ — $ 301 $ 322
Liabilities:
Contingent purchase consideration liabilities (c) $ — $ — $ — $ — $ 266 $ 268 $ 266 $ 268
Total liabilities measured at fair value $ — $ — $ — $ — $ 266 $ 268 $ 266 $ 268
(a) Included in other assets in the consolidated balance sheets.
(b) Included in cash and cash equivalents in the consolidated balance sheets.
(c) Included in accounts payable and accrued liabilities and other liabilities in the consolidated balance sheets.
For the three months ended March 31, 2026 and 2025, there were no assets or liabilities that were transferred between levels.
The following table sets forth a summary of the changes in fair value of the Company’s Level 3 liabilities for the three months ended March 31,
2026 and 2025:
Three Months Ended
March 31,
(In millions) 2026 2025
Balance at beginning of period $ 268 $ 161
Net additions 1 5
Payments (18) (19)
Revaluation impact 11 9
Other 4 4
Balance at end of period $ 266 $ 160
25
-- 25 of 156 --
Long-Term Investments
The Company has investments in certain private equity funds as well as in public and private companies that are accounted for using the equity
method of accounting. The carrying value of these investments was $324 million and $301 million at March 31, 2026 and December 31, 2025,
respectively.
Private Equity Investments
The Company's investments in private equity funds were $237 million and $220 million at March 31, 2026 and December 31, 2025, respectively.
The carrying values of these private equity investments approximate fair value. The underlying private equity funds follow investment company
accounting, where investments within the fund are carried at fair value. The Company records in earnings its proportionate share of the change in
fair value of the funds in the investment income line in the consolidated statements of income. These investments are included in other assets in
the consolidated balance sheets. The Company recorded net investment income of $4 million and $2 million for the three months ended March 31,
2026 and 2025, respectively.
At March 31, 2026, the Company has commitments of potential future investments of approximately $102 million in private equity funds that invest
primarily in financial services companies.
Investments in Public and Private Companies
The Company has investments in private insurance brokerage and consulting companies with a carrying value of $87 million and $81 million at
March 31, 2026 and December 31, 2025, respectively. These investments are accounted for using the equity method of accounting, the results of
which are included in revenue in the consolidated statements of income and the carrying value of which is included in other assets in the
consolidated balance sheets. The Company records its share of income or loss on its equity method investments, some of which are on a one
quarter lag basis.
Other Investments
The Company held certain equity investments with readily determinable market values at March 31, 2026 and December 31, 2025, of $26 million
and $24 million, respectively. For the three months ended March 31, 2026 and 2025, the Company recorded mark-to-market gains on these
investments of $2 million and $3 million, respectively.
The Company also held investments without readily determinable market values of $16 million and $17 million at March 31, 2026 and December
31, 2025, respectively.
In January 2025, the Company disposed an investment in a unit trust fund.
11. Derivatives
Net Investment Hedge
The Company has investments in various subsidiaries with Euro functional currencies. As a result, the Company is exposed to the risk of
fluctuations between the Euro and U.S. dollar exchange rates. As part of its risk management program, the Company designated its €1.1 billion
senior note debt instruments ("Euro notes") as a net investment hedge (the "hedge") of its Euro denominated subsidiaries. The hedge effectiveness
is re-assessed each quarter to confirm that the designated equity balance at the beginning of each period continues to equal or exceed 80% of the
outstanding balance of the Euro debt instrument and that all the critical terms of the hedging instrument and the hedged net investment continue to
match. If the hedge is highly effective, the change in the debt balance related to foreign exchange fluctuations is recorded in accumulated other
comprehensive loss in the consolidated balance sheets.
The U.S. dollar value of the Euro notes decreased by $29 million through March 31, 2026 related to the change in foreign exchange rates. The
Company concluded that the hedge was highly effective and recorded a decrease to accumulated other comprehensive loss for the three months
ended March 31, 2026.
26
-- 26 of 156 --
12. Leases
The Company leases office facilities under non-cancelable operating leases with terms generally ranging between 10 and 25 years. The Company
utilizes these leased office facilities for use by its employees in countries in which the Company conducts its business. The Company’s leases have
no restrictions on the payment of dividends, the acquisition of debt or additional lease obligations, or entering into additional lease obligations. The
leases also do not contain significant purchase options.
Operating leases are recognized on the consolidated balance sheets as ROU assets and operating lease liabilities based on the present value of
the remaining future minimum payments over the lease term at commencement date of the lease.
The Company determined that $3 million of ROU assets were impaired for the three months ended March 31, 2026 and recorded a charge to the
consolidated statements of income with an offsetting reduction to ROU assets.
The following table provides additional information about the Company’s property leases:
Three Months Ended
March 31,
(In millions, except weighted average data) 2026 2025
Lease Cost:
Operating lease cost (a) $ 90 $ 86
Short-term lease cost 1 2
Variable lease cost 34 32
Sublease income (6) (4)
Net lease cost $ 119 $ 116
Other information:
Operating cash outflows from operating leases $ 103 $ 98
ROU assets obtained in exchange for new operating lease liabilities $ 85 $ 30
Weighted average remaining lease term – real estate leases 7.3 years 7.4 years
Weighted average discount rate – real estate leases 3.82 % 3.71 %
(a) Excludes ROU asset impairment charges.
Future minimum lease payments for the Company’s operating leases at March 31, 2026 are as follows:
(In millions) Real Estate Leases
2026 (excludes payments through March 31, 2026) $ 293
2027 365
2028 290
2029 244
2030 209
2031 186
Subsequent years 519
Total future lease payments 2,106
Less: Imputed interest (257)
Total $ 1,849
Current lease liabilities $ 326
Long-term lease liabilities 1,523
Total lease liabilities $ 1,849
Note: The above table excludes obligations for leases with original terms of 12 months or less which have not been recognized as a ROU asset or liability in the
consolidated balance sheets.
At March 31, 2026, the Company had additional operating real estate leases that had not yet commenced of $45 million. These operating leases
will commence over the next 12 months.
27
-- 27 of 156 --
13. Retirement Benefits
The Company maintains qualified and non-qualified defined benefit pension plans for its U.S. and non-U.S. eligible employees. The Company’s
policy for funding its tax-qualified defined benefit retirement plans is to contribute amounts at least sufficient to meet the funding requirements set
forth by U.S. law and the laws of the non-U.S. jurisdictions in which the Company offers defined benefit plans.
The weighted average actuarial assumptions utilized to calculate the net periodic benefit cost or credit for the U.S. and significant non-U.S. defined
benefit plans are as follows:
Combined U.S. and significant non-U.S. Plans Pension Benefits
March 31, 2026 2025
Weighted average assumptions:
Discount rate 5.39 % 5.36 %
Expected return on plan assets 5.94 % 5.43 %
Rate of compensation increase* 3.12 % 3.16 %
(*) There are no rate of compensation increase assumptions for the primary U.S. defined benefit plans since future benefit accruals were discontinued for those
plans after December 31, 2016 and earned benefits are not subject to final salary level adjustments.
The target asset allocation for the U.S. plans at March 31, 2026 is 50% equities and equity alternatives and 50% fixed income. At March 31, 2026,
the actual allocation for the U.S. plan was 49% equities and equity alternatives and 51% fixed income. The target allocation for the U.K. plans at
March 31, 2026 is 7% equities and equity alternatives and 93% fixed income. At March 31, 2026, the actual allocation for the U.K. plans was 8%
equities and equity alternatives and 92% fixed income. The Company's U.K. plans comprised approximately 78% of non-U.S. plan assets at
December 31, 2025.
The assets of the Company's defined benefit plans are diversified and are managed in accordance with applicable laws and with the goal of
maximizing the plans' asset returns within acceptable risk parameters. Asset allocation is frequently monitored to ensure the actual portfolio
remains consistent with target asset allocation ranges. This includes the use of threshold-based portfolio re-balancing where appropriate.
The net benefit (credit) or cost of the Company's defined benefit plans is measured on an actuarial basis using various methods and assumptions.
The components of the net benefit (credit) or cost for the defined benefit plans is as follows:
Combined U.S. and significant non-U.S. Plans
For the Three Months Ended March 31, Pension Benefits
(In millions) 2026 2025
Service cost $ 6 $ 6
Interest cost 144 145
Expected return on plan assets (220) (204)
Recognized actuarial loss 23 10
Net periodic benefit credit $ (47) $ (43)
Settlement loss 2 5
Net benefit credit $ (45) $ (38)
28
-- 28 of 156 --
The following tables provide the amounts reported in the consolidated statements of income:
Combined U.S. and significant non-U.S. Plans
For the Three Months Ended March 31, Pension Benefits
(In millions) 2026 2025
Compensation and benefits expense $ 6 $ 6
Other net benefit credits (a) (51) (44)
Net benefit credit $ (45) $ (38)
(a) For both the three months ended March 31, 2026 and 2025, the Company recorded $1 million of net benefit cost related to the post-retirement plans.
The components of the net benefit credit for the U.S. defined benefit plans are as follows:
U.S. Plans only
For the Three Months Ended March 31, Pension Benefits
(In millions) 2026 2025
Interest cost 62 64
Expected return on plan assets (70) (73)
Recognized actuarial loss 9 6
Net benefit cost (credit) $ 1 $ (3)
The components of the net benefit credit for the non-U.S. defined benefit plans are as follows:
Significant non-U.S. Plans only
For the Three Months Ended March 31, Pension Benefits
(In millions) 2026 2025
Service cost $ 6 $ 6
Interest cost 82 81
Expected return on plan assets (150) (131)
Recognized actuarial loss 14 4
Net periodic benefit credit $ (48) $ (40)
Settlement loss 2 5
Net benefit credit $ (46) $ (35)
The Company made contributions to its U.S. and non-U.S. defined benefit pension plans for the three months ended March 31, 2026 of
approximately $15 million compared to contributions of $18 million for the corresponding period in the prior year. The Company expects to
contribute approximately $91 million to its U.S. and non-U.S. defined benefit pension plans during the remainder of 2026.
Defined Contribution Plans
The Company maintains defined contribution plans ("DC Plans") for its employees, the most significant being in the U.S. and the U.K. The cost of
the U.S. DC Plans were $56 million for each of the three months ended March 31, 2026 and 2025. The cost of the U.K. DC Plans was $69 million
and $56 million for the three months ended March 31, 2026 and 2025, respectively.
29
-- 29 of 156 --
14. Debt
The Company’s outstanding debt is as follows:
(In millions)
March 31,
2026 December 31, 2025
Short-term:
Commercial paper $ 1,049 $ —
Current portion of long-term debt 653 1,267
$ 1,702 $ 1,267
Long-term:
Senior notes – 1.349% due 2026 $ 633 $ 647
Senior notes – 3.750% due 2026 — 600
Senior notes – 4.550% due 2027 946 946
Senior notes – Floating due 2027 (a) 299 299
Senior notes – 4.375% due 2029 1,500 1,499
Senior notes – 1.979% due 2030 631 646
Senior notes – 2.250% due 2030 744 744
Senior notes – 4.650% due 2030 993 992
Senior notes – 2.375% due 2031 398 398
Senior notes – 4.850% due 2031 993 992
Senior notes – 5.750% due 2032 495 494
Senior notes – 5.875% due 2033 299 298
Senior notes – 5.400% due 2033 594 594
Senior notes – 5.150% due 2034 496 496
Senior notes – 5.000% due 2035 1,982 1,983
Senior notes – 4.950% due 2036 596 —
Senior notes – 4.750% due 2039 496 496
Senior notes – 5.350% due 2044 495 495
Senior notes – 4.350% due 2047 494 494
Senior notes – 4.200% due 2048 594 594
Senior notes – 4.900% due 2049 1,239 1,240
Senior notes – 2.900% due 2051 346 346
Senior notes – 6.250% due 2052 492 492
Senior notes – 5.450% due 2053 591 591
Senior notes – 5.700% due 2053 989 989
Senior notes – 5.450% due 2054 494 493
Senior notes – 5.400% due 2055 1,479 1,479
Mortgage – 5.701% due 2035 244 249
Other 1 1
19,553 19,587
Less: current portion 653 1,267
$ 18,900 $ 18,320
(a) For the Floating Notes, interest is calculated based on a compounded SOFR benchmark rate plus 0.700%.
The senior notes in the table above are registered by the Company with the Securities and Exchange Commission and are not guaranteed.
30
-- 30 of 156 --
The Company has a $3.5 billion short-term debt financing program through the issuance of commercial paper. The proceeds from the issuance of
commercial paper are used for general corporate purposes. The Company had $1.0 billion of commercial paper outstanding at March 31, 2026, at
an average effective interest rate of 4.06%. The Company did not have any commercial paper outstanding at December 31, 2025.
Credit Facilities
The Company has a $3.5 billion multi-currency unsecured five-year revolving credit facility (the "Credit Facility") expiring October 2028. Borrowings
under the Credit Facility bear interest at a rate per annum, equal, at the Company's option, either at (a) the Secured Overnight Financing Rate
("SOFR") benchmark rate for U.S. dollar borrowings, or (b) a currency specific benchmark rate, plus an applicable margin which varies with the
Company's credit ratings. The Company is required to maintain certain coverage and leverage ratios for the Credit Facility, which are evaluated
quarterly.
The Credit Facility includes provisions for determining a benchmark replacement rate in the event existing benchmark rates are no longer available,
or in certain other circumstances, in which an alternative rate may be required. At March 31, 2026 and December 31, 2025, the Company had no
borrowings under this facility.
The Company also maintains other credit and overdraft facilities with various financial institutions aggregating $121 million and $122 million at
March 31, 2026 and December 31, 2025, respectively. There were no outstanding borrowings under these facilities at March 31, 2026 and
December 31, 2025.
The Company also has outstanding guarantees and letters of credit with various banks aggregating $155 million and $150 million at March 31,
2026 and December 31, 2025, respectively.
Senior Notes
In March 2026, the Company repaid $600 million of 3.750% senior notes at maturity.
In February 2026, the Company issued $600 million of 4.950% senior notes due 2036. The Company used the net proceeds from these issuances
for general corporate purposes.
In March 2025, the Company repaid $500 million of 3.500% senior notes at maturity.
Fair Value of Short-term and Long-term Debt
The estimated fair value of the Company's short-term and long-term debt is provided below. Certain estimates and judgments were required to
develop the fair value amounts. The fair value amounts shown in the following table are not necessarily indicative of the amounts that the Company
would realize upon disposition, nor do they indicate the Company’s intent or need to dispose of the financial instrument.
March 31, 2026 December 31, 2025
(In millions)
Carrying
Amount
Fair
Value
Carrying
Amount
Fair
Value
Short-term debt $ 1,702 $ 1,698 $ 1,267 $ 1,261
Long-term debt $ 18,900 $ 18,229 $ 18,320 $ 18,093
The fair value of the Company's short-term debt consists primarily of term debt maturing within the next year and its fair value approximates its
carrying value. The estimated fair value of a primary portion of the Company's long-term debt is based on discounted future cash flows using
current interest rates available for debt with similar terms and remaining maturities. Short-term and long-term debt would be classified as Level 2 in
the fair value hierarchy.
31
-- 31 of 156 --
15. Restructuring Costs
The Company incurred a total of $45 million for restructuring costs for the three months ended March 31, 2026.
In the third quarter of 2025, the Company launched a three-year program, Thrive (the "Program"), which focuses on brand strategy, delivering
greater value to clients, accelerating growth and improving efficiency. Based on current Program estimates, the Company expects to incur
approximately $500 million of cost over the three years. Costs will primarily relate to severance, technology and outside services. The Company
expects charges incurred to be evenly distributed over the Program period.
The Company incurred $187 million of restructuring costs in connection with the Program through March 31, 2026, primarily severance, of which
$37 million were for the three months ended March 31, 2026. The Company continues to refine its detailed plans for the Program which may
change the timing and estimates of expected costs.
For the three months ended March 31, 2025, the Company incurred a total of $32 million for restructuring activities related primarily to severance
and lease exit charges.
The Company incurred restructuring costs as follows:
Three Months Ended
March 31,
(In millions) 2026 2025
Risk and Insurance Services $ 27 $ 23
Consulting 13 8
Corporate 5 1
Total $ 45 $ 32
Details of the restructuring activity from January 1, 2025 through March 31, 2026, are as follows:
(In millions) Severance Real Estate Related
Costs (a) Information
Technology
Consulting and
Other Outside
Services Total
Liability at January 1, 2025 $ 75 $ 42 $ — $ — $ 117
2025 charges 174 32 — 16 222
Cash payments (150) (39) — (16) (205)
Non-cash charges — (5) — — (5)
Liability at December 31, 2025 $ 99 $ 30 $ — $ — $ 129
2026 charges 32 5 — 8 45
Cash payments (68) (3) — (8) (79)
Non-cash charges — (1) — — (1)
Liability at March 31, 2026 $ 63 $ 31 $ — $ — $ 94
(a) Includes ROU and fixed asset impairments and other real estate related costs.
The expenses associated with these initiatives are included in compensation and benefits and other operating expenses in the consolidated
statements of income. The liabilities associated with these initiatives are classified on the consolidated balance sheets as accounts payable and
accrued liabilities, other liabilities or accrued compensation and employee benefits, depending on the nature of the items.
32
-- 32 of 156 --
16. Common Stock
The Company has a share repurchase program authorized by the Board of Directors.
In November 2025, the Board of Directors authorized the Company to repurchase up to $6 billion of the Company’s common stock, which
superseded any prior authorizations.
For the three months ended March 31, 2026, the Company repurchased 4.2 million shares of its common stock for $750 million. At March 31, 2026,
the Company remained authorized by the Board of Directors to repurchase up to approximately $4.9 billion in shares of its common stock. There is
no time limit on the authorization. For the three months ended March 31, 2025, the Company repurchased 1.3 million shares of its common stock
for $300 million.
The Company issued approximately 1.5 million and 2.6 million shares related to stock compensation and employee stock purchase plans for the
three months ended March 31, 2026 and 2025, respectively.
In February 2026, the Board of Directors of the Company declared a quarterly dividend of $0.900 per share on outstanding common stock, payable
in May 2026. In February 2026, the Company also paid the quarterly dividend declared in January 2026 by the Company's Board of Directors of
$0.900 per share on outstanding common stock.
17. Claims, Lawsuits and Other Contingencies
Nature of Contingencies
The Company and its subsidiaries are subject to a significant number of claims, lawsuits and proceedings in the course of our business. Such
claims and lawsuits consist principally of alleged errors and omissions in connection with the performance of professional services, including the
placement of insurance, the provision of actuarial services for corporate and public sector clients, the provision of investment advice and investment
management services to pension plans, the provision of advice relating to pension buy-out transactions and the provision of consulting services
relating to the drafting and interpretation of trust deeds and other documentation governing pension plans. These claims often seek damages,
including punitive and treble damages, in amounts that could be significant. In establishing liabilities for errors and omissions claims, the Company
utilizes case level reviews by inside and outside counsel, internal actuarial analysis by Marsh Management Consulting, a subsidiary of the
Company, and other methods to estimate potential losses. A liability is established when a loss is both probable and reasonably estimable. The
liability is reviewed quarterly and adjusted as developments warrant. In many cases, the Company has not recorded a liability, other than for legal
fees to defend the claim, because we are unable, at the present time, to make a determination that a loss is both probable and reasonably
estimable. To the extent that expected losses exceed our deductible in any policy year, the Company also records an asset for the amount that we
expect to recover under any available third-party insurance programs. The Company has varying levels of third-party insurance coverage, with
policy limits and coverage terms varying significantly by policy year.
Our activities are regulated under the laws of the U.S. and its various states, the U.K., the European Union (E.U.) and its member states, Australia
and the many other jurisdictions in which the Company operates.
The Company also receives subpoenas in the ordinary course of business, and from time to time requests for information in connection with
government investigations.
Current Matters
Risk and Insurance Services Segment
• In January 2019, the Company received a notice that the Administrative Council for Economic Defense anti-trust agency in Brazil had
commenced an administrative proceeding against a number of insurance brokers, including both Marsh and JLT, and insurers "to
investigate an alleged sharing of sensitive commercial and competitive confidential information" in the aviation insurance and reinsurance
sector.
• From 2014, Marsh Ltd. was engaged by Greensill Capital (UK) Limited and its affiliates as its insurance broker. Marsh Ltd. placed a number
of trade credit insurance policies for Greensill. On March 1, 2021, Greensill filed an action against certain of its trade credit insurers in
Australia seeking a mandatory injunction compelling these insurers to renew coverage under expiring policies. Later that day, the Australian
court denied Greensill’s application. Since then, a number of Greensill entities have filed for, or been subject to, insolvency proceedings,
and several litigations and investigations have been commenced in the U.K., Australia, Germany, Switzerland and the U.S., including
claims brought by
33
-- 33 of 156 --
Greensill's administrators and loss payees under Greensill's trade credit insurance policies. The applicants in the omnibus trade credit
insurance policy litigation among Greensill and its insurers and loss payees in Australia (the "Australian proceedings") have collectively
claimed losses totaling approximately $5 billion plus interest and costs.
In June 2023, White Oak, a loss payee, filed a claim in the High Court of Justice in London against Marsh Ltd., related to White Oak’s
purchase of accounts receivable from Greensill. In May 2025, Marsh Ltd. reached a settlement with White Oak to resolve the matter in the
U.K. The settlement was recoverable through the Company's E&O insurance and did not have an impact on the consolidated statements of
income for the three months ended March 31, 2026.
In November 2023, two Credit Suisse funds ("Credit Suisse"), bringing claims as loss payees, added Marsh Ltd. as a party to the Australian
proceedings. The claims by Credit Suisse allege that Marsh Ltd. failed to take required steps to ensure representations made to them in
their capacity as loss payees were complete and accurate, and that Marsh Ltd. made misleading statements and omissions.
In November 2024, Greensill Bank AG (in insolvency), an affiliate of Greensill and an insured entity under the policies, added Marsh Pty Ltd
as a party to the Australian proceedings. Greensill Bank subsequently joined Marsh Ltd. to the Australian proceedings in March 2025.
Greensill Bank alleges that Marsh Ltd. and Marsh Pty Ltd. did not arrange suitable insurance cover and made misrepresentations regarding
trade credit insurance placed for Greensill Bank.
The claims in the Australian proceedings are being pursued against a number of parties in addition to Marsh, and the parties are also
pursuing (or are expected to pursue) various cross-claims.
In March 2026, the parties participated in an initial court-sponsored mediation for the omnibus litigation in Australia. Following the
mediation, in the first quarter of 2026, the Company recorded a gross liability of $425 million in connection with the Australian proceedings,
which reflects management’s current best estimate of the costs and loss associated with these matters based on the information available
at the time. The legal charges and fees recorded for these matters are included in other operating expenses in the consolidated statements
of income, with the associated liabilities classified on the consolidated balance sheets in accounts payable and accrued liabilities.
Due to ongoing negotiations among the parties coming out of the mediation and the complexity of the proceedings, including the number of
claims and parties involved, there can be no assurance that the Company’s current estimate will prove to be accurate. The actual outcome
may differ materially from the Company’s current estimate. The Company may record additional charges in future periods as discussions
progress and the facts and circumstances develop. To the extent the Company incurs losses in excess of amounts accrued, such amounts
would be recorded in the period in which they are determined to be probable and reasonably estimable.
Trial is currently scheduled for September 2026.
Other Contingencies-Guarantees
In connection with its acquisition of U.K.-based Sedgwick Group in 1998, the Company acquired several insurance underwriting businesses that
were already in run-off, including River Thames Insurance Company Limited ("River Thames"), which the Company sold in 2001. Sedgwick
guaranteed payment of claims on certain policies underwritten through the Institute of London Underwriters (the "ILU") by River Thames. The
policies covered by this guarantee are partly reinsured by a related party of River Thames. Payment of claims under the reinsurance agreement is
collateralized by funds withheld by River Thames from the reinsurer. To the extent River Thames or the reinsurer is unable to meet its obligations
under those policies, a claimant may seek to recover from the Company under the guarantee.
From 1980 to 1983, the Company owned indirectly the English & American Insurance Company ("E&A"), which was a member of the ILU. The ILU
required the Company to guarantee a portion of E&A's obligations. After E&A became insolvent in 1993, the ILU agreed to discharge the guarantee
in exchange for the Company's agreement to post an evergreen letter of credit that is available to pay claims by policyholders on certain E&A
policies issued through the ILU and incepting between July 3, 1980 and October 6, 1983. Certain claims have been paid under the letter of credit
and the Company anticipates that additional claimants may seek to recover against the letter of credit.
* * * * *
34
-- 34 of 156 --
The pending proceedings described above and other matters not explicitly described in this Note 17 on Claims, Lawsuits and Other Contingencies
may expose the Company or its subsidiaries to liability for significant monetary damages, fines, penalties or other forms of relief. Where a loss is
both probable and reasonably estimable, the Company establishes liabilities in accordance with the Financial Accounting Standards Board
("FASB") guidance on Contingencies - Loss Contingencies.
The Company is not able at this time to provide a reasonable estimate of the range of possible loss attributable to these matters or the impact they
may have on the Company's consolidated results of operations, financial position or cash flows. This is primarily because these matters are still
developing and involve complex issues subject to inherent uncertainty. Adverse determinations in one or more of these matters could have a
material impact on the Company's consolidated results of operations, financial condition or cash flows in a future period.
18. Segment Information
The Company is organized based on the types of services provided. Under this structure, the Company’s operating segments are: Marsh Risk, Guy
Carpenter, Mercer and Marsh Management Consulting. The four segments are aggregated into two operating and reporting segments as follows:
• Risk and Insurance Services, comprising Marsh Risk (insurance services) and Guy Carpenter (reinsurance services); and
• Consulting, comprising Mercer and Marsh Management Consulting.
The accounting policies of the segments are the same as those used for the consolidated financial statements described in Note 1, Summary of
Significant Accounting Policies, in the Company's 2025 Form 10-K. Revenues are attributed to geographic areas based on the location out of which
the services are performed.
The Chief Executive Officer, as the Company's Chief Operating Decision Maker ("CODM"), evaluates segment performance and allocates
resources based on segment operating income, which includes directly related expenses and charges or credits related to restructuring but not the
Company's corporate level expenses. Segment operating income is also used to monitor budget versus actual results.
Selected information about the Company’s segments is as follows:
Three Months Ended March 31,
(In millions) Revenue
Compensation and
benefits
Depreciation
and
amortization
expense
Identified
intangible
amortization
expense
Other
segment
items
Operating
Income
(Loss)
2026 –
Risk and Insurance Services $ 5,051 (a) $ 2,606 $ 50 $ 119 $ 965 $ 1,311
Consulting 2,558 (b) 1,475 25 19 514 525
Total Segments 7,609 4,081 75 138 1,479 1,836
Corporate/Eliminations (12) 49 14 — 7 (82)
Total Consolidated $ 7,597 $ 4,130 $ 89 $ 138 $ 1,486 $ 1,754
2025 –
Risk and Insurance Services $ 4,762 (a) $ 2,451 $ 50 $ 120 $ 528 $ 1,613
Consulting 2,314 (b) 1,363 24 19 452 456
Total Segments 7,076 3,814 74 139 980 2,069
Corporate/Eliminations (15) 36 14 — (1) (64)
Total Consolidated $ 7,061 $ 3,850 $ 88 $ 139 $ 979 $ 2,005
(a) Includes interest income on fiduciary funds of $85 million and $103 million in 2026 and 2025, respectively, and equity method income of $8 million in 2026.
Revenue in 2025 also includes $28 million from a gain on the sale of the TCAS business and a gain on the remeasurement of a previously held equity method
investment to fair value upon consolidation.
(b) Includes inter-segment revenue of $12 million and $15 million in 2026 and 2025, respectively.
35
-- 35 of 156 --
Other Risk and Insurance Services and Consulting segment items consist primarily of costs such as travel and entertainment, outside services,
information and technology, facilities and equipment, and taxes and insurance. In the first quarter of 2026, Risk and Insurance Services also
includes the recording of an estimated liability and legal expenses of $425 million related to the Greensill litigation. Additional information on this
matter is included in Note 17, Claims, Lawsuits and Other Contingencies.
The reconciliation of total consolidated operating income (loss) to income before income taxes is provided on the consolidated statements of
income.
The Company does not report its assets by segment, including capital expenditures, as that information is not used by the CODM in assessing
segment performance and allocating resources.
Details of operating segment revenue are as follows:
Three Months Ended
March 31,
(In millions) 2026 2025
Risk and Insurance Services
Marsh Risk $ 3,782 $ 3,520
Guy Carpenter 1,269 1,242
Total Risk and Insurance Services 5,051 4,762
Consulting
Mercer 1,661 1,496
Marsh Management Consulting 897 818
Total Consulting 2,558 2,314
Total Segments 7,609 7,076
Corporate Eliminations (12) (15)
Total $ 7,597 $ 7,061
36
-- 36 of 156 --
19. New Accounting Pronouncements
Recently Issued Accounting Pronouncements Not Yet Adopted:
In December 2025, the FASB issued an accounting standard update to improve the guidance for interim reporting, by improving the navigability of
the required interim disclosures and clarifying when that guidance is applicable. The update also provides additional guidance on what disclosures
should be provided in interim reporting periods. The new guidance adds a principle that requires entities to disclose events since the end of the last
annual reporting period that have a material impact on the entity. The new guidance is effective for interim reporting periods within annual reporting
periods beginning after December 15, 2027. Early adoption is permitted. The update can either be applied prospectively or retrospectively to any or
all prior periods presented in the financial statements. The Company is currently evaluating the guidance and its impact on results of operations,
cash flows, or financial condition.
In September 2025, the FASB issued an accounting standard update which amends certain aspects of the accounting for and disclosure for
internal-use software costs. The new guidance removes references to software development project stages so that it is neutral to different software
development methods, including methods that entities may use to develop software in the future. The new guidance requires an entity to capitalize
software costs when: (1) Management has authorized and committed to funding the software project and (2) It is probable that the project will be
completed and the software will be used to perform the function intended (referred to as the "probable-to-complete recognition threshold"). In
evaluating the probable-to-complete recognition threshold, an entity is required to consider whether there is significant uncertainty associated with
the development activities of the software. The new guidance is effective for annual reporting periods beginning after December 15, 2027, and
interim reporting periods within those annual reporting periods. Early adoption is permitted as of the beginning of an annual reporting period. The
Company is currently evaluating the guidance and its impact on results of operations, cash flows, or financial condition.
In November 2024, the FASB issued an accounting standard update on the disaggregated disclosure of income statement expenses. The new
guidance requires disclosures about specific types of expenses included in the expense captions presented on the face of the income statement, as
well as disclosures about selling expenses. The new standard does not change the requirements for the presentation of expenses on the face of
the income statement. The standard is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years
beginning after December 15, 2027. Early adoption is permitted. The new guidance will be applied prospectively with the option for retrospective
application. The Company is currently evaluating the guidance and expects it to only impact disclosures with no impact to results of operations,
cash flows, or financial condition.
New Accounting Pronouncement Adopted Effective December 31, 2025:
In December 2023, the FASB issued an accounting standard update on income tax disclosures, primarily related to the rate reconciliation and
income taxes paid information. The new guidance requires public business entities, on an annual basis, disclose specific categories in the rate
reconciliation and provide additional information for reconciling items that meet a quantitative threshold. In addition, all entities are required to
disclose on an annual basis the amount of income taxes paid, net of refunds received, disaggregated by federal, state and foreign taxes, and by
individual jurisdictions if the amount is equal to or greater than 5% of total income taxes paid, net of refunds received. The guidance is effective for
annual periods beginning after December 15, 2024. Early adoption was permitted. An entity should apply the amendments in the standard
prospectively, even though retrospective application is permitted. The Company adopted the new standard effective December 31, 2025, on a
prospective basis, which impacted disclosures only, with no impact to results of operations, cash flows, or financial condition.
37
-- 37 of 156 --
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
References in this report are to Marsh & McLennan Companies, Inc. and its consolidated subsidiaries (the "Company" or "Marsh"), unless the
context otherwise requires. Effective January 14, 2026, the Company updated its brand name from Marsh McLennan to Marsh and the brand
names of Marsh and Oliver Wyman Group businesses to Marsh Risk and Marsh Management Consulting, respectively. References to the
Company and its businesses in this report reflect these changes. Mercer and Guy Carpenter will continue to report under their current brands
through a transition period.
The changes to the brand names had no impact on the Company's operating and reporting segments.
General
Marsh is a global professional services firm in the areas of risk, reinsurance and capital, people and investments, and management consulting,
advising clients in 130 countries. With an annual revenue of $27.0 billion and more than 95,000 colleagues, Marsh helps build the confidence to
thrive through the power of perspective.
The Company conducts business through two segments:
• Risk and Insurance Services: risk management activities and insurance/reinsurance broking and services, conducted through Marsh Risk
and Guy Carpenter.
• Consulting: health, wealth and career advice, solutions and products, and specialized management, strategic, economic and brand
consulting services conducted through Mercer and Marsh Management Consulting.
The results of operations in the Management Discussion & Analysis ("MD&A") include an overview of the Company's consolidated results for the
three months ended March 31, 2026, compared to the corresponding period in 2025, and should be read in conjunction with the consolidated
financial statements and notes. This section also includes a discussion of the key drivers impacting the Company's financial results of operations
both on a consolidated basis and by reportable segments.
We describe the primary sources of revenue and categories of expense for each reportable segment in the discussion of segment financial results.
A reconciliation of segment operating income to total operating income is included in Note 18, Segment Information, in the notes to the consolidated
financial statements included in Part I, Item 1, of this report.
For information and comparability of the Company's results of operations and liquidity and capital resources for the three months ended March 31,
2025, refer to "Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations" of the Company's Form 10-Q for
the quarter ended March 31, 2025.
This MD&A contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995. Refer to "Information
Concerning Forward-Looking Statements" at the outset of this report.
Non-GAAP measures
The Company reports its financial results in accordance with accounting principles generally accepted in the United States (U.S.), referred to as in
accordance with "GAAP" or "reported" results. The Company also refers to and presents a non-GAAP financial measure in non-GAAP revenue,
within the meaning of Regulation G and Item 10(e) of Regulation S-K in accordance with the Securities Exchange Act of 1934. The Company has
included a reconciliation of this non-GAAP financial measure to the most directly comparable financial measure calculated in accordance with
GAAP as part of the consolidated revenue and expense discussion. Percentage changes, referred to as non-GAAP underlying revenue, are
calculated by dividing the period over period change in non-GAAP revenue by the prior period non-GAAP revenue.
The Company believes this non-GAAP financial measure provides useful supplemental information that enables investors to better compare the
Company’s performance across periods. Management also uses this measure internally to assess the operating performance of its businesses and
to decide how to allocate resources. However, investors should not consider this non-GAAP measure in isolation from, or as a substitute for, the
financial information that the Company reports in accordance with GAAP. The Company's non-GAAP measure includes adjustments that reflect
how management views its businesses and may differ from similarly titled non-GAAP measures presented by other companies.
38
-- 38 of 156 --
Financial Highlights
• Consolidated revenue for the three months ended March 31, 2026 was $7.6 billion, an increase of 8%, or 4% on an underlying basis.
• Consolidated operating income for the three months ended March 31, 2026 was $1.8 billion, a decrease of 12%, compared to the
corresponding period in the prior year. Net income attributable to the Company was $1.1 billion. Earnings per share on a diluted basis was
$2.36, a decrease of 15%, compared to the corresponding period in the prior year.
• Risk and Insurance Services revenue for the three months ended March 31, 2026 was $5.1 billion, an increase of 6%, or 3% on an
underlying basis. Operating income was $1.3 billion, compared with $1.6 billion for the corresponding period in the prior year.
• Marsh Risk's revenue for the three months ended March 31, 2026 was $3.7 billion, an increase of 8%, or 4% on an underlying basis. Guy
Carpenter's revenue for the three months ended March 31, 2026 was $1.2 billion, an increase of 3%, or 2% on an underlying basis.
• Consulting revenue for the three months ended March 31, 2026 was $2.6 billion, an increase of 11%, or 5% on an underlying basis.
Operating income was $525 million, compared with $456 million for the corresponding period in the prior year.
• Mercer's revenue for the three months ended March 31, 2026 was $1.7 billion, an increase of 11%, or 5% on an underlying basis. Marsh
Management Consulting's revenue for the three months ended March 31, 2026 was $897 million, an increase of 10%, or 6% on an
underlying basis.
• In the first quarter of 2026, the Company recorded an estimated liability and legal expenses of $425 million related to the Greensill litigation.
Additional information on this matter is included in Note 17, Claims, Lawsuits and Other Contingencies, in the notes to the consolidated
financial statements.
• The Company's results of operations for the three months ended March 31, 2026 included restructuring costs of $45 million related
primarily to severance, lease exit charges, and consulting and outside services.
• The Company completed 2 acquisitions in the first quarter of 2026 for a total purchase consideration of $45 million.
• The Company's effective tax rate for the three months ended March 31, 2026 was 25.0%.
• For the three months ended March 31, 2026, the Company repurchased 4.2 million shares for $750 million.
• In March 2026, the Company repaid $600 million of 3.750% senior notes at maturity.
• In February 2026, the Company issued $600 million of 4.950% senior notes due 2036.
• In February 2026, the Board of Directors of the Company declared a quarterly dividend of $0.900 per share on outstanding common stock,
payable in May 2026.
* * * * *
The macroeconomic and geopolitical environment including from the conflict in the Middle East and other wars and global conflicts, social unrest,
tariffs or changes in trade policies, slower GDP growth or recession, fluctuations in foreign exchange rates, lower interest rates, capital markets
volatility, inflation and changes in insurance premium rates could impact our business, financial condition, results of operations and cash flows. For
more information about these risks, please see "Part I, Item 1A. Risk Factors" in our annual Report on Form 10-K for the year ended December 31,
2025.
For additional details, refer to the Consolidated Results of Operations and Liquidity and Capital Resources sections in this MD&A.
Acquisitions and dispositions impacting the Risk and Insurance Services and Consulting segments are discussed in Note 8, Acquisitions and
Dispositions, in the notes to the consolidated financial statements.
39
-- 39 of 156 --
Consolidated Results of Operations
Three Months Ended
March 31,
(In millions, except per share data) 2026 2025
Revenue $ 7,597 $ 7,061
Expense:
Compensation and benefits 4,130 3,850
Other operating expenses 1,713 1,206
Operating expenses 5,843 5,056
Operating income $ 1,754 $ 2,005
Income before income taxes $ 1,581 $ 1,827
Net income before non-controlling interests $ 1,186 $ 1,412
Net income attributable to the Company $ 1,146 $ 1,381
Net income per share attributable to the Company:
– Basic $ 2.37 $ 2.81
– Diluted $ 2.36 $ 2.79
Average number of shares outstanding:
– Basic 484 492
– Diluted 486 495
Shares outstanding at March 31, 482 493
Consolidated operating income decreased $251 million, or 12% to $1.8 billion for the three months ended March 31, 2026, compared to $2.0 billion
for the corresponding period in the prior year, reflecting an 8% increase in revenue and a 16% increase in expenses. Revenue growth was driven
by increases in the Risk and Insurance Services and Consulting segments of 6% and 11%, respectively. The increase in expenses was driven
primarily by the recording of an estimated liability and legal expenses of $425 million related to the Greensill litigation.
For the three months ended March 31, 2026, foreign exchange movements associated with the weakening of the U.S. dollar, increased
consolidated revenue, expenses and operating income by approximately 3%.
Diluted earnings per share decreased to $2.36 from $2.79, or 15% from the prior year, reflecting a decrease in operating income.
40
-- 40 of 156 --
Consolidated Revenue and Expense
Revenue – Non-GAAP Revenue and Components of Change
The Company advises clients in 130 countries. As a result, foreign exchange rate movements may impact period over period comparisons of
revenue. Similarly, certain other items such as acquisitions and dispositions, including transfers among businesses, may impact period over period
comparisons of revenue. Non-GAAP revenue measures the change in revenue from one period to the next by isolating these impacts on an
underlying revenue basis. Percentage changes, referred to as non-GAAP underlying revenue, are calculated by dividing the period over period
change in non-GAAP revenue by the prior period non-GAAP revenue.
The non-GAAP revenue measure is presented on a constant currency basis excluding the impact of foreign currency fluctuations. The Company
isolates the impact of foreign exchange rate movements period over period, by translating the current period foreign currency GAAP revenue into
U.S. Dollars based on the difference in the current and corresponding prior period exchange rates.
The percentage change for acquisitions, dispositions, and other includes the impact of current and prior year items excluded from the calculation of
non-GAAP underlying revenue for comparability purposes. Details on these items are provided in the reconciliation of non-GAAP revenue to GAAP
revenue tables.
The following tables present the Company's non-GAAP revenue for the three months ended March 31, 2026 and 2025, and the related non-GAAP
underlying revenue change:
Three Months Ended March 31,
(In millions, except percentages)
GAAP Revenue % Change
GAAP Revenue*
Non-GAAP Revenue Non-GAAP
Underlying
Revenue* 2026 2025 2026 2025
Risk and Insurance Services
Marsh Risk $ 3,726 $ 3,453 8 % $ 3,582 $ 3,435 4 %
Guy Carpenter 1,240 1,206 3 % 1,214 1,194 2 %
Subtotal 4,966 4,659 7 % 4,796 4,629 4 %
Fiduciary interest income 85 103 84 103
Total Risk and Insurance Services 5,051 4,762 6 % 4,880 4,732 3 %
Consulting
Mercer 1,661 1,496 11 % 1,562 1,494 5 %
Marsh Management Consulting 897 818 10 % 870 818 6 %
Total Consulting 2,558 2,314 11 % 2,432 2,312 5 %
Corporate Eliminations (12) (15) (12) (15)
Total Revenue $ 7,597 $ 7,061 8 % $ 7,300 $ 7,029 4 %
The following table provides more detailed revenue information for certain of the components presented in the previous table:
Three Months Ended March 31,
(In millions, except percentages)
GAAP Revenue % Change
GAAP Revenue*
Non-GAAP Revenue Non-GAAP
Underlying
Revenue* 2026 2025 2026 2025
Marsh Risk:
EMEA $ 1,208 $ 1,059 14 % $ 1,117 $ 1,057 6 %
Asia Pacific 369 335 10 % 352 334 5 %
Latin America 136 124 10 % 127 124 2 %
Total International 1,713 1,518 13 % 1,596 1,515 5 %
U.S./Canada 2,013 1,935 4 % 1,986 1,920 3 %
Total Marsh Risk $ 3,726 $ 3,453 8 % $ 3,582 $ 3,435 4 %
Mercer:
Wealth $ 752 $ 670 12 % $ 702 $ 666 5 %
Health 661 608 9 % 639 603 6 %
Career 248 218 13 % 221 225 (2)%
Total Mercer $ 1,661 $ 1,496 11 % $ 1,562 $ 1,494 5 %
(*) Rounded to whole percentages.
41
-- 41 of 156 --
Revenue – Reconciliation of Non-GAAP Measures
The following tables provide the reconciliation of GAAP revenue to Non-GAAP revenue for the three months ended March 31, 2026 and 2025:
2026 2025
Three Months Ended March 31,
(In millions)
GAAP
Revenue
Currency
Impact
Acquisitions/
Dispositions/
Other Impact
Non-GAAP
Revenue
GAAP
Revenue
Acquisitions/
Dispositions/
Other Impact
Non-GAAP
Revenue
Risk and Insurance Services
Marsh Risk $ 3,726 $ (108) $ (36) $ 3,582 $ 3,453 $ (18) $ 3,435
Guy Carpenter 1,240 (26) — 1,214 1,206 (12) 1,194
Subtotal 4,966 (134) (36) 4,796 4,659 (30) 4,629
Fiduciary interest income 85 (1) — 84 103 — 103
Total Risk and Insurance Services 5,051 (135) (36) 4,880 4,762 (30) 4,732
Consulting
Mercer 1,661 (68) (31) 1,562 1,496 (2) 1,494
Marsh Management Consulting 897 (26) (1) 870 818 — 818
Total Consulting 2,558 (94) (32) 2,432 2,314 (2) 2,312
Corporate Eliminations (12) — — (12) (15) — (15)
Total Revenue $ 7,597 $ (229) $ (68) $ 7,300 $ 7,061 $ (32) $ 7,029
The following table provides more detailed revenue information for certain of the components presented in the previous table:
2026 2025
Three Months Ended March 31,
(In millions) GAAP
Revenue Currency
Impact
Acquisitions/
Dispositions/
Other Impact Non-GAAP
Revenue GAAP
Revenue
Acquisitions/
Dispositions/
Other Impact Non-GAAP
Revenue
Marsh Risk:
EMEA $ 1,208 $ (82) $ (9) $ 1,117 $ 1,059 $ (2) $ 1,057
Asia Pacific 369 (13) (4) 352 335 (1) 334
Latin America 136 (9) — 127 124 — 124
Total International 1,713 (104) (13) 1,596 1,518 (3) 1,515
U.S./Canada 2,013 (4) (23) 1,986 1,935 (15) 1,920
Total Marsh Risk $ 3,726 $ (108) $ (36) $ 3,582 $ 3,453 $ (18) $ 3,435
Mercer:
Wealth $ 752 $ (38) $ (12) $ 702 $ 670 $ (4) $ 666
Health 661 (20) (2) 639 608 (5) 603
Career 248 (10) (17) 221 218 7 225
Total Mercer $ 1,661 $ (68) $ (31) $ 1,562 $ 1,496 $ (2) $ 1,494
Note: Amounts in the tables above are rounded to whole numbers.
42
-- 42 of 156 --
Consolidated Revenue
Consolidated revenue increased $536 million, or 8%, to $7.6 billion for the three months ended March 31, 2026, compared to $7.1 billion for the
three months ended March 31, 2025. Consolidated revenue increased 4% on an underlying basis, 3% from the impact of foreign currency
translation, and 1% from acquisitions. On an underlying basis, revenue increased 3% and 5% for the three months ended March 31, 2026, in the
Risk and Insurance Services and Consulting segments, respectively.
Consolidated revenue growth for the three months ended March 31, 2026 reflects the continued demand for our advice and solutions.
Consolidated Operating Expenses
Consolidated operating expenses increased $787 million, or 16%, to $5.8 billion for the three months ended March 31, 2026, compared to $5.1
billion for the three months ended March 31, 2025. Expenses also reflect a 3% increase from the impact of foreign currency translation and 1%
from acquisitions.
Consolidated operating expenses for the three months ended March 31, 2026 reflect the recording of an estimated liability and legal expenses of
$425 million related to the Greensill litigation. Consolidated operating expenses also reflect increased compensation and benefits, driven by higher
base salaries and incentive compensation.
Restructuring Activities
The Company incurred a total of $45 million for restructuring costs for the three months ended March 31, 2026.
In the third quarter of 2025, the Company launched a three-year program, Thrive (the "Program"), which focuses on brand strategy, delivering
greater value to clients, accelerating growth and improving efficiency. The Company also announced the formation of Business Client Services
("BCS"), to accelerate innovation and centralize investments in operational excellence, data, artificial intelligence and other analytics. BCS brings
together operations and technology teams across the Company to improve client service through enhancing our technology and effective
deployment of resources.
The Program will generate savings from process and automation efficiencies and optimization of our global operating model.
Based on current Program estimates, the Company expects to incur approximately $500 million of cost over the three years. Costs will primarily
relate to severance, technology and outside services. Total annualized savings are expected to be approximately $400 million. The Company
expects savings realized and charges incurred to be evenly distributed over the Program period.
The Company incurred $187 million of restructuring costs in connection with the Program through March 31, 2026, primarily severance, of which
$37 million were incurred for the three months ended March 31, 2026.
The Company continues to refine its detailed plans for the Program which may change the timing, expected costs, and related savings.
For the three months ended March 31, 2025, the Company incurred a total of $32 million for restructuring activities related primarily to severance
and lease exit charges.
Additional details are included in Note 14, Restructuring Costs, in the notes to the consolidated financial statements.
43
-- 43 of 156 --
Risk and Insurance Services
The Company conducts business in its Risk and Insurance Services segment through Marsh Risk and Guy Carpenter. Marsh Risk is an insurance
broker and risk advisor, offering risk management, insurance broking, insurance program management, risk consulting, analytical modeling and
alternative risk financing services to a wide range of businesses, government entities, professional service organizations and individuals in over 130
countries. Guy Carpenter, the Company's reinsurance intermediary and advisor, provides specialized reinsurance broking, strategic advisory and
actuarial services, and analytics solutions.
The results of operations for the Risk and Insurance Services segment are as follows:
Three Months Ended
March 31,
(In millions, except percentages) 2026 2025
Revenue $ 5,051 $ 4,762
Compensation and benefits 2,606 2,451
Other operating expenses 1,134 698
Operating expenses 3,740 3,149
Operating income $ 1,311 $ 1,613
Operating income margin 26.0% 33.9%
Revenue
Revenue in the Risk and Insurance Services segment increased $289 million, or 6%, to $5.1 billion for the three months ended March 31, 2026,
compared to $4.8 billion for the three months ended March 31, 2025. Revenue increased 3% on both an underlying basis and from the impact of
foreign currency translation.
Interest earned on fiduciary funds decreased $18 million to $85 million for the three months ended March 31, 2026, compared to $103 million for
the three months ended March 31, 2025, due to lower average interest rates compared to the corresponding period in the prior year.
In Risk and Insurance Services, underlying revenue growth for the three months ended March 31, 2026 was driven by higher new business and
renewal revenue at Marsh Risk, partially offset by declining insurance premium rates.
Marsh Risk's revenue increased $273 million, or 8%, to $3.7 billion for the three months ended March 31, 2026, compared to $3.5 billion for the
three months ended March 31, 2025. This reflects an increase of 4% on an underlying basis, 3% from the impact of foreign currency translation and
1% from acquisitions. U.S./Canada rose 3% on an underlying basis. Total International produced underlying revenue growth of 5%, reflecting
growth of 6% in EMEA, 5% in Asia Pacific and 2% in Latin America.
Guy Carpenter's revenue increased $34 million, or 3%, to $1.2 billion for the three months ended March 31, 2026, compared to the corresponding
period in the prior year. This reflects an increase of 2% on both an underlying basis and from the impact of foreign currency translation, partially
offset by a decrease of 1% from acquisitions.
Guy Carpenter’s underlying revenue growth for the three months ended March 31, 2026 was driven by new business growth across most regions
and global specialties, partially offset by declining reinsurance premium rates.
The Risk and Insurance Services segment completed one acquisition for the three months ended March 31, 2026. Information regarding these
acquisitions is included in Note 8, Acquisitions and Dispositions, in the notes to the consolidated financial statements.
Operating Expenses
Expenses in the Risk and Insurances Services segment increased $591 million, or 19%, to $3.7 billion for the three months ended March 31, 2026,
compared to $3.1 billion for the three months ended March 31, 2025. Expenses reflect an increase of 3% from the impact of foreign currency
translation and 1% from acquisitions.
Expenses for the three months ended March 31, 2026 reflect the recording of an estimated liability and legal expenses of $425 million related to the
Greensill litigation. Expenses also reflect increased compensation and benefits, driven by higher base salaries and incentive compensation.
44
-- 44 of 156 --
Consulting
The Company conducts business in its Consulting segment through Mercer and Marsh Management Consulting. Mercer is a provider in delivering
advice, solutions and products that help organizations meet the health, wealth and career needs of a changing workforce. Marsh Management
Consulting offers management consulting and advisory services across various industries.
The results of operations for the Consulting segment are as follows:
Three Months Ended
March 31,
(In millions, except percentages) 2026 2025
Revenue $ 2,558 $ 2,314
Compensation and benefits 1,475 1,363
Other operating expenses 558 495
Operating expenses 2,033 1,858
Operating income $ 525 $ 456
Operating income margin 20.5% 19.7%
Revenue
Consulting revenue increased $244 million, or 11%, to $2.6 billion for the three months ended March 31, 2026, compared to $2.3 billion for the
three months ended March 31, 2025. This reflects an increase of 5% on an underlying basis, 4% from the impact of foreign currency translation,
and 1% from acquisitions.
In Consulting, underlying revenue growth for the three months ended March 31, 2026 was driven by growth in both Mercer and Marsh Management
Consulting.
Mercer's revenue increased $165 million, or 11%, to $1.7 billion for the three months ended March 31, 2026, compared to $1.5 billion for the three
months ended March 31, 2025. This reflects an increase of 5% on an underlying basis, 5% from the impact of foreign currency translation, and 2%
from acquisitions.
On an underlying basis, revenue for Health and Wealth increased 6% and 5%, respectively, and decreased 2% in Career, as compared to the
corresponding period in the prior year.
Underlying revenue growth at Mercer was driven by solid growth in Health and Wealth, offset by a contraction in Career. Health reflected growth
across all regions. Wealth growth was driven by investment management, primarily reflecting positive net flows and the impact of capital markets.
Career reflected a decline in project-related work in the U.S. and Canada.
Marsh Management Consulting's revenue increased $79 million, or 10%, to $897 million for the three months ended March 31, 2026, compared to
$818 million for the three months ended March 31, 2025. This reflects an increase of 6% on an underlying basis and 3% from the impact of foreign
currency translation.
The increase in underlying revenue growth at Marsh Management Consulting for the three months ended March 31, 2026 was driven by growth in
most regions.
The Consulting segment completed one acquisition for the three months ended March 31, 2026. Information regarding these acquisitions is
included in Note 8, Acquisitions and Dispositions, in the notes to the consolidated financial statements.
Operating Expenses
Expenses in the Consulting segment increased $175 million, or 9%, to $2.0 billion for the three months ended March 31, 2026, compared to $1.9
billion for the three months ended March 31, 2025. Expenses reflect an increase of 4% from the impact of foreign currency translation and 1% from
acquisitions.
Expenses for the three months ended March 31, 2026 reflect increased compensation and benefits, driven by higher base salaries and incentive
compensation.
45
-- 45 of 156 --
Corporate and Other
Corporate expenses increased $18 million, or 28%, to $82 million for the three months ended March 31, 2026, compared to $64 million for the three
months ended March 31, 2025, reflecting primarily increased compensation and benefits and restructuring costs in the current period compared to
the prior year.
Interest Income
Interest income was $11 million for the three months ended March 31, 2026, compared to $19 million for the three months ended March 31, 2025.
Interest income decreased $8 million for the three months ended March 31, 2026 due to lower average interest rates compared to the
corresponding period in the prior year.
Interest Expense
Interest expense was $240 million for the three months ended March 31, 2026, compared to $245 million for the three months ended March 31,
2025.
Investment Income
The caption "Investment income" in the consolidated statements of income comprises realized and unrealized gains and losses from investments. It
includes, when applicable, other than temporary declines in the value of securities, mark-to-market increases or decreases in equity investments
with readily determinable fair values and equity method gains or losses on the Company's investments in private equity funds. The Company's
investments may include direct investments in insurance, consulting or other strategically linked companies and investments in private equity funds.
The Company recorded net investment income of $6 million for the three months ended March 31, 2026, compared to net investment income of $5
million for the three months ended March 31, 2025.
Income and Other Taxes
The Company's effective tax rate for the three months ended March 31, 2026 was 25.0%, compared with 22.7% for the corresponding period of
2025.
The tax rate in each period reflects the impact of discrete tax items such as excess tax benefits related to share-based compensation, enacted tax
legislation, changes in uncertain tax positions, deferred tax adjustments, non-taxable adjustments related to contingent consideration for
acquisitions, and valuation allowances for certain tax credits and attributes.
Purchases of U.S. tax credits are the most significant discrete item for the three months ended March 31, 2026, reducing the effective tax rate by
0.3%. For the three months ended March 31, 2025, the most significant discrete item was the excess tax benefit related to share-based payments,
which reduced the effective tax rate by 2.1%.
The effective tax rate may vary significantly from period to period. The effective tax rate is sensitive to the geographic mix of earnings and the cost
to repatriate the Company's earnings, which may result in higher or lower effective tax rates. Therefore, a shift in the mix of profits among
jurisdictions, or changes in the Company's repatriation strategy to access offshore cash, can affect the effective tax rate.
In addition, losses in certain jurisdictions cannot be offset by earnings from other operations and may require valuation allowances that affect the
rate in a particular period, depending on estimates of the value of associated deferred tax assets which can be realized. A valuation allowance was
recorded to reduce deferred tax assets to the amount that the Company believes is more likely than not to be realized. The effective tax rate is also
sensitive to changes in unrecognized tax benefits, including the impact of settled tax audits and expired statutes of limitations.
The Company has established liabilities for uncertain tax positions in relation to potential assessments in the jurisdictions in which it operates.
In 2024, the Company received closure notices and assessments from the U.K. tax authority in relation to its 2016-2020 examinations which
disallowed certain interest expense deductions. The Company has appealed the assessments and resolving this matter through litigation or
alternative dispute resolution may take several years. The Company believes the resolution of tax matters will not have a material effect on the
consolidated financial position of the Company. However, an adverse resolution of tax matters could have a material impact on the Company's net
income or cash flows and on its effective tax rate in a particular future period.
46
-- 46 of 156 --
Changes in tax laws, rulings, policies, or related legal and regulatory interpretations occur frequently and may have significant favorable or adverse
impacts on our effective tax rate.
On July 4, 2025, U.S tax legislation was signed into law (known as the "One Big Beautiful Bill Act" or "OBBBA") which made permanent many of the
tax provisions enacted in 2017 as part of the Tax Cuts and Jobs Act. In addition, the OBBBA made changes to certain U.S. corporate tax
provisions, which are effective beginning in 2026. The enactment of the OBBBA does not have a material impact on the results from operations for
the current year or future years.
The Organization for Economic Cooperation and Development ("OECD") provided model rules for a 15% global minimum tax, known as Pillar Two.
Pillar Two has now been enacted by most key non-U.S. jurisdictions where the Company operates, including the U.K. and Ireland. Parts of the
minimum tax rules were applicable for 2024, with the remaining provisions becoming fully effective for 2025. This minimum tax is treated as a
period cost and does not have a material impact on the Company's financial results of operations for the current period.
While the U.S. has negotiated a "side-by-side" arrangement for the existing U.S. minimum taxes with the intent to exempt U.S. multinational
companies from certain of the Pillar Two provisions, uncertainty remains related to the implementation of this arrangement. The Company
continues to monitor legislative developments, as well as additional guidance from countries that have enacted Pillar Two legislation, and will
ensure it complies with any changes.
As a U.S. domiciled parent holding company, the Company is the issuer of essentially all the Company's external indebtedness, and incurs the
related interest expense in the U.S. The Company’s interest expense deductions are not currently limited. However, the Company may not be able
to fully deduct intercompany interest on loans used to finance the Company's foreign operations.
Further, most senior executive and oversight functions are conducted in the U.S. and the associated costs are incurred primarily in the U.S. Some
of these expenses may not be deductible in the U.S., which may impact the effective tax rate. Changes to the U.S. tax law in recent years have
allowed the Company to repatriate foreign earnings without incurring additional U.S. federal income tax costs as foreign income is generally already
taxed in the U.S. However, permanent reinvestment continues to be a component of the Company's global capital strategy. The Company
continues to evaluate its global investment and repatriation strategy in light of our capital requirements and potential costs of repatriation, which are
generally limited to local country withholding taxes.
47
-- 47 of 156 --
Liquidity and Capital Resources
The Company is organized as a legal entity separate and distinct from its operating subsidiaries. As the Company does not have significant
operations of its own, the Company is dependent upon dividends and other payments from its operating subsidiaries to pay principal and interest on
its outstanding debt obligations, pay dividends to stockholders, repurchase its shares and pay corporate expenses. The Company can also provide
financial support to its operating subsidiaries for acquisitions, investments and certain parts of their business that require liquidity, such as the
capital markets business of Guy Carpenter. Other sources of liquidity include borrowing facilities discussed in the Financing Cash Flows section.
The Company derives a significant portion of its revenue and operating profit from operating subsidiaries located outside of the U.S. Funds from
those operating subsidiaries are regularly repatriated to the U.S. out of annual earnings. At March 31, 2026, the Company had approximately $1.5
billion of cash and cash equivalents in its foreign operations, which includes $511 million of operating funds required to be maintained for regulatory
requirements or as collateral under certain captive insurance arrangements. The Company expects to continue its practice of repatriating available
funds from its non-U.S. operating subsidiaries out of current annual earnings. Where appropriate, a portion of the current year earnings will
continue to be permanently reinvested.
For the three months ended March 31, 2026, the Company recorded foreign currency translation adjustments which decreased net equity by $150
million. Continued strengthening of the U.S. dollar against foreign currencies would further decrease the translated U.S. dollar value of the
Company’s net investments in its non-U.S. subsidiaries, as well as the translated U.S. dollar value of cash repatriations from those subsidiaries.
Cash and cash equivalents on the consolidated balance sheets includes funds available for general corporate purposes. Fiduciary assets are
shown separately in the consolidated balance sheets as cash and cash equivalents held in a fiduciary capacity, with a corresponding amount in
current liabilities. Fiduciary assets cannot be used for general corporate purposes, and should not be considered as a source of liquidity for the
Company.
Operating Cash Flows
The Company used $688 million of cash from operations for the three months ended March 31, 2026, compared to $622 million for the first three
months of 2025. These amounts reflect the net income of the Company during those periods, excluding gains or losses from investments, adjusted
for non-cash charges and changes in working capital which relate primarily to the timing of payments of accrued liabilities, including incentive
compensation, or receipts of receivables and pension plan contributions. The Company used cash of $79 million and $57 million related to its
restructuring activities for the three months ended March 31, 2026 and 2025, respectively.
Pension Related Items
Contributions
The Company's policy for funding its tax-qualified defined benefit plans is to contribute amounts at least sufficient to meet the funding requirements
set forth in accordance with applicable law. For the three months ended March 31, 2026, the Company contributed $9 million to its U.S. defined
benefit pension plans and $6 million to its non-U.S. defined benefit pension plans. For the three months ended March 31, 2025, the Company
contributed $11 million to its U.S. defined benefit pension plans and $7 million to its non-U.S. defined benefit pension plans.
In the U.S., contributions to the tax-qualified defined benefit plans are based on Employee Retirement Income Security Act ("ERISA") guidelines
and the Company generally expects to maintain a funded status of 80% or more of the liability determined in accordance with the ERISA guidelines.
For the three months ended March 31, 2026, the Company made contributions of $9 million to its non-qualified plans. The Company expects to
contribute approximately $33 million to its U.S. qualified plan and an additional $25 million to its U.S. non-qualified plans over the remainder of
2026.
Outside the U.S., the Company has a large number of non-U.S. defined benefit pension plans, the largest of which are in the U.K., which comprise
approximately 78% of non-U.S. plan assets at December 31, 2025. Contribution rates for non-U.S. plans are generally based on local funding
practices and statutory requirements, which may differ significantly from measurements in accordance with U.S. GAAP.
In the U.K., the assumptions used to determine pension contributions are the result of legally-prescribed negotiations between the Company and
the plans' trustee that typically occur every three years in conjunction with the actuarial valuation of the plans. Currently, this results in a lower
funded status compared to U.S. GAAP and may result in contributions irrespective of the U.S. GAAP funded status.
48
-- 48 of 156 --
The MMC U.K. Pension Fund has four segregated defined benefit sections, all in a surplus funding position at December 31, 2024. Based on that
funding position, an agreement was reached with the trustee in the fourth quarter of 2025 that no deficit funding will be required to any of the
defined benefit sections until 2029 at the earliest, following the completion in 2028 of the December 31, 2027 valuation. The Company’s prior
agreement to support certain annual deficit contributions that may have been required by U.K. operating companies under certain circumstances,
expiring on December 31, 2025, was not renewed in January 2026 due to the improved surplus funding position.
The Company expects to fund an additional $33 million to its non-U.S. defined benefit plans over the remainder of 2026, comprising approximately
$1 million to the U.K. non-qualified plan and $32 million to plans outside of the U.K.
Financing Cash Flows
Net cash provided by financing activities was $114 million for the three months ended March 31, 2026, compared with $138 million used for
financing activities for the corresponding period in 2025.
Credit Facilities
The Company has a $3.5 billion multi-currency unsecured five-year revolving credit facility (the "Credit Facility") expiring October 2028. Borrowings
under the Credit Facility bear interest at a rate per annum, equal, at the Company's option, either at (a) the Secured Overnight Financing Rate
("SOFR") benchmark rate for U.S. dollar borrowings, or (b) a currency specific benchmark rate, plus an applicable margin which varies with the
Company's credit ratings. The Company is required to maintain certain coverage and leverage ratios for the Credit Facility, which are evaluated
quarterly.
The Credit Facility includes provisions for determining a benchmark replacement rate in the event existing benchmark rates are no longer available,
or in certain other circumstances, in which an alternative rate may be required. At March 31, 2026 and December 31, 2025, the Company had no
borrowings under this facility.
The Company maintains other credit and overdraft facilities with various financial institutions aggregating $121 million and $122 million at March 31,
2026 and December 31, 2025, respectively. There were no outstanding borrowings under these facilities at March 31, 2026 and December 31,
2025.
The Company also has outstanding guarantees and letters of credit with various banks aggregating $155 million and $150 million at March 31,
2026 and December 31, 2025, respectively.
Debt
The Company has a $3.5 billion short-term debt financing program through the issuance of commercial paper. The proceeds from the issuance of
commercial paper are used for general corporate purposes. The Company had $1.0 billion of commercial paper outstanding at March 31, 2026, at
an average effective interest rate of 4.06%. The Company did not have any commercial paper outstanding at December 31, 2025.
In March 2026, the Company repaid $600 million of 3.750% senior notes at maturity.
In February 2026, the Company issued $600 million of 4.950% senior notes due 2036. The Company used the net proceeds from these issuances
for general corporate purposes.
In March 2025, the Company repaid $500 million of 3.500% senior notes at maturity.
The Company's senior debt is currently rated A- by Standard & Poor's ("S&P"), A3 by Moody's and A- by Fitch. The Company's short-term debt is
currently rated A-2 by S&P, P-2 by Moody's and F-2 by Fitch. The Company carries a Stable outlook with S&P, Moody's and Fitch.
Share Repurchases
The Company has a share repurchase program authorized by the Board of Directors.
In November 2025, the Board of Directors authorized the Company to repurchase up to $6 billion of the Company’s common stock, which
superseded any prior authorizations.
For the three months ended March 31, 2026, the Company repurchased 4.2 million shares of its common stock for $750 million. At March 31, 2026,
the Company remained authorized by the Board of Directors to repurchase up to approximately $4.9 billion in shares of its common stock. There is
no time limit on the authorization.
49
-- 49 of 156 --
For the three months ended March 31, 2025, the Company repurchased 1.3 million shares of its common stock for $300 million.
Dividends
The Company paid dividends on its common stock shares of $440 million ($0.900 per share) for the three months ended March 31, 2026,
compared with $405 million ($0.815 per share) for the first three months of 2025.
In February 2026, the Board of Directors of the Company declared a quarterly dividend of $0.900 per share on outstanding common stock, payable
in May 2026. In February 2026, the Company also paid the quarterly dividend declared in January 2026 by the Company's Board of Directors of
$0.900 per share on outstanding common stock.
Contingent and Deferred Payments Related to Acquisitions
The classification of contingent consideration in the consolidated statements of cash flows is dependent upon whether the receipt, payment, or
adjustment was part of the initial liability established on the acquisition date (financing) or an adjustment to the acquisition date liability (operating).
The following amounts are included in the consolidated statements of cash flows as operating and financing activities:
For the Three Months Ended March 31,
(In millions) 2026 2025
Operating:
Contingent consideration payments for prior year acquisitions $ (1) $ (14)
Acquisition/disposition related net charges for adjustments 11 9
Adjustments and payments related to contingent consideration $ 10 $ (5)
Financing:
Contingent consideration for prior year acquisitions $ (17) $ (5)
Deferred consideration for prior year acquisitions (14) (27)
Payments of deferred and contingent consideration for acquisitions $ (31) $ (32)
Receipt of deferred and contingent consideration for dispositions $ 12 $ —
For acquisitions completed during the first three months of 2026 and in prior years, remaining estimated future contingent payments of $266 million
and deferred consideration payments of $149 million, are recorded in accounts payable and accrued liabilities or other liabilities in the consolidated
balance sheets at March 31, 2026.
Derivatives - Net Investment Hedge
The Company has investments in various subsidiaries with Euro functional currencies. As a result, the Company is exposed to the risk of
fluctuations between the Euro and U.S. dollar exchange rates. As part of its risk management program, the Company designated its €1.1 billion
senior note debt instruments ("Euro notes") as a net investment hedge (the "hedge") of its Euro denominated subsidiaries. The hedge is re-
assessed each quarter to confirm that the designated equity balance at the beginning of each period continues to equal or exceed 80% of the
outstanding balance of the Euro debt instrument and that all the critical terms of the hedging instrument and the hedged net investment continue to
match. If the hedge is highly effective, the change in the debt balance related to foreign exchange fluctuations is recorded in accumulated other
comprehensive loss in the consolidated balance sheets.
The U.S. dollar value of the Euro notes decreased by $29 million through March 31, 2026, due to the change in foreign exchange rates. The
Company concluded that the hedge was highly effective and recorded a decrease to accumulated other comprehensive loss for the three months
ended March 31, 2026.
Fiduciary Liabilities
Since fiduciary assets are not available for corporate use, they are shown separately in the consolidated balance sheets as cash and cash
equivalents held in a fiduciary capacity, with a corresponding amount in current liabilities. Financing cash flows reflect increases of $361 million and
$86 million for the three months ended March 31, 2026 and 2025, respectively, related to fiduciary liabilities.
50
-- 50 of 156 --
Investing Cash Flows
Net cash used for investing activities amounted to $104 million for the first three months of 2026, compared with $26 million provided by investing
activities for the corresponding period in 2025.
The Company paid $41 million and $18 million, net of cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity acquired,
for acquisitions it made in the first three months of 2026 and 2025, respectively.
In the first quarter of 2025, the Company sold Marsh McLennan Agency's ("MMA") Technology Consulting and Administrative Solutions ("TCAS")
business for approximately $25 million, and recorded a gain of $15 million, which is included in revenue in the consolidated statements of income.
The Company's additions to fixed assets and capitalized software for the three months ended March 31, 2026 and 2025, amounted to $62 million
and $55 million, respectively, related primarily to software development costs, the refurbishing and modernizing of office facilities, and technology
equipment purchases.
Cash from the sale of long-term investments for the three months ended March 31, 2025 is primarily due to the disposal of an investment in a unit
trust fund.
Cash used for long-term investments for the three months ended March 31, 2026 is due to investments in private equity funds. At March 31, 2026,
the Company has commitments for potential future investments of approximately $102 million in private equity funds that invest primarily in financial
services companies.
Commitments and Obligations
The following sets forth the Company’s future contractual obligations by the type at March 31, 2026:
Payment due by Period
(In millions) Total
Within
1 Year 1-3 Years 4-5 Years
After
5 Years
Commercial paper $ 1,049 $ 1,049 $ — $ — $ —
Current portion of long-term debt 653 653 — — —
Long-term debt 19,057 — 2,793 2,431 13,833
Interest on long-term debt 12,946 913 1,740 1,491 8,802
Net operating leases 2,106 387 628 434 657
Service agreements 595 282 201 112 —
Other long-term obligations (a) 504 237 202 65 —
Total $ 36,910 $ 3,521 $ 5,564 $ 4,533 $ 23,292
(a) Primarily reflects the future payments of deferred and contingent purchase consideration.
The table does not include the liability for unrecognized tax benefits of $114 million as the Company is unable to reasonably predict the timing of
settlement of these liabilities, other than approximately $63 million that may become payable within one year. The table also does not include the
remaining transitional tax payments related to the Tax Cuts and Jobs Act (the "TCJA") of $13 million, which will be paid in April 2026.
Management’s Discussion of Critical Accounting Policies and Estimates
The Company’s discussion of critical accounting policies and estimates that place the most significant demands on management’s judgment and
requires management to make significant estimates about matters that are inherently uncertain are discussed in the MD&A in the 2025 Form 10-K.
New Accounting Pronouncements
Note 19, New Accounting Pronouncements, in the notes to the consolidated financial statements in this report, contains a discussion of recently
issued accounting guidance and their impact or potential future impact on the Company’s financial results, if determinable.
51
-- 51 of 156 --
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Market Risk and Credit Risk
Certain of the Company’s revenues, expenses, assets and liabilities are exposed to the impact of interest rate changes and fluctuations in foreign
currency exchange rates and equity markets.
Interest Rate Risk and Credit Risk
Interest income generated from the Company's cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity will vary with the
general level of interest rates.
The Company had the following investments subject to variable interest rates:
(In millions) March 31, 2026 December 31, 2025
Cash and cash equivalents $ 1,611 $ 2,687
Cash and cash equivalents held in a fiduciary capacity $ 11,744 $ 11,473
Based on the above balances at March 31, 2026, if short-term interest rates increased or decreased by 10%, or 30 basis points, for the year,
annual interest income, including interest earned on cash and cash equivalents held in a fiduciary capacity, would increase or decrease by
approximately $30 million.
Changes in interest rates can also affect the discount rate and assumed rate of return on plan assets, two of the assumptions among several others
used to measure net periodic pension cost. The assumptions used to measure plan assets and liabilities are typically assessed at the end of each
year, and determine the expense for the subsequent year. Assumptions used to determine net periodic cost for 2026 are discussed in Note 8,
Retirement Benefits, in the notes to the consolidated financial statements included in our most recently filed Annual Report on Form 10-K. For a
discussion on pension expense sensitivity to changes in these rates, see the "Management’s Discussion and Analysis of Financial Condition and
Results of Operations - Management’s Discussion of Critical Accounting Estimates - Retirement Benefits" section of our most recently filed Annual
Report on Form 10-K.
In addition to interest rate risk, our cash investments and fiduciary cash investments are subject to potential loss of value due to counter-party credit
risk. To minimize this risk, the Company and its subsidiaries invest pursuant to a Board-approved investment policy. The policy mandates the
preservation of principal and liquidity and requires broad diversification with counter-party limits assigned based primarily on credit rating and type
of investment. The Company carefully monitors its cash, cash equivalents, and cash and cash equivalents held in a fiduciary capacity, and will
further restrict the portfolio as appropriate to market conditions. The majority of cash, cash equivalents, and cash and cash equivalents held in a
fiduciary capacity are invested in bank or short-term time deposits and liquid money market funds.
Foreign Currency Risk
The translated values of revenue and expense from the Company’s international operations are subject to fluctuations due to changes in currency
exchange rates. The non-U.S. based revenue that is exposed to foreign exchange fluctuations is approximately 51% of total revenue. We
periodically use forward contracts and options to limit foreign currency exchange rate exposure on net income and cash flows for specific, clearly
defined transactions arising in the ordinary course of business. Although the Company has significant revenue generated in foreign locations which
is subject to foreign exchange rate fluctuations, in most cases both the foreign currency revenue and expense are in the functional currency of the
foreign location. As such, under normal circumstances, the U.S. dollar translation of both the revenue and expense, as well as the potentially
offsetting movements of various currencies against the U.S. dollar, generally tend to mitigate the impact on net operating income of foreign currency
risk.
However, there have been periods where the impact was not mitigated due to external market factors, and external macroeconomic events may
result in greater foreign exchange rate fluctuations in the future. If foreign exchange rates of major currencies (Euro, British Pound, Australian dollar
and Canadian dollar) moved 10% in the same direction against the U.S. dollar that held constant over the course of the year, the Company
estimates that full year net operating income would increase or decrease by approximately $123 million. The Company has exposure to
approximately 80 foreign currencies. If exchange rates at March 31, 2026, hold constant for the rest of 2026, the Company estimates the year-over-
year impact from the conversion of foreign currency earnings will increase full year net operating income by approximately $82 million.
52
-- 52 of 156 --
In Continental Europe, the largest amount of revenue from renewals for the Risk and Insurance Services segment occurs in the first quarter.
Equity Price Risk
The Company has investments in certain private equity funds as well as in public and private companies of approximately $324 million that are
accounted for using the equity method of accounting. The Company also holds investments of approximately $26 million that are valued using
readily determinable fair values and approximately $16 million of investments without readily determinable fair values. The Company's investments
are subject to risk of decline in market value, which, if determined to be other than temporary, could result in realized impairment losses. The
Company periodically reviews the carrying value of such investments to determine if any valuation adjustments are appropriate under the
applicable accounting pronouncements.
Other
A number of lawsuits and regulatory proceedings are pending. Refer to Note 17, Claims, Lawsuits and Other Contingencies, in the notes to the
consolidated financial statements included in this report.
Item 4. Controls & Procedures.
a. Evaluation of Disclosure Controls and Procedures
Based on their evaluation, as of the end of the period covered by this report, the Company’s Chief Executive Officer and Chief Financial Officer
have concluded that the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange
Act of 1934) are effective.
b. Changes in Internal Control
There were no changes in the Company’s internal control over financial reporting identified in connection with the evaluation required by Rules 13a-
15(d) or 15d-15(d) under the Securities Exchange Act of 1934 that occurred during the Company’s last fiscal quarter that have materially affected,
or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
53
-- 53 of 156 --
PART II. OTHER INFORMATION
Item 1. Legal Proceedings.
The Company and its subsidiaries are party to a variety of other legal, administrative, regulatory and government proceedings, claims and inquiries
arising in the normal course of business.
Additional information regarding certain legal proceedings and related matters as set forth in Note 17, Claims, Lawsuits and Other Contingencies, in
the notes to the consolidated financial statements provided in Part I of this report is incorporated herein by reference.
Item 1A. Risk Factors.
The Company and its subsidiaries face a number of risks and uncertainties. In addition to the other information in this report and our other filings
with the SEC, readers should consider carefully the risk factors discussed in "Part I, Item 1A. Risk Factors" in our Annual Report on Form 10-K for
the year ended December 31, 2025.
If any of the risks described in our Annual Report on Form 10-K or such other risks actually occur, our business, results of operations or financial
condition could be materially adversely affected.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
Issuer Repurchases of Equity Securities
For the three months ended March 31, 2026, the Company repurchased 4.2 million shares of its common stock for $750 million. At March 31, 2026,
the Company remained authorized to repurchase up to approximately $4.9 billion in shares of its common stock. There is no time limit on the
authorization.
Period
(a)
Total
Number of
Shares (or
Units)
Purchased
(b)
Average
Price
Paid per
Share
(or Unit)
(c)
Total Number of
Shares (or Units)
Purchased as Part
of Publicly
Announced Plans
or Programs
(d)
Maximum
Number (or
Approximate
Dollar Value) of
Shares (or
Units) that May
Yet Be
Purchased
Under the Plans
or Programs
January 1 - 31, 2026 820,037 $ 182.9185 820,037 $ 5,525,345,373
February 1 - 28, 2026 1,852,282 $ 178.9176 1,852,282 $ 5,193,939,578
March 1 - 31, 2026 1,519,498 $ 176.7646 1,519,498 $ 4,925,346,151
Total 4,191,817 $ 178.9198 4,191,817 $ 4,925,346,151
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosure.
Not Applicable.
Item 5. Other Information.
None.
Item 6. Exhibits.
See the Exhibit Index immediately following the signature page of this report, which is incorporated herein by reference.
54
-- 54 of 156 --
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned thereunto duly authorized.
Date: April 16, 2026 /s/ Mark C. McGivney
Mark C. McGivney
Chief Financial Officer
Date: April 16, 2026 /s/ Stacy M. Mills
Stacy M. Mills
Vice President & Controller
(Chief Accounting Officer)
55
-- 55 of 156 --
EXHIBIT INDEX
Exhibit No. Exhibit Name
4.1 Twenty-first Supplemental Indenture, dated December 13, 2024, between Marsh & McLennan Companies, Inc. and the Bank
of New York Mellon, as trustee (incorporated by reference to the Company's Current Report on Form 10-K dated February 10,
2025)
10.1 Letter Agreement Amendment, dated February 24, 2026, between Marsh & McLennan Companies, Inc. and John Q. Doyle
10.2 Letter Agreement Amendment, dated February 24, 2026, between Marsh & McLennan Companies, Inc. and Mark C.
McGivney
10.3 Letter Agreement Amendment, dated March 6, 2026, between Marsh & McLennan Companies, Inc. and Martin South
10.4 Letter Agreement Amendment, dated February 24, 2026, between Marsh & McLennan Companies, Inc. and Dean M. Klisura
10.5 Letter Agreement Amendment, dated February 24, 2026, between Marsh & McLennan Companies, Inc. and Patrick Tomlinson
10.6 Form of Stock Option Award, dated as of February 24, 2026, under the Amended and Restated Marsh & McLennan
Companies, Inc. 2020 Incentive and Stock Award Plan
10.7 Form of Performance Stock Unit Award, dated as of February 24, 2026, under the Amended and Restated Marsh &
McLennan Companies, Inc. 2020 Incentive and Stock Award Plan
10.8 Form of Restricted Stock Unit Award, dated as of February 24, 2026, under the Amended and Restated Marsh & McLennan
Companies, Inc. 2020 Incentive and Stock Award Plan
10.9 Form of Deferred Stock Unit Award, with grant dates from March 1, 2026 through February 1, 2027, under the Amended and
Restated Marsh & McLennan Companies, Inc. 2020 Incentive and Stock Award Plan – Cliff Vesting
10.10 Form of Deferred Stock Unit Award, with grant dates from March 1, 2026 through February 1, 2027, under the Amended and
Restated Marsh & McLennan Companies, Inc. 2020 Incentive and Stock Award Plan – Ratable Vesting
31.1 Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer
31.2 Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer
32.1 Section 1350 Certifications
101.INS XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are
embedded within the Inline XBRL document.
101.SCH XBRL Taxonomy Extension Schema
101.CAL XBRL Taxonomy Extension Calculation Linkbase
101.DEF XBRL Taxonomy Extension Definition Linkbase
101.LAB XBRL Taxonomy Extension Label Linkbase
101.PRE XBRL Taxonomy Extension Presentation Linkbase
104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
56
-- 56 of 156 --
Steven A. Mills
Chairman of the Compensation Committee of the Board of Directors
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036
T +1 212 345 5000
www.corporate.marsh.com
February 24, 2026
John Q. Doyle
Electronic Delivery
Subject: Terms of Employment
Dear John,
This fourth amendment to the Letter Agreement, dated November 10, 2022, between you and Marsh & McLennan Companies, Inc.
(“Marsh”) as subsequently amended on February 22, 2024, July 10, 2024 and February 18, 2025 (taken together, the “Letter
Agreement”), revises the terms and conditions of your employment as President and Chief Executive Officer of Marsh. The Letter
Agreement will continue to govern your employment except as specified below:
1 Exhibit A to the Letter Agreement shall be deleted and replaced in its entirety with the attached Exhibit A.
The terms of this amendment are effective as of February 24, 2026. Please acknowledge your agreement with the terms of the Letter
Agreement, as further amended by this fourth amendment, by signing and dating this amendment.
Sincerely,
/s/ Steven A. Mills
Steven A. Mills Chairman of the Compensation Committee of the Board of Directors
Marsh
-- 57 of 156 --
Page 2
February 24, 2026
John Doyle
Accepted and Agreed:
/s/ John Q. Doyle
(Signature)
February 26, 2026
(Date)
-- 58 of 156 --
Page 3
February 24, 2026
John Doyle
Exhibit A
Board or Committee Memberships • The Board of the Greenberg School of Risk Management at St. John’s University
• The Board of New York Police and Fire Widows and Children’s Benefit Fund
• Inner-City Scholarship Fund
Annual Base Salary $1,500,000 effective as of April 1, 2024.
Annual Target Bonus Opportunity Bonus awards are discretionary.
Target bonus of $4,000,000 commencing with the 2026 performance year (awarded in
February 2027). Actual bonus may range from 0% - 200% of target, based on
achievement of individual and Marsh performance objectives as Marsh may establish
from time to time
Annual Target Long-Term Incentive
Opportunity
Long-term incentive awards are discretionary.
Target grant date fair value of $17,500,000 commencing with the award granted in
2026.
Other Benefits • You will have access to a car and driver for business purposes and personal use
including work/home travel.
• You will have access to corporate aircraft for personal travel, up to $275,000 in
aggregate incremental cost each calendar year, commencing with the 2024
calendar year, as calculated by Marsh for disclosure purposes for the Summary
Compensation Table of Marsh’s Proxy Statement; provided that this amount and
calculation methodology will be reviewed from time to time and subject to
adjustment to reflect market trends and security considerations. Marsh currently
calculates incremental cost by totaling the incremental variable costs associated
with personal flights on the aircraft (including hourly charges, taxes, passenger
fees, international fees and catering)
If the imputed income attributable to these benefits is taxable to you, then the taxes
associated with this taxable income will not be reimbursed or paid by Marsh.
-- 59 of 156 --
John Q. Doyle
President and Chief Executive Officer
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036
T +1 212 345 5000
www.corporate.marsh.com
February 24, 2026
Mark C. McGivney
Electronic delivery
Subject: Terms of Employment
Dear Mark,
This sixth amendment to the Letter Agreement, dated September 17, 2015, between you and Marsh & McLennan Companies, Inc.
(“Marsh”) as subsequently amended on January 17, 2018, February 19, 2019, September 22, 2022, February 22, 2024 and February
18, 2025 (taken together, the “Letter Agreement”), revises the terms and conditions of your employment as Senior Vice President and
Chief Financial Officer of Marsh. The Letter Agreement will continue to govern your employment except as specified below:
1 Exhibit A to the Letter Agreement shall be deleted and replaced in its entirety with the attached Exhibit A.
The terms of this amendment are effective as of February 24, 2026. Please acknowledge your agreement with the terms of the Letter
Agreement, as further amended by this sixth amendment, by signing and dating this amendment.
Sincerely,
/s/ John Q. Doyle
John Q. Doyle
President and Chief Executive Officer
Marsh
-- 60 of 156 --
Page 2
February 24, 2026
Mark C. McGivney
Accepted and Agreed:
/s/ Mark C. McGivney
(Signature)
February 26, 2026
(Date)
-- 61 of 156 --
Page 3
February 24, 2026
Mark C. McGivney
Exhibit A
Board or Committee Memberships None
Annual Base Salary $1,000,000 effective as of April 1, 2024.
Annual Target Bonus Opportunity Bonus awards are discretionary.
Target bonus of $2,000,000 commencing with the 2026 performance year (awarded in
February 2027). Actual bonus may range from 0% - 200% of target, based on
achievement of individual and Marsh performance objectives, as Marsh may establish
from time to time
Annual Target Long-Term Incentive
Opportunity
Long-term incentive awards are discretionary.
Target grant date fair value of $3,000,000 commencing with the award granted in
2024.
Other Benefits You will have access to a car and driver for business purposes and work/home travel.
If the imputed income attributable to this benefit is taxable to you, then the taxes
associated with this taxable income will not be reimbursed or paid by Marsh.
-- 62 of 156 --
John Q. Doyle
President and Chief Executive Officer
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036
T +1 212 345 5000
www.corporate.marsh.com
Marsh 6, 2026
Martin South
Hand Delivery
Subject: Terms of Employment
Dear Martin,
This amendment to the Letter Agreement, dated December 1, 2021, between you and Marsh & McLennan Companies, Inc. (“Marsh”)
as subsequently amended on February 22, 2024 and February 18, 2025 (taken together, the “Letter Agreement”), revises the terms
and conditions of your employment previously by Marsh Risk as its President and Chief Executive Officer and Vice Chair, Marsh. The
Letter Agreement will continue to govern your employment except as specified below:
1 You will now be employed by Marsh & McLennan Companies, Inc.
2 Your title is Senior Vice President and Chief Client Officer.
3 Section 3. a. of your Letter Agreement shall be deleted in its entirety and replaced with the following:
You have been designated as a “Key Employee” under the Marsh & McLennan Companies, Inc. Senior Executive Severance
Pay Plan (the “Senior Executive Severance Plan”). From April 1, 2026 until March 31, 2027, in the event that you are terminated
involuntarily by the Company without Cause (as defined in the Senior Executive Severance Plan), or you terminate your employment
for any reason (other than death or Permanent Disability), you will be entitled to severance under the Senior Executive Severance
Plan as if the Company terminated your employment involuntarily without Cause on April 1, 2026. In the event that your employment
with the Company terminates for any other reason, or you are terminated involuntarily by the Company without Cause or you
terminate employment for Good Reason on or after April 1, 2027, the Senior Executive Severance Plan in effect at the time of your
termination will exclusively govern the terms under which you may be eligible to receive severance and/or other transition benefits
from the Company. In the event that you are entitled to receive severance benefits under Article 5 of the Senior Executive Severance
Plan, the Company shall also pay you the earned annual bonus, if any, for the calendar year that preceded your termination to the
extent not theretofore paid.
1. Exhibit A to the Letter Agreement shall be deleted and replaced in its entirety with the attached Exhibit A.
-- 63 of 156 --
Page 2
March 6, 2026
Martin South
The terms of this amendment are effective as of April 1, 2026. Please acknowledge your agreement with the terms of the Letter
Agreement, as further amended by this amendment, by signing and dating this and the enclosed copy and returning one to me.
Sincerely,
/s/ John Q. Doyle
John Q. Doyle
President and Chief Executive Officer
Marsh
Accepted and Agreed:
/s/ Martin South
(Signature)
March 12, 2026
(Date)
-- 64 of 156 --
Page 3
March 6, 2026
Martin South
Exhibit A
Board or Committee Memberships None
Annual Base Salary $1,000,000 effective January 1, 2022.
Annual Target Bonus Opportunity Bonus awards are discretionary.
Target bonus of $1,500,000 commencing with the 2026 performance year (awarded in February
2027). Actual bonus may range from 0% - 200% of target, based on achievement of individual
and Marsh performance objectives, as Marsh may establish from time to time.
Annual Target Long-Term Incentive
Opportunity
Long-term incentive awards are discretionary. Target grant date fair value of $1,750,000,
commencing with the award made in 2027.
Other Benefits You will have access to a car and driver for business purposes and work/home travel.
If the imputed income attributable to this benefit is taxable to you, then the taxes associated
with this taxable income will not be reimbursed or paid by Marsh.
-- 65 of 156 --
John Q. Doyle
President and Chief Executive Officer
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036
T +1 212 345 5000
www.corporate.marsh.com
February 24, 2026
Dean Klisura
Electronic Delivery
Subject: Terms of Employment
Dear Dean,
This third amendment to the Letter Agreement, dated December 1, 2021, between you and Marsh & McLennan Companies, Inc.
(“Marsh”) as subsequently amended on February 22, 2024 and February 18, 2025 (taken together, the “Letter Agreement”), revises
the terms and conditions of your employment as President and Chief Executive Officer of Guy Carpenter and Vice Chair, Marsh. The
Letter Agreement will continue to govern your employment except as specified below:
1 Exhibit A to the Letter Agreement shall be deleted and replaced in its entirety with the attached Exhibit A.
The terms of this amendment are effective as of February 24, 2026. Please acknowledge your agreement with the terms of the Letter
Agreement, as further amended by this third amendment, by signing and dating this amendment.
Sincerely,
/s/ John Q. Doyle
John Q. Doyle
President and Chief Executive Officer
Marsh
-- 66 of 156 --
Page 2
February 24, 2026
Dean Klisura
Accepted and Agreed:
/s/ Dean M. Klisura
(Signature)
March 9, 2026
(Date)
Exhibit A
-- 67 of 156 --
Page 3
February 24, 2026
Dean Klisura
Board or Committee Memberships None
Annual Base Salary $900,000 effective as of April 1, 2025.
Annual Target Bonus Opportunity Bonus awards are discretionary.
Target bonus of $2,200,000 commencing with the 2026 performance year (awarded in
February 2027). Actual bonus may range from 0% - 200% of target, based on
achievement of individual and Guy Carpenter and/or Marsh performance objectives,
as Marsh may establish from time to time
Annual Target Long-Term Incentive
Opportunity
Long-term incentive awards are discretionary.
Target grant date fair value of $2,000,000 commencing with the award granted in
2025.
Other Benefits You will have access to a car and driver for business purposes and work/home travel.
If the imputed income attributable to this benefit is taxable to you, then the taxes
associated with this taxable income will not be reimbursed or paid by Marsh.
-- 68 of 156 --
John Q. Doyle
President and Chief Executive Officer
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036
T +1 212 345 5000
www.corporate.marsh.com
February 24, 2026
Patrick Tomlinson
Electronic Delivery
Subject: Terms of Employment
Dear Pat,
This second amendment to the Letter Agreement, dated March 20, 2024, between you and Marsh & McLennan Companies, Inc.
(“Marsh”) as subsequently amended on February 18, 2025 (taken together, the “Letter Agreement”), revises the terms and
conditions of your employment as President and Chief Executive Officer of Mercer and Vice Chair, Marsh. The Letter Agreement will
continue to govern your employment except as specified below:
1 Exhibit A to the Letter Agreement shall be deleted and replaced in its entirety with the attached Exhibit A.
The terms of this amendment are effective as of February 24, 2026. Please acknowledge your agreement with the terms of the Letter
Agreement, as further amended by this second amendment, by signing and dating this amendment.
Sincerely,
/s/ John Q. Doyle
John Q. Doyle
President and Chief Executive Officer
Marsh
-- 69 of 156 --
Page 2
February 24, 2026
Patrick Tomlinson
Accepted and Agreed:
/s/ Patrick Tomlinson
(Signature)
February 27, 2026
(Date)
-- 70 of 156 --
Page 3
February 24, 2026
Patrick Tomlinson
Exhibit A
Board or Committee Memberships None
Annual Base Salary $900,000 effective as of April 1, 2024.
Annual Target Bonus Opportunity Bonus awards are discretionary.
Target bonus of $2,200,000 commencing with the 2026 performance year (awarded in
February 2027). Actual bonus may range from 0% - 200% of target, based on
achievement of individual and Mercer and/or Marsh performance objectives, as Marsh
may establish from time to time
Annual Target Long-Term Incentive
Opportunity
Long-term incentive awards are discretionary.
Target grant date fair value of $2,300,000 commencing with the award granted in
2025.
Other Benefits You will have access to a car and driver for business purposes and work/home travel.
If the imputed income attributable to this benefit is taxable to you, then the taxes
associated with this taxable income will not be reimbursed or paid by Marsh.
-- 71 of 156 --
MARSH & McLENNAN COMPANIES, INC.
AMENDED AND RESTATED 2020 INCENTIVE AND STOCK AWARD PLAN
TERMS AND CONDITIONS
OF
STOCK OPTION AWARDS
GRANTED ON [DATE], 2026
-- 72 of 156 --
TABLE OF CONTENTS
Page
I. BACKGROUND 1
II. AWARDS 1
III. EMPLOYMENT EVENTS 4
IV. CHANGE IN CONTROL PROVISIONS 8
V. DEFINITIONS 9
VI. ADDITIONAL PROVISIONS 10
VII. QUESTIONS AND ADDITIONAL INFORMATION 12
-- 73 of 156 --
I. BACKGROUND
A Stock Option award (“Award”) has been granted to you under the Marsh & McLennan Companies, Inc.
Amended and Restated 2020 Incentive and Stock Award Plan (the “Plan”), subject to your acceptance as
described in Section II.A.1. The number of shares of Marsh & McLennan Companies, Inc. (“Marsh”) common
stock covered by the Award, instructions on how to accept or decline the Award and the deadline for accepting
the Award will be provided to you by Executive Compensation and/or the stock plan service provider of the
Company (as defined in Section V.). The Award is also subject to the terms and conditions set forth herein (the
“Terms and Conditions”) and to additional terms and conditions as set forth in the country-specific notices (the
“Country-Specific Notices”). The Prospectus dated [DATE], also describes important information about the
Plan. The Terms and Conditions, the Country-Specific Notices and the Plan will be referred to herein as the
“Award Documentation.” As used herein, “Common Stock” means common stock of Marsh.
Capitalized terms in these Terms and Conditions are defined in Section V.
II. AWARDS
A. General.
1. Award Acceptance. The grant of this Award is contingent upon your acceptance, by the date and
in the manner specified by Executive Compensation and/or the Company’s stock plan service
provider, of these Terms and Conditions, the Country-Specific Notices and Restrictive Covenants
Agreement as described in Section II.A.3. If you decline the Award or if you do not accept the Award
and any applicable documents described in the preceding sentence by the deadline date and in the
manner specified, then the Award will be cancelled as of the grant date of the Award.
2. Rights of Award Holders. Unless and until the vesting conditions of the Award have been
satisfied and shares of Common Stock, as applicable, have been delivered to you upon your exercise
of the Award in accordance with the Award Documentation, you have none of the rights of ownership
to such shares (e.g., Options cannot be transferred or assigned; Options have no voting rights, etc.).
3. Restrictive Covenants Agreement. As described in Section II.A.1., a Restrictive Covenants
Agreement (“Restrictive Covenants Agreement”) in a form determined by Marsh must be in place in
order to accept the Award, you must execute or reaffirm, as determined by Marsh, in its sole
discretion, the Restrictive Covenants Agreement in order for the Award to vest pursuant to certain
employment events as described in Section III., and you must further execute or reaffirm, as
determined by Marsh, in its sole discretion, and be in compliance with the Restrictive Covenants
Agreement in order to exercise an Option whether or not you are employed by the Company at that
time. Failure to timely execute the Restrictive Covenants Agreement by the date specified by the
Company or failure to timely execute or reaffirm and comply with the Restrictive Covenants
Agreement as described in Section III.G.1. or 2., as applicable, will result in cancellation or
1
-- 74 of 156 --
forfeiture of any rights, title and interest in and to the Award, without any liability to the Company.
B. Stock Options.
1. General. A stock option (“Option”) represents the right to purchase a number of shares of
Common Stock (the “Option Shares”) at a specified exercise price for a specified period.
2. Vesting. Subject to your continued employment, 25% of the Option Shares covered by the Option
will vest on each of the first four anniversaries of the grant date of the Award. Each date on which an
Option Share covered by the Option is scheduled to vest is an “Option Scheduled Vesting Date.” In
the event of your termination of employment or occurrence of your Permanent Disability (as defined
in Section V.) prior to an Option Scheduled Vesting Date, your right to any Option Shares covered by
the Option that are unvested immediately prior to your termination of employment or occurrence of
your Permanent Disability, as applicable, will be determined in accordance with Section III. For the
avoidance of doubt, the date of your termination of employment for purposes of this Section II.B.2.
will be determined in accordance with Section III.F.
3. Term. Subject to your continued employment, the Option will expire on the day immediately
preceding the tenth anniversary of the grant date of the Award (“Option Expiration Date”). If your
employment terminates before the Option Expiration Date, your right to exercise any vested Option
Shares covered by the Option will be determined in accordance with Section III.
4. Exercisability. The Option Shares covered by the Option will become exercisable when they vest.
You are responsible for keeping track of exercise periods while actively employed and, if applicable,
any post-termination exercise periods.
5. Method of Exercise of an Option.
a. General Procedures. An Option may be exercised by electronic notice to the Company’s stock
plan service provider (or other notice as required by the Company and/or its stock plan service
provider). Such notice must (i) be in form and substance acceptable to Marsh and under local law
(ii) state the election to exercise such Option and the number of Option Shares for which such
Option is being exercised and (iii) include such other representations and agreements as may be
required pursuant to the provisions of the Award Documentation (the “Exercise Notice”). The
Exercise Notice must be accompanied by (i) any required income tax forms and (ii) any required
reaffirmation of the Restrictive Covenants Agreement, unless (A) the Option is being exercised
after your death in accordance with Section III. or (B) as otherwise determined by Marsh.
b. Payment of Exercise Price. Payment of the aggregate exercise price may be made with U.S.
dollars or by tendering shares of Common Stock (including shares of Common Stock acquired
from a
2
-- 75 of 156 --
stock option exercise or a stock unit award vesting) at your election.
c. Distribution of Option Shares. The shares of Common Stock from the Option exercise will be
distributed as specified in the Exercise Notice, after you have satisfied applicable tax obligations,
as described in Section II.C., and fees.
C. Satisfaction of Tax Obligations.
1. Personal Tax Advisor. Neither the Company nor any Company employee is authorized to provide
personal tax advice to you. It is recommended that you consult with your personal tax advisor for
more detailed information regarding the tax treatment of the Award, especially before making any
decisions that rely on that tax treatment.
2. U.S. Employees. Applicable taxes (including employment taxes) are required by law to be
withheld when a nonqualified Option is exercised. A sufficient number of whole shares of Common
Stock resulting from the Option exercise will be retained by Marsh to satisfy the tax-withholding
obligation unless you elect in the Exercise Notice to satisfy all applicable tax withholding in another
manner.
3. Non-U.S. Employees.
a. In most countries, the value of an Option is generally not taxable on the grant date. If the value
of the Option is not taxable on the grant date, it will, in most countries, be taxed at a later time,
for example, upon exercise of the Option and delivery of shares of Common Stock in respect of
the Option, and/or the subsequent sale of the shares of Common Stock.
b. Withholding. Marsh and/or your employer shall have the power and the right to deduct and
withhold from the Award and other compensation or to require you to remit to Marsh and/or to
your employer, an amount sufficient to satisfy any Tax-Related Items (as defined in Section V.)
that Marsh expects to be payable under the laws of any country, state, province, city or other
jurisdiction. If applicable, Marsh and/or your employer will, to the extent permissible under
applicable law or otherwise agreed between you and Marsh and/or your employer, either (a)
withhold from proceeds of the sale a sufficient number of whole shares of Common Stock issued
to you in settlement of the Award (either through your voluntary sale or through a mandatory
sale arranged by Marsh on your behalf) for purposes of satisfying applicable obligations with
respect to Tax-Related Items and/or (b) withhold a sufficient number of whole shares of Common
Stock distributable to you in in respect of the Award to satisfy applicable obligations with respect
to Tax-Related Items. Further, depending on the withholding method, Marsh and/or your
employer may withhold or account for obligations for Tax-Related Items by considering statutory
or other withholding rates, including minimum or maximum rates applicable in your
jurisdiction(s).
In the event of over-withholding, you may receive a refund from Marsh and/or your employer of
any over-withheld amount in cash
3
-- 76 of 156 --
(with no entitlement to the equivalent in shares of Common Stock), or if not refunded by Marsh
and/or your employer, you must seek a refund from the local tax authorities to the extent you
wish to recover the over-withheld amount in the form of a refund.
III. EMPLOYMENT EVENTS
A. Death. In the event your employment is terminated because of your death, the Option will fully vest with
respect to any unvested Option Shares and will become exercisable as of the date of your death. The
person or persons to whom your rights under the Option shall pass by will or the laws of descent and
distribution shall be entitled to exercise such Option with respect to any Option Shares that vest (and
any Option Shares that were already vested at the time of your death) within two years after the date
of death, but in no event shall the Option be exercisable after the Option Expiration Date.
B. Permanent Disability. Upon the occurrence of your Permanent Disability, the Option will fully vest with
respect to any unvested Option Shares and will become exercisable; provided that you satisfy the
conditions described in Section III.G.1; and provided further that any such Option Shares that vest in
accordance with this Section III.B. (and any Option Shares that were already vested at the time your
Permanent Disability occurred) shall be exercisable for two years following the occurrence of your
Permanent Disability, but in no event shall the Option be exercisable after the Option Expiration Date.
C. Termination by You – Age and Service Treatment. If you have satisfied Age and Service Criteria I
(as defined in Section V.) or Age and Service Criteria II (as defined in Section V.) on or before the date
you terminate your employment with the Company for any reason other than death or the occurrence of
your Permanent Disability, then:
1. If you have satisfied Age and Service Criteria I but not Age and Service Criteria II, your rights, title
and interest in and to any unvested Option Shares will be canceled upon such termination of
employment. Provided that you satisfy the conditions described in Section III.G.1., any Option
Shares that were vested at the time of your termination of employment shall be exercisable until the
earlier of the fifth anniversary of your termination of employment and the Option Expiration Date.
2. If you have satisfied Age and Service Criteria II, the Option will continue to vest with respect to
any unvested Option Shares as provided in Section II.B.2. as if your employment had not terminated
and the Option Shares will become exercisable as provided in Section II.B.4., provided that you
satisfy the conditions described in Section III.G.1. Provided that you satisfy the conditions described
in Section III.G.1., any such Option Shares that vest (and any Option Shares that were already
vested at the time of your termination of employment) shall be exercisable until the earlier of the
fifth anniversary of your termination of employment and the Option Expiration Date.
4
-- 77 of 156 --
For the avoidance of doubt, Section III.D. will govern the treatment of the Award in the event your
employment is terminated by the Company other than for Cause (as defined in Section V.).
For the avoidance of doubt, the date of your termination of employment for purposes of determining
whether you have satisfied either Age and Service Criteria I or Age and Service Criteria II under this
Section III.C. will be determined in accordance with Section III.F.
Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it has received an
opinion of counsel that there has been a legal judgment and/or legal development in the jurisdiction
where you are employed that would likely result in the favorable treatment applicable to the Option
pursuant to this Section III.C. being deemed unlawful and/or discriminatory, then the Company will not
apply this favorable treatment upon your termination of employment, and the Option will be treated as
set forth in the other subparagraphs of this Section III., as applicable.
D. Termination by the Company Other Than for Cause.
1. Treatment of Stock Options.
a. General. Except as otherwise provided in Sections III.D.1.b., III.D.1.c., and IV., in the event
the Company, in its sole discretion, determines that your employment is terminated other than
for Cause, your rights, title and interest in and to any unvested Option Shares will be canceled
upon such termination of employment. Provided that you satisfy the conditions described in
Section III.G.2., any Option Shares that were vested at the time of your termination of
employment shall be exercisable until the earlier of 90 days following your termination of
employment and the Option Expiration Date.
b. Termination by the Company Other Than for Cause After Satisfaction of Age and
Service Criteria I but not Age and Service Criteria II. In the event the Company, in its sole
discretion, determines that your employment is terminated other than for Cause, and on or
before such time you satisfy Age and Service Criteria I but not Age and Service Criteria II, your
rights, title and interest in and to any unvested Option Shares will be canceled upon such
termination of employment. Provided that you satisfy the conditions described in Section III.G.2.,
any Option Shares that were vested at the time of your termination of employment shall be
exercisable until the earlier of the fifth anniversary of your termination of employment and the
Option Expiration Date.
c. Termination by the Company Other Than for Cause After Satisfaction of Age and
Service Criteria II. In the event the Company, in its sole discretion, determines that your
employment is terminated other than for Cause, and on or before such time you satisfy Age and
Service Criteria II, the Option will continue to vest with respect to any unvested Option Shares as
provided in Section II.B.2. as if your employment had not terminated and the Option Shares will
become exercisable as provided in Section II.B.4.;
5
-- 78 of 156 --
provided that you satisfy the conditions described in Section III.G.2. Provided that you satisfy the
conditions described in Section III.G.2., any such Option Shares that vest (and any Option Shares
that were already vested at the time of your termination of employment) shall be exercisable
until the earlier of the fifth anniversary of your termination of employment and the Option
Expiration Date.
2. Important Notes.
a. Sale of Business Unit. For purposes of this Award, in the event of a sale or similar transaction
involving the business unit for which you work (“Employing Company”) as a result of which the
Employing Company ceases to be a subsidiary or affiliate of Marsh, your employment will be
deemed terminated by the Company other than for Cause, even if your employment with the
Employing Company continues after the sale or similar transaction.
b. Constructive Discharge. The Award will not vest upon a constructive discharge, including if
any court or regulatory agency retroactively concludes or interprets events to have constituted a
constructive discharge.
E. All Other Terminations. For all other terminations of employment not described in Sections III.A.
through D. or Section IV. (including, but not limited to, a termination by the Company for Cause, or
your resignation without having satisfied either Age and Service Criteria I or Age and Service Criteria II
as described in Section III.C.), any rights, title and interest in and to any remaining unvested portion of
the Award shall be cancelled as of the date your employment is treated as having terminated as
described in Section III.F. Provided that you satisfy the conditions described in Section III.G.1., any
Option Shares that were vested at the time of your termination of employment (except if you are
terminated by the Company for Cause) shall be exercisable until the earlier of 90 days following your
termination of employment and the Option Expiration Date. If you are terminated by the Company for
Cause, any rights, title and interest in and to any remaining vested or unvested portion of the Award
shall be cancelled as of the date your employment is treated as having terminated as described in
Section III.F.
F. Date of Termination of Employment.
1. If Section III.F.2 does not apply to you, then for purposes of determining vesting under Section
II.B.2., your employment will be treated as having terminated on your last day of employment with
the Company.
2. If you are obligated (whether by law or contract) to provide the Company advance notice of your
intention to terminate your employment or service relationship then, in the event you terminate your
employment pursuant to Section III.C., or III.E. (regardless of the reason for such termination and
whether or not later found to be invalid or in breach of employment laws in the jurisdiction where
you are employed or the terms of your employment agreement, if any), for purposes of determining
vesting under Section II.B.2., your
6
-- 79 of 156 --
employment will be treated as having terminated on your last day of active service with the
Company, as determined by the Company in its sole discretion.
You shall be deemed to have ceased active service with the Company when you are no longer
required by the Company to provide regular services to the Company even if you remain legally
employed by the Company, such as may occur if the Company were to place you on “garden leave”,
a terminal leave of absence or any similar period mandated under employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any (in each
case as determined by the Company in its sole discretion).
G. Conditions for All or a Portion of an Award to Remain Outstanding Following a Termination of
Employment and Exercisability of Options Following a Termination of Employment.
1. Restrictive Covenants Agreement. In the event of (i) the occurrence of your Permanent
Disability as described in Section III.B., (ii) your termination of employment after satisfying either
Age and Service Criteria I or Age and Service Criteria II as described in Sections III.C., or (iii) your
termination of employment (other than a termination by the Company for Cause) as described in
Section III.E., you will be required to execute or reaffirm, as determined by Marsh in its sole
discretion, and return to Marsh (or an agent appointed by Marsh) a Restrictive Covenants
Agreement. Failure to (a) execute or reaffirm such an agreement by the date specified by the
Company, which shall be in no event later than 60 days following the occurrence of your Permanent
Disability as described in Section III.B. or your termination of employment as described in Section
III.C. or III.E., or (b) comply with the Restrictive Covenants Agreement will result in the cancellation
or forfeiture of any rights, title and interest in and to the Award without any liability to the Company.
2. Waiver and Release and Restrictive Covenants Agreement. In the event of your termination
of employment by the Company other than for Cause as described in Section III.D., you will be
required to (i) execute or reaffirm, as determined by Marsh in its sole discretion, and return to Marsh
(or an agent appointed by Marsh) a Restrictive Covenants Agreement and (ii) execute and not
revoke a waiver and release agreement, if provided to you by the Company at the time of your
termination of employment. Failure to meet these requirements by the date specified by the
Company, which shall be in no event later than 60 days following your termination of employment,
or failure to comply with the waiver and release agreement or the Restrictive Covenants Agreement,
as applicable, or failure to continue to be in compliance with the applicable agreement will result in
the cancellation or forfeiture of any rights, title and interest in and to the Award without any liability
to the Company.
7
-- 80 of 156 --
IV. CHANGE IN CONTROL PROVISIONS
A. Treatment of Stock Options. Upon the occurrence of a Change in Control (as defined in Section V.), the
Option Shares will continue to vest in accordance with the vesting schedule specified in Section II.B.2.
and subject to earlier vesting or forfeiture pursuant to Section III.; provided that the Option Shares will
become fully vested at your termination of employment by the Company other than for Cause, or by
you for Good Reason (as defined in Section V.), during the 24-month period following such Change in
Control and will be treated as set forth below, provided that you satisfy the conditions described in
Section IV.B. Notwithstanding the foregoing, if the Option Share is not assumed, converted or replaced
in connection with a Change in Control on an equivalent basis, the Option Shares will fully vest
immediately prior to the Change in Control and will be treated as follows:
Provided that you satisfy the conditions described in Section IV.B., any such Option Shares that vest
(and any Option Shares that were already vested at the time of your termination of employment) shall
be exercisable until the earlier of (a) 90 days following your termination of employment or the
occurrence of the Change in Control, as applicable, and (b) the Option Expiration Date.
B. Waiver and Release. In the event of your termination of employment by the Company other than for
Cause or by you for Good Reason during the 24-month period following such Change in Control, you will
be required to execute and not revoke a waiver and release agreement, if provided by the Company at
the time of your termination of employment. Failure to meet these requirements by the date specified
by the Company, which shall be in no event later than 60 days following your termination of
employment, or failure to comply with the waiver and release agreement, and be in compliance with the
agreement, if applicable, will result in the cancellation or forfeiture of any rights, title and interest in and
to the Award.
C. Other Matters. For the avoidance of doubt, in the event of your termination of employment by the
Company other than for Cause or by you for Good Reason during the 24-month period following such
Change in Control and, on or before the date of your termination of employment you satisfy either Age
and Service Criteria I or Age and Service Criteria II as described in Section III.C., any unvested Options
covered by the Award will be treated as described in this Section IV.; provided that you satisfy or have
satisfied, as applicable, the conditions described in Section IV.B.; provided further that (i) if you satisfy
Age and Service Criteria II, any such Option Shares that vest (and any Option Shares that were already
vested at the time of your termination of employment) shall be exercisable until the earlier of the fifth
anniversary of your termination of employment and the Option Expiration Date, and (ii) if you satisfy
Age and Service Criteria I but not Age and Service Criteria II, any such Option Shares that were already
vested at the time of your termination of
8
-- 81 of 156 --
employment shall be exercisable until the earlier of the fifth anniversary of your termination of
employment and the Option Expiration Date.
V. DEFINITIONS
As used in these Terms and Conditions:
A. “Age and Service Criteria I” shall mean you are at least age 55 but are not yet age 62 and have a
minimum of five years of service with the Company.
B. “Age and Service Criteria II” shall mean you are at least age 62 and have a minimum of five years
of service with the Company.
C. “Cause” shall mean:
1. willful failure to substantially perform the duties consistent with your position which is not
remedied within 30 days after receipt of written notice from the Company specifying such failure;
2. willful violation of any written Company policies, including but not limited to, The Marsh Code of
Conduct, The Greater Good;
3. commission at any time of any act or omission that results in a conviction, plea of no contest, plea
of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral
turpitude;
4. unlawful use (including being under the influence) or possession of illegal drugs;
5. any gross negligence or willful misconduct resulting in a material loss to the Company, or material
damage to the reputation of the Company; or
6. any violation of any statutory or common law duty of loyalty to the Company, including the
commission at any time of any act of fraud, embezzlement, or material breach of fiduciary duty
against the Company.
D. “Change in Control” shall have the meaning set forth in the Plan.
E. “Committee” shall mean the Compensation Committee of the Board of Directors of Marsh.
F. “Company” shall mean Marsh or any of its subsidiaries or affiliates.
G. “Good Reason” shall mean any one of the following events without your written consent:
1. material reduction in your base salary;
2. material reduction in your annual incentive opportunity (including a material adverse change in the
method of calculating your annual incentive);
3. material diminution of your duties, responsibilities or authority; or
4. relocation of more than 50 miles from your principal place of employment immediately prior to the
Change in Control; provided that you provide Marsh with written notice of your intent to terminate
your
9
-- 82 of 156 --
employment for Good Reason within 60 days of your becoming aware of any circumstances set forth
above (with such notice indicating the specific termination provision above on which you are relying
and describing in reasonable detail the facts and circumstances claimed to provide a basis for
termination of your employment under the indicated provision) and that you provide Marsh with at
least 30 days following receipt of such notice to remedy such circumstances.
H. “Permanent Disability” will be deemed to occur when it is determined (by Marsh’s disability carrier for
the primary long-term disability plan or program applicable to you because of your employment with the
Company) that you are unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in death or can be expected
to last for a continuous period of not less than 12 months.
I. “Tax-Related Items” shall have the meaning ascribed to such term in the Plan.
VI. ADDITIONAL PROVISIONS
A. Additional Provisions—General
1. Administrative Rules. The Award shall be subject to such additional administrative regulations as
the Committee (as defined in Section V.) may, from time to time, adopt. All decisions of the
Committee upon any questions arising under the Award Documentation shall be conclusive and
binding. The Committee may delegate to any other individual or entity the authority to perform any
or all of the functions of the Committee under the Award, and references to the Committee shall be
deemed to include any such delegate.
2. Amendment. The Committee may, in its sole discretion, amend the terms of the Award, including,
without limitation, to impose additional requirements on the Award and on any shares of Common
Stock acquired with respect to the Award; provided, however, that if the Committee concludes, in its
sole discretion, that such amendment is likely to materially impair your rights with respect to the
Award, such amendment shall not be implemented with respect to the Award without your consent,
except to the extent that any such action (a) is made to cause the Award to comply with applicable
law, currency controls, stock market or exchange rules and regulations, or accounting or tax rules
and regulations, (b) is made to obtain or maintain corporate tax deductibility or other favorable tax
treatment with respect to the Award, or (c) is otherwise made in accordance with Section VI.A.4.
3. Limitations. Payment of the Award is not secured by trust, insurance contract or other funding
medium, and you do not have any interest in any fund or specific asset of Marsh by reason of the
Award. Your right to payment of the Award is the same as the right of an unsecured general creditor
of Marsh.
4. Cancellation or Clawback of Awards.
10
-- 83 of 156 --
a. Marsh may, to the extent permitted or required by any applicable law, stock exchange rules,
currency controls, or the Company Incentive Compensation Clawback Policy or any other
applicable Company policy or arrangement in effect prior to the vesting of any unvested portion
of the Award, or as specified in the Award Documentation, cancel, reduce or require
reimbursement of the Award in the event of fraud, financial restatements, or other events as may
be determined by the Committee.
b. If you fail to repay any amount due pursuant to this Section VI.A.4., the Company may bring an
action in court to recover the amount due. You acknowledge that, by accepting the Award, you
agree to pay all costs, expenses and attorney’s fees incurred by the Company in any proceeding
for the collection of amounts due pursuant to this Section VI.A.4., provided that the Company
prevails in whole or in part in any such proceeding. The Company may also, to the extent
permitted by applicable law, reduce any amounts owed to you by the Company in an amount up
to the full amount of the repayment due.
5. Governing Law; Choice of Forum. The Award and the Award Documentation applicable to the
Award are governed by and subject to the laws of the State of Delaware, without regard to the
conflict of law provisions, as set forth in Section 10.K of the Plan. For purposes of any action,
lawsuit, or other proceedings arising out of or relating to this Award, including without limitation, to
enforce the Award Documentation, the Company and you each hereby irrevocably and
unconditionally submits to the exclusive jurisdiction of any New York state court or federal court of
the United States of America sitting in the State of New York, and any appellate court thereof. The
Company and you agree that a final judgment in any such action or proceeding shall be conclusive
and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by law.
6. Severability; Captions. In the event that any provision of this Award is determined to be invalid
or unenforceable, in whole or in part, the remaining provisions of this Award will be unaffected
thereby and will remain in full force and effect to the fullest extent permitted by law. The captions of
this Award are not part of the provisions of this Award and will have no force or effect.
7. Electronic Delivery and Acceptance. Marsh may, in its sole discretion, decide to deliver any
documents related to the Award and/or your current or future participation in the Plan by electronic
means. You hereby consent to receive such documents by electronic delivery and agree to
participate in the Plan through an on-line or electronic system established and maintained by Marsh
or an agent appointed by Marsh.
8. Waiver. You acknowledge that neither a waiver by Marsh of your breach of any provision of the
Award Documentation nor a prior waiver by Marsh of a breach of any provision of the Award
Documentation by any other participant of the Plan shall operate or be construed as a
11
-- 84 of 156 --
waiver of any other provision of the Award Documentation, or of any subsequent breach by you.
9. Eligibility for Award. In order to be granted an Award, you must satisfy the eligibility criteria for
grantees set forth in the Plan as of the grant date.
B. Additional Provisions—Outside of the United States
1. Changes to Delivery. In the event that Marsh considers that due to legal, regulatory or tax issues
the normal exercise of an Award (as described in these Terms and Conditions) by a participant
outside the United States would not be appropriate, then Marsh may, in its sole discretion, determine
how and when the value of the Award will be delivered. Without limitation, this may include making
any payments due under the Award in an amount equivalent to the value of the Award on the date of
exercise after payment of applicable Tax-Related Items and fees and any exercise price. If the value
of an Award is to be delivered in cash instead of shares of Common Stock, Marsh may sell any
shares of Common Stock distributable in respect of the Award on your behalf and use the proceeds
(after payment of applicable Tax-Related Items, fees and any exercise price) to satisfy the Award.
2. Amendment and Modification. The Committee may modify the terms of any Award under the
Plan granted to you in any manner deemed by the Committee to be necessary or appropriate in
order for such Award to conform to laws, regulations and customs of the country (other than the
United States) in which you are then resident or primarily employed or were resident or primarily
employed at the time of grant or during the term of the Award, or so that the value and other
benefits of the Award to you, as affected by non-U.S. tax laws and other restrictions applicable as a
result of your residence or employment outside of the United States, shall be comparable to the
value of such an Award to an individual who is resident or primarily employed in the United States.
VII. QUESTIONS AND ADDITIONAL INFORMATION
Please retain this document in your permanent records. If you have any questions regarding the Award
Documentation or if you would like an account statement detailing each type of equity-based award and the number
of shares of Common Stock covered by such equity-based award that comprises the Award, and the exercise price,
vesting date(s) and expiration date of such equity-based awards that comprise the Award, or any other information,
please contact:
Executive Compensation
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036-2774
United States of America
Telephone Number: +1 212 345-9722
Email: mmc.compensation@mmc.com
12
-- 85 of 156 --
IN WITNESS WHEREOF, Marsh has caused these Terms and Conditions to be duly executed by the facsimile signature
of its Senior Vice President, Chief People Officer as of the day and year first above written. By consenting to these
Terms and Conditions, you agree to the following: (i) you have carefully read, fully understand and agree to all of the
terms and conditions described herein and in the Award Documentation; and (ii) you understand and agree that
these Terms and Conditions and the Award Documentation constitute the entire understanding between you and
Marsh regarding the Award, and that any prior agreements, commitments or negotiations concerning the Award are
replaced and superseded. The grant of the Award is contingent upon your acceptance of these Terms and Conditions,
Country-Specific Notices and Restrictive Covenants Agreement (if applicable) by the date and in the manner specified
in materials provided to you by Executive Compensation and/or the Company’s stock plan service provider. If you
decline the Award or you do not accept the Award and any applicable documents described in the preceding sentence
by the date and in the manner specified, the Award will be cancelled as of the grant date of the Award.
/s/ Carmen Fernandez
Carmen Fernandez
SVP, Chief People Officer
13
-- 86 of 156 --
MARSH & McLENNAN COMPANIES, INC.
AMENDED AND RESTATED 2020 INCENTIVE AND STOCK AWARD PLAN
TERMS AND CONDITIONS
OF
PERFORMANCE STOCK UNIT AWARDS
GRANTED ON [DATE], 2026
-- 87 of 156 --
TABLE OF CONTENTS
Page
I. BACKGROUND 1
II. AWARDS 1
III. EMPLOYMENT EVENTS 4
IV. CHANGE IN CONTROL PROVISIONS 11
V. DEFINITIONS 13
VI. ADDITIONAL PROVISIONS 14
VII. QUESTIONS AND ADDITIONAL INFORMATION 17
-- 88 of 156 --
I. BACKGROUND
A Performance Stock Unit award (“Award”) has been granted to you under the Marsh & McLennan Companies,
Inc. Amended and Restated 2020 Incentive and Stock Award Plan (the “Plan”), subject to your acceptance as
described in Section II.A.1. The number of shares of Marsh & McLennan Companies, Inc. (“Marsh”) common
stock covered by the Award, instructions on how to accept or decline the Award and the deadline for accepting
the Award will be provided to you by Executive Compensation and/or the stock plan service provider of the
Company (as defined in Section V.). The Award is also subject to the terms and conditions set forth herein (the
“Terms and Conditions”) and to additional terms and conditions as set forth in the country-specific notices (the
“Country-Specific Notices”). The Prospectus dated [DATE], also describes important information about the
Plan. The Terms and Conditions, the Country-Specific Notices and the Plan will be referred to herein as the
“Award Documentation”. As used herein, “Common Stock” means common stock of Marsh.
Capitalized terms in these Terms and Conditions are defined in Section V.
II. AWARDS
A. General.
1. Award Acceptance. The grant of this Award is contingent upon your acceptance, by the date and in
the manner specified by Executive Compensation and/or the Company’s stock plan service provider,
of these Terms and Conditions, the Country-Specific Notices and Restrictive Covenants Agreement as
described in Section II.A.3. If you decline the Award or if you do not accept the Award and any
applicable documents described in the preceding sentence by the deadline date and in the manner
specified, then the Award will be cancelled as of the grant date of the Award.
2. Rights of Award Holders. Unless and until the vesting conditions of the Award have been
satisfied and cash or shares of Common Stock, as applicable, have been delivered to you in
accordance with the Award Documentation, you have only the rights of a general unsecured creditor
of Marsh. Unless and until shares of Common Stock have been delivered to you, you have none of
the rights of ownership to such shares (e.g., units cannot be used as payment for stock option
exercises; units may not be transferred or assigned; units have no voting rights, etc.).
3. Restrictive Covenants Agreement. As described in Section II.A.1., a Restrictive Covenants
Agreement (“Restrictive Covenants Agreement”) in a form determined by Marsh must be in place in
order to accept the Award, you must execute or reaffirm, as determined by Marsh in its sole
discretion, the Restrictive Covenants Agreement in order for the Award to vest pursuant to certain
employment events as described in Section III., and you must further execute or reaffirm, as
determined by Marsh in its sole discretion, and be in compliance with the Restrictive Covenants
Agreement in order for the Award to become distributable to you whether or not you are employed
by the Company at that time. Failure to timely execute the Restrictive Covenants
1
-- 89 of 156 --
Agreement by the date specified by the Company or failure to timely execute or reaffirm and comply
with the Restrictive Covenants Agreement as described in Section III.H.1. or 2., as applicable, will
result in cancellation or forfeiture of any rights, title and interest in and to the Award, without any
liability to the Company.
B. Performance Stock Units.
1. General. A performance stock unit (“PSU”) represents an unfunded and unsecured promise to
deliver (or cause to be delivered) to you, subject to the terms of the Award Documentation, a
minimum of zero (0) and up to a maximum of two (2) shares of Common Stock after vesting,
depending on the achievement, as determined by the Compensation Committee of the Board of
Directors of Marsh (the “Committee”), of the Company earnings per share performance factor (the
“EPS Performance Factor”) and relative shareholder return modifier (“Relative TSR Modifier”)
performance objectives established by the Committee for the Performance Period (as defined in
Section V.). In the event of your termination of employment or occurrence of your Permanent
Disability (as defined in Section V.) prior to the PSU Scheduled Vesting Date (defined below), the
number of shares of Common Stock deliverable in respect of a PSU shall be determined as provided
in Sections III. and IV.
2. Vesting. Subject to your continued employment, the PSUs are scheduled to vest on [DATE] (the
“PSU Scheduled Vesting Date”). In the event of your termination of employment, the occurrence of
your Permanent Disability or the occurrence of a Change in Control (as defined in the Plan) prior to
the PSU Scheduled Vesting Date, your right to the PSUs will be determined in accordance with
Section III. or Section IV., as applicable. For the avoidance of doubt, the date of your termination of
employment for purposes of this Section II.B.2. will be determined in accordance with Section III.G.
3. Dividend Equivalents. A payment will be made that is equal to the dividend payment (if any) that
would have been made, on each dividend record date that occurs on or after the date of grant while
the PSUs are outstanding, in respect of the number of shares of Common Stock that is determined
under Section II.B.1. to be delivered in respect of vested PSUs (a “Dividend Equivalent”). Dividend
Equivalents will vest when the PSUs, in respect of which such Dividend Equivalents were calculated,
vest. Prior to the determination described in Section II.B.1., for each outstanding PSU, an amount
equal to the dividend payment (if any) made in respect of one share of Common Stock will accrue in
U.S. dollars on each dividend record date that occurs on or after the grant date of the Award while
the Award is outstanding, with no interest paid on such amounts. No further dividend equivalents will
accrue on PSUs that do not vest or are cancelled or forfeited. If a pro-rata amount of the outstanding
unvested PSUs is eligible to vest upon a termination of employment as described in Section III.C.
and III.E., the pro-rata calculation applied to the outstanding PSUs described in Section III.I. will be
applied to the dividend equivalents that have accrued on the Award as of the
2
-- 90 of 156 --
date of termination. Accrued dividend equivalents will not be paid, and no further dividend
equivalents will accrue, on PSUs that do not vest or are cancelled or forfeited as described in Section
III.F.
4. Delivery.
a. Shares of Common Stock deliverable, if any, in respect of the PSUs covered by the Award that
vest on the PSU Scheduled Vesting Date shall be delivered to you as soon as practicable following
the PSU Scheduled Vesting Date, and in no event later than 60 days following the PSU Scheduled
Vesting Date, except as otherwise provided in Sections III., IV., and VI.B.
b. The value of vested Dividend Equivalents that vest on the PSU Scheduled Vesting Date will be
delivered to you in cash as soon as practicable after delivery of the shares of Common Stock
described in II.B.4.a. above, and in no event later than 60 days following the PSU Scheduled
Vesting Date, except as otherwise provided in Sections III., IV., and VI.B.
c. The delivery of shares of Common Stock and/or cash or other property that may be deliverable
under these Terms and Conditions, is conditioned on the satisfaction or withholding of any
applicable tax obligations, as described in Section II.C.
d. Any shares of Common Stock and/or cash or other property that may be deliverable following
your death shall be delivered to the person or persons to whom your rights pass by will or the law
of descent and distribution, and such delivery shall completely discharge the Company’s
obligations under the Award.
e. Notwithstanding the foregoing, additional delivery rules for certain Award recipients subject to
U.S. federal income tax (whether or not the recipient is a U.S. citizen or employed in the U.S.)
are reflected in Section III.J.
C. Satisfaction of Tax Obligations.
1. Personal Tax Advisor. Neither the Company nor any Company employee is authorized to provide
personal tax advice to you. It is recommended that you consult with your personal tax advisor for
more detailed information regarding the tax treatment of the Award, especially before making any
decisions that rely on that tax treatment.
2. U.S. Employees - Performance Stock Units and Dividend Equivalents. Applicable
employment taxes are required by law to be withheld when a PSU or Dividend Equivalent vests, or, if
later, when the number of shares of Common Stock deliverable in respect of a PSU (or the amount of
cash payable in respect of a Dividend Equivalent corresponding to a PSU) is determined. Applicable
income taxes are required by law to be withheld when shares of Common Stock in respect of PSUs or
cash in respect of Dividend Equivalents are delivered to you. A sufficient number of whole shares of
Common Stock, cash or other property, as applicable, will be retained by Marsh to satisfy the tax
withholding obligation.
3. Non-U.S. Employees.
3
-- 91 of 156 --
a. Performance Stock Units and Dividend Equivalents. In most countries, the value of a PSU
or Dividend Equivalent is generally not taxable on the grant date. If the value of the PSU or
Dividend Equivalent is not taxable on the grant date, it will, in most countries, be taxed at a later
time, for example, upon delivery of a share of Common Stock in respect of the PSU that vests,
and/or the subsequent sale of the share of Common Stock received in connection with the vesting
of the PSU, or upon delivery of cash in respect of a Dividend Equivalent.
b. Withholding. Marsh and/or your employer shall have the power and the right to deduct and
withhold from the Award and other compensation or to require you to remit to Marsh and/or to
your employer, an amount sufficient to satisfy any Tax-Related Items (as defined in Section V.)
that Marsh expects to be payable under the laws of any country, state, province, city or other
jurisdiction. If applicable, Marsh and/or your employer will, to the extent permissible under
applicable law or otherwise agreed between you and Marsh and/or your employer, either (a)
withhold from proceeds of the sale a sufficient number of whole shares of Common Stock issued
to you in settlement of the Award (either through your voluntary sale or through a mandatory
sale arranged by Marsh on your behalf) for purposes of satisfying applicable obligations with
respect to Tax-Related Items and/or (b) withhold a sufficient number of whole shares of Common
Stock distributable to you in in respect of the Award to satisfy applicable obligations with respect
to Tax-Related Items. Further, depending on the withholding method, Marsh and/or your
employer may withhold or account for obligations for Tax-Related Items by considering statutory
or other withholding rates, including minimum or maximum rates applicable in your
jurisdiction(s).
In the event of over-withholding, you may receive a refund from Marsh and/or your employer of
any over-withheld amount in cash (with no entitlement to the equivalent in shares of Common
Stock), or if not refunded by Marsh and/or your employer, you must seek a refund from the local
tax authorities to the extent you wish to recover the over-withheld amount in the form of a
refund.
III. EMPLOYMENT EVENTS
A. Death. In the event your employment is terminated because of your death, all of the unvested PSUs that
are outstanding as of the date of your death will fully vest and will be distributed within 60 days
following such date. The Performance Period will be deemed to have ended on December 31st of the
year immediately preceding the date of your death, and the number of shares of Common Stock
distributable in respect of the PSUs will be determined in accordance with Section II.B.1.; provided that,
in the event that your death occurs on or prior to December 31st of the
4
-- 92 of 156 --
year in which the PSUs are granted, you will receive one (1) share of Common Stock in respect of each
PSU.
B. Permanent Disability. Upon the occurrence of your Permanent Disability, all of the unvested PSUs that
are outstanding as of the occurrence of your Permanent Disability will remain outstanding until the PSU
Scheduled Vesting Date and will be distributed as soon as practicable following the PSU Scheduled
Vesting Date as described in Section II.B.4.; provided that you have satisfied the conditions described in
Section III.H.1.; and provided further that the number of shares of Common Stock distributable in
respect of such PSUs will be determined in accordance with Section II.B.1.
C. Termination by You– Age and Service Pro-Rata Vesting. If you have satisfied the Age and Service
Criteria for Pro-Rata Vesting (as defined in Section V.) but do not satisfy the Age and Service Criteria for
Full Vesting (as defined in Section V.) on or before the date you terminate your employment with the
Company for any reason other than death or the occurrence of your Permanent Disability, then this
Section III.C. shall apply. For the avoidance of doubt, Section III.E. will govern the treatment of the
Award in the event your employment is terminated by the Company other than for Cause (as defined in
Section V.).
Upon such termination of employment, a pro-rata portion of the unvested PSUs that are outstanding as of
such termination of employment will remain outstanding (as described in Section III.I.) until the PSU
Scheduled Vesting Date and will be distributed as soon as practicable following the PSU Scheduled
Vesting Date as described in Section II.B.4.; provided that you have satisfied the conditions described in
Section III.H.1., and provided further that the number of shares of Common Stock distributable in
respect of such PSUs will be determined in accordance with Section II.B.1. The portion of the unvested
PSUs that does not remain outstanding pursuant to this paragraph will be forfeited and cancelled.
For the avoidance of doubt, the date of your termination of employment for purposes of determining
whether you have satisfied the Age and Service Criteria for Pro-Rata Vesting under this Section III.C.
will be determined in accordance with Section III.G.
Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it has received an
opinion of counsel that there has been a legal judgment and/or legal development in the jurisdiction
where you are employed that would likely result in the favorable treatment applicable to the Stock Units
pursuant to this Section III.C. being deemed unlawful and/or discriminatory, then the Company will not
apply this favorable treatment upon your termination of employment, and the Stock Units will be
treated as set forth in the other subparagraphs of this Section III., as applicable.
D. Termination by You – Age and Service Full Vesting. If you have satisfied the Age and Service
Criteria for Full Vesting on or before the date you terminate your employment with the Company for any
reason other
5
-- 93 of 156 --
than death or the occurrence of your Permanent Disability, then this Section III.D. shall apply. For the
avoidance of doubt, Section III.E. will govern the treatment of the Award in the event your employment
is terminated by the Company other than for Cause.
Upon such termination of employment, all of the unvested PSUs that are outstanding as of such termination
of employment will remain outstanding until the PSU Scheduled Vesting Date and will be distributed as
soon as practicable following the PSU Scheduled Vesting Date as described in Section II.B.4.; provided
that you have satisfied the conditions described in Section III.H.1., and provided further that the
number of shares of Common Stock distributable in respect of such PSUs will be determined in
accordance with Section II.B.1.
For the avoidance of doubt, the date of your termination of employment for purposes of determining
whether you have satisfied the Age and Service Criteria for Full Vesting under this Section III.D. will be
determined in accordance with Section III.G.
Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it has received an
opinion of counsel that there has been a legal judgment and/or legal development in the jurisdiction
where you are employed that would likely result in the favorable treatment applicable to the Stock Units
pursuant to this Section III.D. being deemed unlawful and/or discriminatory, then the Company will not
apply this favorable treatment upon your termination of employment, and the Stock Units will be
treated as set forth in the other subparagraphs of this Section III., as applicable.
E. Termination by the Company Other Than for Cause.
1. Treatment of Performance Stock Units.
a. General. Except as otherwise provided in Sections III.E.1.b. and IV., in the event the Company,
in its sole discretion, determines that your employment is terminated other than for Cause, a pro-
rata portion of the unvested PSUs that are outstanding as of such termination of employment will
remain outstanding (as described in Section III.I.) until the PSU Scheduled Vesting Date and will
be distributed as soon as practicable following the PSU Scheduled Vesting Date as described in
Section II.B.4.; provided that you have satisfied the conditions described in Section III.H.2., and
provided further that the number of shares of Common Stock distributable in respect of such
PSUs will be determined in accordance with Section II.B.1. The portion of the unvested PSUs that
does not remain outstanding pursuant to this paragraph will be forfeited and cancelled. For the
avoidance of doubt, this Section III.E.1.a. shall apply regardless of whether you have satisfied
the Age and Service Criteria for Pro-Rata Vesting on or before your termination of employment by
the Company.
b. Termination by the Company Other Than for Cause After Satisfaction of Age and
Service Criteria for Full Vesting. In the event the Company, in its sole discretion, determines
that your
6
-- 94 of 156 --
employment is terminated other than for Cause, and on or before such time you satisfy the Age
and Service Criteria for Full Vesting, all unvested PSUs that are outstanding as of such
termination of employment will remain outstanding until the PSU Scheduled Vesting Date and will
be distributed as soon as practicable following the PSU Scheduled Vesting Date as described in
Section II.B.4.; provided that you have satisfied the conditions described in Section III.H.2., and
provided further that the number of shares of Common Stock distributable in respect of such
PSUs will be determined in accordance with Section II.B.1.
2. Important Notes.
a. Sale of Business Unit. For purposes of this Award, in the event of a sale or similar transaction
involving the business unit for which you work (“Employing Company”) as a result of which the
Employing Company ceases to be a subsidiary or affiliate of Marsh, your employment will be
deemed terminated by the Company other than for Cause, even if your employment with the
Employing Company continues after the sale or similar transaction.
b. Constructive Discharge. The Award will not vest, whether on a pro-rata or full basis, upon a
constructive discharge, including if any court or regulatory agency retroactively concludes or
interprets events to have constituted a constructive discharge.
F. All Other Terminations. For all other terminations of employment not described in Sections III.A.
through E. or Section IV. (including, but not limited to, a termination by the Company for Cause, or your
resignation without having satisfied the Age and Service Criteria for Pro-Rata Vesting as described in
Section III.C., or the Age and Service Criteria for Full Vesting as described in Section III.D.), any rights,
title and interest in and to any remaining unvested portion of the Award shall be cancelled as of the
date your employment is treated as having terminated as described in Section III.G.
G. Date of Termination of Employment.
1. If Section III.G.2. does not apply to you, then for purposes of determining vesting under Section
II.B.2. and the number of unvested PSUs that vest on a pro-rata basis as described in Section III.I.,
your employment will be treated as having terminated on your last day of employment with the
Company.
2. If you are obligated (whether by law or contract) to provide the Company advance notice of your
intention to terminate your employment then, in the event you terminate your employment or
service relationship pursuant to Section III.C., III.D., or III.F. (and regardless of the reason for such
termination and whether or not later found to be invalid or in breach of employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any), for
purposes of determining vesting under Section II.B.2. and the pro rata calculation described in
Section III.I., your employment will be treated as having terminated on your last day of active
service
7
-- 95 of 156 --
with the Company, as determined by the Company in its sole discretion.
You shall be deemed to have ceased active service with the Company when you are no longer
required by the Company to provide regular services to the Company even if you remain legally
employed by the Company, such as may occur if the Company were to place you on “garden leave”,
a terminal leave of absence or any similar period mandated under employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any (in each
case as determined by the Company in its sole discretion).
H. Conditions for All or a Portion of an Award to Remain Outstanding Following a Termination of
Employment.
1. Restrictive Covenants Agreement. In the event of (i) the occurrence of your Permanent
Disability as described in Section III.B. or (ii) your termination of employment after satisfying the
Age and Service Criteria for Pro-Rata Vesting or the Age and Service Criteria for Full Vesting as
described in Sections III.C. and D., respectively, you will be required to execute or reaffirm, as
determined by Marsh in its sole discretion, and return to Marsh (or an agent appointed by Marsh) a
Restrictive Covenants Agreement. Failure to (a) execute or reaffirm such an agreement by the date
specified by the Company, which shall be in no event later than 60 days following the occurrence of
your Permanent Disability as described in Section III.B. or your termination of employment as
described in Section III.C. or III.D. (b) comply with the Restrictive Covenants Agreement or to
continue to be in compliance with the Restrictive Covenants Agreement as of the delivery date for
Performance Stock Units (as described in Section II.B.4.) or, at the Company’s discretion, to reaffirm
compliance prior to the delivery date, will result in the cancellation or forfeiture of any rights, title
and interest in and to the Award without any liability to the Company.
2. Waiver and Release and Restrictive Covenants Agreement. In the event of your termination
of employment by the Company other than for Cause as described in Section III.E., you will be
required to (i) execute or reaffirm, as determined by Marsh in its sole discretion, and return to Marsh
(or an agent appointed by Marsh) a Restrictive Covenants Agreement and (ii) execute and not
revoke a waiver and release agreement, if provided to you by the Company at the time of your
termination of employment. Failure to meet these requirements by the date specified by the
Company, which shall be in no event later than 60 days following your termination of employment,
or failure to comply with the waiver and release agreement or the Restrictive Covenants Agreement,
as applicable, or failure to continue to be in compliance with the applicable agreement as of the
delivery date for Performance Stock Units (as described in Section II.B.4.) and, at the Company’s
discretion, to reaffirm compliance prior to the delivery date, will result in the cancellation or
forfeiture of any rights, title and interest in and to the Award without any liability to the Company.
8
-- 96 of 156 --
I. Determination of Pro-Rata Calculation upon Termination of Employment.
The pro-rata portion of the unvested PSUs and accrued dividend equivalents that are outstanding as of
a termination of employment that will become distributable under certain circumstances described in
Section III. will be determined using the following formula:
where
A = the number of PSUs/accrued dividend equivalents covered by the Award;
B = the number of days in the period beginning on the grant date of the Award and ending on the
date of your termination of employment, as determined in accordance with Section III.G.;
C = the number of days in the period beginning on the grant date of the Award and ending on the
PSU Scheduled Vesting Date, as applicable; and
D = the number of PSUs/accrued dividend equivalents that have previously vested, as determined in
accordance with Section III.G.
J. Section 409A of the Code for Award Recipients Subject to U.S. Federal Income Tax (whether or
not the recipient is a U.S. citizen or employed in the U.S.).
1. For Award recipients subject to U.S. federal income tax, notwithstanding any other provision
herein, the Award may be subject to additional restrictions to ensure compliance with (or continued
exemption from) the requirements of Section 409A of the Code (as defined in Section V.). The
Committee intends to administer the Award in accordance with Section 409A of the Code and
reserves the right to make changes in the terms or operations of the Award (including changes that
may have retroactive effect) deemed necessary or desirable to comply with Section 409A of the
Code. This means, for example, that the timing of distributions may be different from those
described in the Award Documentation that do not reflect Section 409A of the Code. If the Award is
not in compliance with Section 409A of the Code, you may be subject to immediate taxation of all
unpaid awards under the Plan that are subject to Section 409A of the Code at your regular federal
income tax rate, plus a 20% additional tax, plus interest at the underpayment rate plus 1%, as well
as any state and local taxes, penalties, additional taxes and interest, if applicable, imposed under
any state tax law similar to Section 409A of the Code.
2. Notwithstanding any other provision herein, if any portion of the Award is determined to be
nonqualified deferred compensation subject to Section 409A of the Code, any references to
“termination of employment,” or “when you are no longer employed” in these Terms and Conditions
shall have the following meaning:
9
-- 97 of 156 --
Your “termination of employment” (or similar terms) shall occur when you have incurred a
“separation from service” within the meaning of Section 409A of the Code and as further defined
herein. Specifically, you will have incurred a “separation from service” when the level of services you
provide to the Company in any capacity, including as an employee, director, independent contractor
or consultant, does not exceed 20% of the average level of services that you provided to the
Company in the preceding 36 months (or shorter period of service if, for example, your total service
with the Company is less than 36 months), all as determined in accordance with Section 409A of the
Code. In determining whether a “separation from service” has occurred, any period of up to six
months during which you are on a bona fide leave of absence or up to 29 months during which you
are absent from work due to a disability for which you are receiving Marsh long-term disability
benefits will be ignored.
3. Notwithstanding any other provision herein, if at the time of your termination of employment you
are a “specified employee” (as defined in Section 409A of the Code), no portion of the Award that is
determined to be nonqualified deferred compensation subject to Section 409A of the Code can be
distributed prior to the first day of the seventh month after your termination of employment and any
such distributions to which you would otherwise be entitled during the first six months following your
termination of employment will be accumulated and paid without interest on the first day of the
seventh month after your termination of employment, except to the extent that earlier distribution
would not result in your incurring interest or additional tax under Section 409A of the Code.
4. Notwithstanding any provision herein, if (i) a Change in Control occurs on or prior to December
31st of the second year of the three-year Performance Period and (ii) no earlier than in the third
year of the three-year Performance Period, (A) you satisfy the Age and Service Criteria for Pro-Rata
Vesting, (B) you satisfy the Age and Service Criteria for Full Vesting, (C) you are terminated by the
Company other than for Cause, or (D) the occurrence of your Permanent Disability, then shares of
Common Stock deliverable on the PSU Scheduled Vesting Date in respect of the PSUs covered by the
Award shall be distributed to you as soon as practicable following the PSU Scheduled Vesting Date,
and in no event later than March 15th of the year in which the PSU Scheduled Vesting Date occurs.
5. Special 409A Distribution Provisions for Performance Stock Units and payments
attributable to Performance Stock Units.
a. Notwithstanding any provision herein, with respect to distributions of PSUs or cash attributable
to such PSUs (i) where, prior to [DATE], you have satisfied or would satisfy the Age and Service
Criteria either for Full Vesting or Pro-Rata Vesting and (ii) where such distributions are subject to
one or more Employment-Related Actions (as defined in Section V.):
i. With respect to PSUs, no later than December 31 of the year in which the PSU Scheduled
Vesting Date occurs, shares of
st
10
-- 98 of 156 --
Common Stock underlying such PSUs that relate to the PSU Scheduled Vesting Date, shall be
delivered to you (to the extent not previously delivered), subject to a stop transfer order and
subject to withholding of any applicable tax obligations, as described in Section II.C. at the
time of such delivery. Upon your timely satisfaction of all applicable Employment-Related
Actions, Marsh will remove or cause to be removed such stop transfer order; and
ii. With respect to a cash payment attributable to PSUs, to the extent any such payment will
not be made by December 31 of the year in which the PSU Scheduled Vesting Date occurs,
any payment that relates to the PSU Scheduled Vesting Date shall be placed in escrow or
contributed to a secular trust (in the sole discretion of Marsh) for your benefit on or before
such December 31 and subject to withholding of any applicable tax obligations, as described
in Section II.C. at the time of such placement or contribution. Upon your timely satisfaction of
all applicable Employment-Related Actions, Marsh shall cause such amounts to be released
from escrow or paid to you out of such trust.
In either case, if any Employment-Related Action is not timely satisfied, the shares of Common
Stock or the cash payment shall revert to Marsh with no further compensation due to you.
6. Nothing in this Section III.J. is intended to nor does it guarantee that the Award will not be subject
to “additional tax” or other adverse tax consequences under Section 409A of the Code or any similar
state tax law. In no event will the Company be liable for all or any portion of any taxes, penalties,
interest or other expenses that may be incurred on account of non-compliance with Section 409A of
the Code.
IV. CHANGE IN CONTROL PROVISIONS
A. Treatment of Performance Stock Units.
1. General. Upon the occurrence of a Change in Control the PSUs will continue to vest in accordance
with the vesting schedule specified in Sections II.B.2., subject to earlier vesting or forfeiture
pursuant to Section III.; provided that upon your termination of employment by the Company other
than for Cause, or by you for Good Reason (as defined in Section V.), during the 24-month period
following such Change in Control, all unvested PSUs that are outstanding as of your termination of
employment will remain outstanding and will be distributed as soon as practicable following the PSU
Scheduled Vesting Date, as described in Section II.B.4., as applicable; provided that you have
satisfied the conditions described in Section IV.B. and provided further that the number of shares
distributable with respect to PSUs is as described in Section IV.A.3.
2. Awards Not Assumed. Notwithstanding the foregoing, if the PSUs are not assumed, converted or
replaced in connection with a Change in Control on an equivalent basis, such PSUs as described in
Section
st
st
11
-- 99 of 156 --
IV.A.3. (to the extent permitted in accordance with the requirements of Treas. Reg. § 1.409A-3(j)(4)
(ix)(B)) will fully vest immediately prior to the Change in Control and will be distributed as soon as
practicable following vesting and in no event later than 60 days following vesting.
3. Calculation of Shares Distributable with Respect to PSUs. Upon the occurrence of a “Change
in Control”, the Performance Period shall be deemed to have ended on (i) December 31st of the year
preceding the year in which the Change in Control occurs for determination of the EPS Performance
Factor and (ii) the date of the occurrence of the Change in Control for determination of the Relative
TSR Modifier, and the number of shares of Common Stock distributable in respect of the PSUs
(subject to the vesting conditions applicable thereto) will be determined in accordance with Section
II.B.1.; provided that, in the event that the Change in Control occurs on or prior to December 31st
of the year in which the PSUs are granted, the number of shares of Common Stock distributable with
respect to the PSUs will be determined based on (i) the “target” EPS Performance Factor and (ii) the
actual Relative TSR modifier, determined as of the date of the occurrence of the Change in Control.
B. Waiver and Release
In the event of your termination of employment by the Company other than for Cause or by you for Good
Reason during the 24-month period following such Change in Control, you will be required to execute
and not revoke a waiver and release agreement, if provided by the Company at the time of your
termination of employment. Failure to meet these requirements by the date specified by the Company,
which shall be in no event later than 60 days following your termination of employment, or failure to
comply with the waiver and release agreement, and be in compliance with the agreement, if applicable,
as of the delivery date Performance Stock Units (as described in Section II.B.4.), will result in the
cancellation or forfeiture of any rights, title and interest in and to the Award.
C. Other Matters
For the avoidance of doubt, in the event of your termination of employment by the Company other than for
Cause or by you for Good Reason during the 24-month period following such Change in Control and, on
or before the date of your termination of employment you satisfy the Age and Service Criteria for Pro-
Rata Vesting or the Age and Service Criteria for Full Vesting as described in Sections III.C. and D.,
respectively, any unvested PSUs covered by the Award will be treated as described in this Section IV.;
provided that you satisfy or have satisfied, as applicable, the conditions described in Section IV.B.
V. DEFINITIONS
As used in these Terms and Conditions:
12
-- 100 of 156 --
A. “Age and Service Criteria for Full Vesting” shall mean you are at least age 62 and have a minimum of five
years of service with the Company.
B. “Age and Service Criteria for Pro-Rata Vesting” shall mean you are at least age 55 but are not yet age 62
and have a minimum of five years of service with the Company.
C. “Cause” shall mean:
1. willful failure to substantially perform the duties consistent with your position which is not remedied
within 30 days after receipt of written notice from the Company specifying such failure;
2. willful violation of any written Company policies, including but not limited to, The Marsh Code of
Conduct, The Greater Good;
3. commission at any time of any act or omission that results in a conviction, plea of no contest, plea
of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral
turpitude;
4. unlawful use (including being under the influence) or possession of illegal drugs;
5. any gross negligence or willful misconduct resulting in a material loss to the Company, or material
damage to the reputation of the Company; or
6. any violation of any statutory or common law duty of loyalty to the Company, including the
commission at any time of any act of fraud, embezzlement, or material breach of fiduciary duty
against the Company.
D. “Change in Control” shall have the meaning set forth in the Plan.
E. “Company” shall mean Marsh or any of its subsidiaries or affiliates.
F. “Employment-Related Action” shall mean the execution and effectiveness of a release of claims and/or a
restrictive covenant.
G. “Good Reason” shall mean any one of the following events without your written consent:
1. material reduction in your base salary;
2. material reduction in your annual incentive opportunity (including a material adverse change in the
method of calculating your annual incentive);
3. material diminution of your duties, responsibilities or authority; or
4. relocation of more than 50 miles from your principal place of employment immediately prior to the
Change in Control; provided that you provide Marsh with written notice of your intent to terminate
your employment for Good Reason within 60 days of your becoming aware of any circumstances set
forth above (with such notice indicating the specific termination provision above on which you are
relying and describing in reasonable detail the facts and circumstances claimed to
13
-- 101 of 156 --
provide a basis for termination of your employment under the indicated provision) and that you
provide Marsh with at least 30 days following receipt of such notice to remedy such circumstances.
H. “Performance Period” shall mean the period that begins on [DATE] and ends on [DATE]; provided that in
the event of a termination of your employment due to death prior to a Change in Control, such period
will end on December 31st of the year prior to such termination of employment for the PSUs covered by
the Award; and provided further that in the event of a Change in Control, such period will end on (i)
December 31st of the year prior to the occurrence of such Change in Control for determination of the
EPS Performance Factor and (ii) the date of the occurrence of such Change in Control for determination
of the Relative TSR Modifier.
I. “Permanent Disability” will be deemed to occur when it is determined (by Marsh’s disability carrier for the
primary long-term disability plan or program applicable to you because of your employment with the
Company) that you are unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in death or can be expected
to last for a continuous period of not less than 12 months.
J. “Section 409A of the Code” shall mean Section 409A of the U.S. Internal Revenue Code of 1986, as
amended, and the regulations and guidance thereunder (regarding nonqualified deferred
compensation).
K. “Tax-Related Items” shall have the meaning ascribed to such term in the Plan.
VI. ADDITIONAL PROVISIONS
A. Additional Provisions—General
1. Administrative Rules. The Award shall be subject to such additional administrative regulations as
the Committee may, from time to time, adopt. All decisions of the Committee upon any questions
arising under the Award Documentation shall be conclusive and binding. The Committee may
delegate to any other individual or entity the authority to perform any or all of the functions of the
Committee under the Award, and references to the Committee shall be deemed to include any such
delegate.
2. Amendment. The Committee may, in its sole discretion, amend the terms of the Award, including,
without limitation, to impose additional requirements on the Award and on any shares of Common
Stock acquired with respect to the Award; provided, however, that if the Committee concludes, in its
sole discretion, that such amendment is likely to materially impair your rights with respect to the
Award, such amendment shall not be implemented with respect to the Award without your consent,
except to the extent that any such action (a) is made to cause the Award to comply with applicable
law, currency controls, stock market or exchange rules and regulations, or
14
-- 102 of 156 --
accounting or tax rules and regulations, (b) is made to obtain or maintain corporate tax deductibility
or other favorable tax treatment with respect to the Award, or (c) is otherwise made in accordance
with Section VI.A.4.
3. Limitations. Payment of the Award is not secured by trust, insurance contract or other funding
medium, and you do not have any interest in any fund or specific asset of Marsh by reason of the
Award. Your right to payment of the Award is the same as the right of an unsecured general creditor
of Marsh.
4. Cancellation or Clawback of Awards.
a. Marsh may, to the extent permitted or required by any applicable law, stock exchange rules,
currency controls, the Company Incentive Compensation Clawback Policy or any other applicable
Company policy or arrangement in effect prior to the vesting of any unvested portion of the
Award, or as specified in the Award Documentation, cancel, reduce or require reimbursement of
the Award in the event of fraud, financial restatements, or other events as may be determined by
the Committee.
b. If you fail to repay any amount due pursuant to this Section VI.A.4., the Company may bring an
action in court to recover the amount due. You acknowledge that, by accepting the Award, you
agree to pay all costs, expenses and attorney’s fees incurred by the Company in any proceeding
for the collection of amounts due pursuant to this Section VI.A.4., provided that the Company
prevails in whole or in part in any such proceeding. The Company may also, to the extent
permitted by applicable law, reduce any amounts owed to you by the Company in an amount up
to the full amount of the repayment due.
5. Governing Law; Choice of Forum. The Award and the Award Documentation applicable to the
Award are governed by and subject to the laws of the State of Delaware, without regard to the
conflict of law provisions, as set forth in Section 10.K of the Plan. For purposes of any action,
lawsuit, or other proceedings arising out of or relating to this Award, including without limitation, to
enforce the Award Documentation, the Company and you each hereby irrevocably and
unconditionally submits to the exclusive jurisdiction of any New York state court or federal court of
the United States of America sitting in the State of New York, and any appellate court thereof. The
Company and you agree that a final judgment in any such action or proceeding shall be conclusive
and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by law.
6. Severability; Captions. In the event that any provision of this Award is determined to be invalid
or unenforceable, in whole or in part, the remaining provisions of this Award will be unaffected
thereby and will remain in full force and effect to the fullest extent permitted by law. The captions of
this Award are not part of the provisions of this Award and will have no force or effect.
15
-- 103 of 156 --
7. Electronic Delivery and Acceptance. Marsh may, in its sole discretion, decide to deliver any
documents related to the Award and/or your current or future participation in the Plan by electronic
means. You hereby consent to receive such documents by electronic delivery and agree to
participate in the Plan through an on-line or electronic system established and maintained by Marsh
or an agent appointed by Marsh.
8. Waiver. You acknowledge that neither a waiver by Marsh of your breach of any provision of the
Award Documentation nor a prior waiver by Marsh of a breach of any provision of the Award
Documentation by any other participant of the Plan shall operate or be construed as a waiver of any
other provision of the Award Documentation, or of any subsequent breach by you.
9. Eligibility for Award. In order to be granted an Award, you must satisfy the eligibility criteria for
grantees set forth in the Plan as of the grant date.
B. Additional Provisions—Outside of the United States
1. Changes to Delivery. In the event that Marsh considers that due to legal, regulatory or tax issues
the normal delivery of an Award (as described in these Terms and Conditions) to a participant
outside the United States would not be appropriate, then Marsh may, in its sole discretion, determine
how and when the value of the Award will be delivered. Without limitation, this may include making
any payments due under the Award in cash instead of shares of Common Stock, or in shares of
Common Stock instead of cash or vesting after payment of applicable Tax-Related Items and fees or,
delivering or paying out the Award as soon as practicable following a termination of employment. If
the value of an Award is to be delivered in cash instead of shares of Common Stock, Marsh may sell
any shares of Common Stock distributable in respect of the Award on your behalf and use the
proceeds (after payment of applicable Tax-Related Items and fees) to satisfy the Award.
2. Amendment and Modification. The Committee may modify the terms of any Award under the
Plan granted to you in any manner deemed by the Committee to be necessary or appropriate in
order for such Award to conform to laws, regulations and customs of the country (other than the
United States) in which you are then resident or primarily employed or were resident or primarily
employed at the time of grant or during the term of the Award, or so that the value and other
benefits of the Award to you, as affected by non-U.S. tax laws and other restrictions applicable as a
result of your residence or employment outside of the United States, shall be comparable to the
value of such an Award to an individual who is resident or primarily employed in the United States.
VII. QUESTIONS AND ADDITIONAL INFORMATION
Please retain this document in your permanent records. If you have any questions regarding the Award
Documentation or if you would like an account statement detailing
16
-- 104 of 156 --
each type of equity-based award and the number of shares of Common Stock covered by such equity-based award
that comprises the Award, and the vesting date(s) of such equity-based awards that comprise the Award, or any
other information, please contact:
Executive Compensation
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036-2774
United States of America
Telephone Number: +1 212 345-9722
Email: mmc.compensation@mmc.com
17
-- 105 of 156 --
IN WITNESS WHEREOF, Marsh has caused these Terms and Conditions to be duly executed by the facsimile signature
of its Senior Vice President, Chief People Officer as of the day and year first above written. By consenting to these
Terms and Conditions, you agree to the following: (i) you have carefully read, fully understand and agree to all of the
terms and conditions described herein and in the Award Documentation; and (ii) you understand and agree that
these Terms and Conditions and the Award Documentation constitute the entire understanding between you and
Marsh regarding the Award, and that any prior agreements, commitments or negotiations concerning the Award are
replaced and superseded. The grant of the Award is contingent upon your acceptance of these Terms and Conditions,
Country-Specific Notices and Restrictive Covenants Agreement (if applicable) by the date and in the manner specified
in materials provided to you by Executive Compensation and/or the Company’s stock plan service provider. If you
decline the Award or you do not accept the Award and any applicable documents described in the preceding sentence
by the date and in the manner specified, the Award will be cancelled as of the grant date of the Award.
/s/ Carmen Fernandez
Carmen Fernandez
SVP, Chief People Officer
18
-- 106 of 156 --
MARSH & McLENNAN COMPANIES, INC.
AMENDED AND RESTATED 2020 INCENTIVE AND STOCK AWARD PLAN
TERMS AND CONDITIONS
OF
RESTRICTED STOCK UNIT AWARDS
GRANTED ON [DATE], 2026
-- 107 of 156 --
TABLE OF CONTENTS
Page
I. BACKGROUND 1
II. AWARDS 1
III. EMPLOYMENT EVENTS 4
IV. CHANGE IN CONTROL PROVISIONS 11
V. DEFINITIONS 12
VI. ADDITIONAL PROVISIONS 13
VII. QUESTIONS AND ADDITIONAL INFORMATION 16
-- 108 of 156 --
I. BACKGROUND
An award (“Award”) has been granted to you under the Marsh & McLennan Companies, Inc. Amended and
Restated 2020 Incentive and Stock Award Plan (the “Plan”), subject to your acceptance as described in Section
II.A.1. The Award type, the number of shares of Marsh & McLennan Companies, Inc. (“Marsh”) common stock
covered by the Award, instructions on how to accept or decline the Award and the deadline for accepting the
Award will be provided to you by Executive Compensation and/or the stock plan service provider of the
Company (as defined in Section V.). The Award is also subject to the terms and conditions set forth herein (the
“Terms and Conditions”) and to additional terms and conditions as set forth in the country-specific notices (the
“Country-Specific Notices”). The Prospectus dated [DATE], also describes important information about the
Plan. The Terms and Conditions, the Country-Specific Notices and the Plan will be referred to herein as the
“Award Documentation.” As used herein, “Common Stock” means common stock of Marsh.
Capitalized terms in these Terms and Conditions are defined in Section V.
II. AWARDS
A. General.
1. Award Acceptance. The grant of this Award is contingent upon your acceptance, by the date and
in the manner specified by Executive Compensation and/or the Company’s stock plan service
provider, of these Terms and Conditions, the Country-Specific Notices and Restrictive Covenants
Agreement as described in Section II.A.3. If you decline the Award or if you do not accept the Award
and any applicable documents described in the preceding sentence by the deadline date and in the
manner specified, then the Award will be cancelled as of the grant date of the Award.
2. Rights of Award Holders. Unless and until the vesting conditions of the Award have been
satisfied and cash or shares of Common Stock, as applicable, have been delivered to you in
accordance with the Award Documentation, you have only the rights of a general unsecured creditor
of Marsh. Unless and until shares of Common Stock have been delivered to you, you have none of
the rights of ownership to such shares (e.g., units cannot be used as payment for stock option
exercises; units may not be transferred or assigned; units have no voting rights).
3. Restrictive Covenants Agreement. As described in Section II.A.1., a Restrictive Covenants
Agreement (“Restrictive Covenants Agreement”) in a form determined by Marsh must be in place in
order to accept the Award, you must execute or reaffirm, as determined by Marsh in its sole
discretion, the Restrictive Covenants Agreement in order for the Award to vest pursuant to certain
employment events as described in Section III., and you must further execute or reaffirm, as
determined by Marsh in its sole discretion, and be in compliance with the Restrictive Covenants
Agreement in order for the Award to become distributable to you whether or not you are employed
by the Company at that time. Failure to timely execute the Restrictive Covenants Agreement by the
date specified by the Company or failure to timely
1
-- 109 of 156 --
execute or reaffirm and comply with the Restrictive Covenants Agreement as described in Section
III.G.1. or 2., as applicable, will result in cancellation or forfeiture of any rights, title and interest in
and to the Award, without any liability to the Company.
B. Stock Units.
1. General. A restricted stock unit (“Stock Unit”) represents an unfunded and unsecured promise to
deliver (or cause to be delivered) to you, subject to the terms of the Award Documentation, one
share of Common Stock after vesting.
2. Vesting. Subject to your continued employment, 33-1/3% of the Stock Units will vest on [DATE]
of [YEAR], [YEAR] and [YEAR]. Each date on which a Stock Unit is scheduled to vest pursuant to this
Section II.B.2. is a “Scheduled Vesting Date.” In the event of your termination of employment, the
occurrence of your Permanent Disability (as defined in Section V.) or the occurrence of a Change in
Control (as defined in the Plan) prior to a Scheduled Vesting Date, your right to any Stock Units that
are unvested immediately prior to your termination of employment or occurrence of your Permanent
Disability, as applicable, will be determined in accordance with Section III. or Section IV., as
applicable. For the avoidance of doubt, the date of your termination of employment for purposes of
determining vesting under this Section II.B.2. will be determined in accordance with Section III.F.
3. Dividend Equivalents. For each outstanding Stock Unit covered by the Award, an amount equal
to the dividend payment (if any) made in respect of one share of Common Stock (a “Dividend
Equivalent”) will accrue in U.S. dollars on each dividend record date that occurs on or after the grant
date of the Award while the Award is outstanding, with no interest paid on such amounts. Accrued
Dividend Equivalents will vest when the Stock Units in respect of which such Dividend Equivalents
were accrued vest. No further Dividend Equivalents will accrue on Stock Units that do not vest or are
cancelled or forfeited. If a pro-rata amount of the outstanding unvested Stock Unit award is eligible
to vest upon a termination of employment event as described in Section III.C.1. and III.D.1., the
pro-rata calculation (as described in Section III.H.) will be applied to the Dividend Equivalents that
have accrued on the Award as of the date of termination. Accrued Dividend Equivalents will not be
paid, and no further Dividend Equivalents will accrue, on Stock Units that do not vest or are
cancelled or forfeited as per a termination of employment event described in Section III.E.
4. Delivery.
a. Shares of Common Stock deliverable in respect of the Stock Units covered by the Award shall be
delivered to you as soon as practicable following the Scheduled Vesting Date, and in no event
later than 60 days following the Scheduled Vesting Date, except as otherwise provided in Sections
III., IV., and VI.B.
b. The value of vested Dividend Equivalents will be delivered to you in cash as soon as practicable
after delivery of the shares of Common
2
-- 110 of 156 --
Stock described in II.B.4.a above, and in no event later than 60 days following the Scheduled
Vesting Date, except as otherwise provided in Sections III., IV., and VI.B.
c. The delivery of shares of Common Stock and/or cash or other property that may be deliverable
under these Terms and Conditions, is conditioned on the satisfaction or withholding of any
applicable tax obligations, as described in Section II.C.
d. Any shares of Common Stock and/or cash or other property that may be deliverable following
your death shall be delivered to the person or persons to whom your rights pass by will or the law
of descent and distribution, and such delivery shall completely discharge Marsh and any of its
subsidiaries’ or affiliates’ obligations under the Award.
e. Notwithstanding the foregoing, additional delivery rules for certain Award recipients subject to
U.S. federal income tax (whether or not the recipient is a U.S. citizen or employed in the U.S.)
are reflected in Section III.I.
C. Satisfaction of Tax Obligations.
1. Personal Tax Advisor. Neither the Company nor any Company employee is authorized to provide
personal tax advice to you. It is recommended that you consult with your personal tax advisor for
more detailed information regarding the tax treatment of the Award, especially before making any
decisions that rely on that tax treatment.
2. U.S. Employees. Applicable employment taxes are required by law to be withheld when a Stock
Unit or Dividend Equivalent vests. Applicable income taxes are required by law to be withheld when
shares of Common Stock in respect of Stock Units or cash in respect of Dividend Equivalents are
delivered to you. A sufficient number of whole shares of Common Stock, cash or other property, as
applicable, will be retained by Marsh to satisfy the tax withholding obligation.
3. Non-U.S. Employees.
a. Stock Units and Dividend Equivalents. In most countries, the value of a Stock Unit or
Dividend Equivalent is generally not taxable on the grant date. If the value of the Stock Unit or
Dividend Equivalent is not taxable on the grant date, it will, in most countries, be taxed at a later
time, for example, upon delivery of a share of Common Stock in respect of the Stock Unit that
vests, and/or the subsequent sale of the share of Common Stock received in connection with the
vesting of the Stock Unit or upon delivery of cash in respect of a Dividend Equivalent.
b. Withholding. Marsh and/or your employer shall have the power and the right to deduct and
withhold from the Award and other compensation or to require you to remit to Marsh and/or to
your employer, an amount sufficient to satisfy any Tax-Related Items (as defined in Section V.)
that Marsh expects to be payable under the laws of any country, state, province, city or other
jurisdiction. If applicable, Marsh and/or your employer will, to the extent
3
-- 111 of 156 --
permissible under applicable law or otherwise agreed between you and Marsh and/or your
employer, either (a) withhold from proceeds of the sale a sufficient number of whole shares of
Common Stock issued to you in settlement of the Award (either through your voluntary sale or
through a mandatory sale arranged by Marsh on your behalf) for purposes of satisfying applicable
obligations with respect to Tax-Related Items and/or (b) withhold a sufficient number of whole
shares of Common Stock distributable to you in in respect of the Award to satisfy applicable
obligations with respect to Tax-Related Items. Further, depending on the withholding method,
Marsh and/or your employer may withhold or account for obligations for Tax-Related Items by
considering statutory or other withholding rates, including minimum or maximum rates applicable
in your jurisdiction(s).
In the event of over-withholding, you may receive a refund from Marsh and/or your employer of
any over-withheld amount in cash (with no entitlement to the equivalent in shares of Common
Stock), or if not refunded by Marsh and/or your employer, you must seek a refund from the local
tax authorities to the extent you wish to recover the over-withheld amount in the form of a
refund.
III. EMPLOYMENT EVENTS
A. Death. In the event your employment is terminated because of your death, all of the unvested Stock
Units that are outstanding as of the date of your death will fully vest and will be distributed within 60
days following such date.
B. Permanent Disability. Upon the occurrence of your Permanent Disability, all of the unvested Stock Units
that are outstanding as of the occurrence of your Permanent Disability will remain outstanding and will
be distributed as soon as practicable following the next Scheduled Vesting Date as described in Section
II.B.4.; provided that you have satisfied the conditions described in Section III.G.1.
For the avoidance of doubt, if the occurrence of your Permanent Disability occurs on a Scheduled Vesting
Date, distribution will occur as soon as practicable following such Scheduled Vesting Date as described
in Section II.B.4.
C. Termination by You – Age and Service Treatment. If you have satisfied the Age and Service Criteria
for Pro-Rata Vesting (as defined in Section V.) or the Age and Service Criteria for Full Vesting (as
defined in Section V.) on or before the date you terminate your employment with the Company for any
reason other than death or the occurrence of your Permanent Disability, then:
1. If you have satisfied the Age and Service Criteria for Pro-Rata Vesting but not the Age and Service
Criteria for Full Vesting, upon such termination of employment, a pro-rata portion of the unvested
Stock Units that are outstanding as of such termination of employment will remain outstanding (as
described in Section III.H.) and will be distributed as soon as practicable following the next
Scheduled Vesting Date as described in Section II.B.4.; provided that you have satisfied
4
-- 112 of 156 --
the conditions described in Section III.G.1. The portion of the unvested Stock Units that does not
remain outstanding pursuant to this paragraph will be forfeited and cancelled.
2. If you have satisfied the Age and Service Criteria for Full Vesting, upon such termination of
employment, all of the unvested Stock Units that are outstanding as of such termination of
employment will remain outstanding and be distributed as soon as practicable following the next
Scheduled Vesting Date as described in Section II.B.4.; provided that you have satisfied the
conditions described in Section III.G.1.
For the avoidance of doubt, for purposes of each of Sections III.C.1. and 2., if your termination of
employment occurs on a Scheduled Vesting Date, distribution will occur as soon as practicable
following such Scheduled Vesting Date as described in Section II.B.4. For the further avoidance of
doubt, Section III.D. will govern the treatment of the Award in the event your employment is
terminated by the Company other than for Cause (as defined in Section V.).
For the avoidance of doubt, the date of your termination of employment for purposes of determining
whether you have satisfied either the Age and Service Criteria for Pro-Rata Vesting or the Age and
Service Criteria for Full Vesting under this Section III.C. will be determined in accordance with
Section III.F.
Notwithstanding the foregoing, if the Company determines, in its sole discretion, that it has received an
opinion of counsel that there has been a legal judgment and/or legal development in the jurisdiction
where you are employed that would likely result in the favorable treatment applicable to the Stock Units
pursuant to this Section III.C. being deemed unlawful and/or discriminatory, then the Company will not
apply this favorable treatment upon your termination of employment, and the Stock Units will be
treated as set forth in the other subparagraphs of this Section III., as applicable.
D. Termination by the Company Other Than for Cause.
1. General. Except as otherwise provided in Sections III.D.2. and IV., in the event the Company, in
its sole discretion, determines that your employment is terminated by the Company other than for
Cause, a pro-rata portion of the unvested Stock Units that are outstanding as of such termination of
employment will remain outstanding (as described in Section III.H.) and will be distributed as soon
as practicable following the next Scheduled Vesting Date as described in Section II.B.4., provided
that you have satisfied the conditions described in Section III.G.2. The portion of the unvested Stock
Units that does not remain outstanding pursuant to this paragraph will be forfeited and cancelled.
For the avoidance of doubt, this Section III.D.1. shall apply regardless of whether you have satisfied
the Age and Service Criteria for Pro-Rata Vesting on or before your termination of employment by
the Company.
2. Prior Satisfaction of Age and Service Criteria for Full Vesting. In the event the Company, in
its sole discretion, determines that your employment is terminated by the Company other than for
Cause, and
5
-- 113 of 156 --
on or before your termination of employment you satisfy the Age and Service Criteria for Full
Vesting, all of the unvested Stock Units that are outstanding as of such termination of employment
will remain outstanding and will be distributed as soon as practicable following the next Scheduled
Vesting Date as described in Section II.B.4.; provided that you have satisfied the conditions
described in Section III.G.2.
For the avoidance of doubt, if your termination of employment occurs on a Scheduled Vesting Date,
distribution will occur as soon as practicable following such Scheduled Vesting Date as described in
Section II.B.4.
3. Important Notes.
a. Sale of Business Unit. For purposes of this Award, in the event of a sale or similar transaction
involving the business unit for which you work (“Employing Company”) as a result of which the
Employing Company ceases to be a subsidiary or affiliate of Marsh, your employment will be
deemed terminated by the Company other than for Cause, even if your employment with the
Employing Company continues after the sale or similar transaction.
b. Constructive Discharge. The Award will not vest, whether on a pro-rata or full basis, upon a
constructive discharge, including if any court or regulatory agency retroactively concludes or
interprets events to have constituted a constructive discharge.
E. All Other Terminations. For all other terminations of employment not described in Sections III.A.
through D. or Section IV. (including, but not limited to, a termination by the Company for Cause or your
resignation without having satisfied the Age and Service Criteria for Pro-Rata Vesting or the Age and
Service Criteria for Full Vesting as described in Section III.C.), any rights, title and interest in and to
any remaining unvested portion of the Award shall be cancelled as of the date your employment is
treated as having terminated as described in Section III.F.
F. Date of Termination of Employment.
1. If Section III.F.2. does not apply to you, then for purposes of determining vesting under Section
II.B.2. and the number of unvested Stock Units that vest on a pro-rata basis as described in Section
III.H., your employment will be treated as having terminated on your last day of employment with
the Company.
2. If you are obligated (whether by law or contract) to provide the Company advance notice of your
intention to terminate your employment or service relationship then, in the event you terminate your
employment pursuant to Section III.C. or III.E. (regardless of the reason for such termination and
whether or not later found to be invalid or in breach of employment laws in the jurisdiction where
you are employed or the terms of your employment agreement, if any), for purposes of determining
vesting under Section II.B.2. and the pro-rata calculation described in Section III.H., your
employment will be treated as having terminated on your last day of active service with the
Company, as determined by the Company in its sole discretion.
6
-- 114 of 156 --
You shall be deemed to have ceased active service with the Company when you are no longer
required by the Company to provide regular services to the Company even if you remain legally
employed by the Company, such as may occur if the Company were to place you on “garden leave”,
a terminal leave of absence or any similar period mandated under employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any (in each
case as determined by the Company in its sole discretion).
G. Conditions for All or a Portion of the Award to Remain Outstanding Following a Termination of
Employment
1. Restrictive Covenants Agreement. In the event of (i) the occurrence of your Permanent
Disability as described in Section III.B., or (ii) your termination of employment after satisfying the
Age and Service Criteria for Pro-Rata Vesting or the Age and Service Criteria for Full Vesting as
described in Section III.C., you will be required to execute or reaffirm, as determined by Marsh in its
sole discretion, and return to Marsh (or an agent appointed by Marsh) a Restrictive Covenants
Agreement. Failure to (a) execute or reaffirm such an agreement by the date specified by the
Company, which shall be in no event later than 60 days following the occurrence of your Permanent
Disability as described in Section III.B. or your termination of employment as described in Section
III.C., or (b) comply with the Restrictive Covenants Agreement or to continue to be in compliance
with the Restrictive Covenants Agreement as of the delivery date (as described in Section II.B.4.) or,
at the Company’s discretion, to reaffirm compliance prior to the delivery date, will result in the
cancellation or forfeiture of any rights, title and interest in and to the Award without any liability to
the Company.
2. Waiver and Release and Restrictive Covenants Agreement. In the event of your termination
of employment by the Company other than for Cause as described in Section III.D., you will be
required to (i) execute or reaffirm, as determined by Marsh in its sole discretion, and return to Marsh
(or an agent appointed by Marsh) a Restrictive Covenants Agreement and (ii) execute and not
revoke a waiver and release agreement, if provided to you by the Company at the time of your
termination of employment. Failure to meet these requirements by the date specified by the
Company, which shall be in no event later than 60 days following your termination of employment,
or failure to comply with the waiver and release agreement or the Restrictive Covenants Agreement,
as applicable, or continue to be in compliance with the applicable agreement as of the delivery date
(as described in Section II.B.4.) and, at the Company’s discretion, to reaffirm compliance prior to the
delivery date, will result in the cancellation or forfeiture of any rights, title and interest in and to the
Award without any liability to the Company.
H. Determination of Pro-Rata Calculation upon Termination of Employment.
The pro-rata portion of the unvested Stock Units and accrued Dividend Equivalents that are outstanding
as of a termination of employment that
7
-- 115 of 156 --
will become distributable under certain circumstances described in Section III. will be determined using
the following formula:
where
A = the number of Stock Units/accrued Dividend Equivalents covered by the Award;
B = the number of days in the period beginning on the grant date of the Award and ending on the
date of your termination of employment, as determined in accordance with Section III.F.;
C = the number of days in the period beginning on the grant date of the Award and ending on the last
Scheduled Vesting Date; and
D = the number of Stock Units/accrued Dividend Equivalents that have previously vested, as
determined in accordance with Section III.F.
I. Section 409A of the Code for Award Recipients Subject to U.S. Federal Income Tax (whether or
not the recipient is a U.S. citizen or employed in the U.S.).
1. For Award recipients subject to U.S. federal income tax, notwithstanding any other provision
herein, the Award may be subject to additional restrictions to ensure compliance with (or continued
exemption from) the requirements of Section 409A of the Code (as defined in Section V.). The
Compensation Committee of the Board of Directors of Marsh (the “Committee”) intends to
administer the Award in accordance with Section 409A of the Code and reserves the right to make
changes in the terms or operations of the Award (including changes that may have retroactive
effect) deemed necessary or desirable to comply with Section 409A of the Code. This means, for
example, that the timing of distributions may be different from those described in the Award
Documentation that do not reflect Section 409A of the Code. If the Award is not in compliance with
Section 409A of the Code, you may be subject to immediate taxation of all unpaid awards under the
Plan that are subject to Section 409A of the Code at your regular federal income tax rate, plus a
20% additional tax, plus interest at the underpayment rate plus 1%, as well as any state and local
taxes, penalties, additional taxes and interest, if applicable, imposed under any state tax law similar
to Section 409A of the Code.
2. Notwithstanding any other provision herein, if any portion of the Award is determined to be
nonqualified deferred compensation subject to Section 409A of the Code, any references to
“termination of employment,” or “when you are no longer employed” in these Terms and Conditions
shall have the following meaning:
Your “termination of employment” (or similar terms) shall occur when you have incurred a
“separation from service” within the meaning of Section 409A of the Code and as further defined
herein. Specifically, you will have incurred a “separation from service” when the level of services
you provide to the Company in any capacity, including as an employee, director, independent
contractor or
8
-- 116 of 156 --
consultant, does not exceed 20% of the average level of services that you provided to the
Company in the preceding 36 months (or shorter period of service if, for example, your total
service with the Company is less than 36 months), all as determined in accordance with Section
409A of the Code. In determining whether a “separation from service” has occurred, any period
of up to six months during which you are on a bona fide leave of absence or up to 29 months
during which you are absent from work due to a disability for which you are receiving Marsh
long-term disability benefits will be ignored.
3. Notwithstanding any other provision herein, if at the time of your termination of employment you
are a “specified employee” (as defined in Section 409A of the Code), no portion of the Award that is
determined to be nonqualified deferred compensation subject to Section 409A of the Code can be
distributed prior to the first day of the seventh month after your termination of employment and any
such distributions to which you would otherwise be entitled during the first six months following your
termination of employment will be accumulated and paid without interest on the first day of the
seventh month after your termination of employment, except to the extent that earlier distribution
would not result in your incurring interest or additional tax under Section 409A of the Code.
4. Notwithstanding any other provision herein other than Section III.I.6., (and any Dividend
Equivalents payable with respect to the Stock Units)
a. If you have satisfied the Age and Service Criteria for Pro-Rata Vesting at any time prior to
[DATE] and you do not satisfy the Age and Service Criteria for Full Vesting at any time prior to
[DATE], then for each Scheduled Vesting Date following the date that you satisfy the Age and
Service Criteria for Pro-Rata Vesting, shares of Common Stock and/or cash pursuant to Section
II.B.4. will be delivered by March 15th of the year in which the Scheduled Vesting Date occurs.
b. If you first satisfy the Age and Service Criteria for Full Vesting in calendar year [YEAR], then
shares of Common Stock and/or cash pursuant to Section II.B.4. with respect to the [DATE]
Scheduled Vesting Date will be delivered by March 15, [YEAR].
c. If your employment is terminated on or after March 1st but on or before December 31st in any
year pursuant to Section III.B. (Permanent Disability), C.1. (Age and Service Pro-rata Vesting), or
D. (Termination Other Than for Cause), then shares of Common Stock and/or cash pursuant to
Section II.B.4. will be delivered by March 15th of the year following the year of such termination.
5. Notwithstanding any provision herein, for distributions of Stock Units or cash attributable to such
Stock Units that are subject to one or more Employment-Related Actions (as defined in Section V.)
where you have not satisfied, and would not satisfy, the Age and Service Criteria for Full Vesting
prior to [DATE]:
9
-- 117 of 156 --
a. With respect to Stock Units, no later than March 15 of the year following the year in which the
substantial risk of forfeiture (as determined under Section 409A of the Code) (the “Substantial
Risk of Forfeiture”) lapses with respect to such Stock Units, shares of Common Stock underlying
such Stock Units shall be delivered to you (to the extent not previously delivered), subject to a
stop transfer order and subject to withholding of any applicable tax obligations, as described in
Section II.C. at the time of such delivery. Upon your timely satisfaction of all applicable
Employment-Related Actions, Marsh will remove or cause to be removed such stop transfer order;
and
b. With respect to a cash payment attributable to Stock Units, to the extent that such payment will
not be made by March 15 of the year following the year in which the Substantial Risk of
Forfeiture lapses with respect to such payment, such payment shall be placed in escrow or
contributed to a secular trust (in the sole discretion of Marsh) for your benefit on or before such
March 15 and subject to withholding of any applicable tax obligations, as described in Section
II.C. at the time of such placement or contribution. Upon your timely satisfaction of all applicable
Employment-Related Actions, Marsh shall cause such amounts to be released from escrow or paid
to you out of such trust.
In either case, if any Employment-Related Action is not timely satisfied, the shares of Common
Stock or the cash payment shall revert to Marsh with no further compensation due to you.
6. Notwithstanding any provision herein, with respect to distributions of Stock Units or cash
attributable to such Stock Units (i) where you have satisfied or would satisfy the Age and Service
Criteria for Full Vesting prior to [DATE] and (ii) where such distributions are subject to one or more
Employment-Related Actions:
a. With respect to Stock Units, no later than December 31 of the year in which Scheduled Vesting
Date occurs, shares of Common Stock underlying such Stock Units shall be delivered to you (to
the extent not previously delivered), subject to a stop transfer order and subject to withholding of
any applicable tax obligations, as described in Section II.C. at the time of such delivery. Upon
your timely satisfaction of all applicable Employment-Related Actions, Marsh will remove or cause
to be removed such stop transfer order; and
b. With respect to a cash payment attributable to Stock Units, to the extent any such payment will
not be made by December 31 of the year in which the Scheduled Vesting Date occurs, any
payment that relates to such Scheduled Vesting Date shall be placed in escrow or contributed to a
secular trust (in the sole discretion of Marsh) for your benefit on or before such December 31
and subject to withholding of any applicable tax obligations, as described in Section II.C. at the
time of such placement or contribution. Upon your timely satisfaction of all applicable
Employment-Related
th
th
th
st
st
st
10
-- 118 of 156 --
Actions, Marsh shall cause such amounts to be released from escrow or paid to you out of such
trust.
In either case, if any Employment-Related Action is not timely satisfied, the shares of Common
Stock or the cash payment shall revert to Marsh with no further compensation due to you.
7. Nothing in this Section III.I. is intended to nor does it guarantee that the Award will not be subject
to “additional tax” or other adverse tax consequences under Section 409A of the Code or any similar
state tax law. In no event will the Company be liable for all or any portion of any taxes, penalties,
interest or other expenses that may be incurred on account of non-compliance with Section 409A of
the Code.
IV. CHANGE IN CONTROL PROVISIONS
A. Upon the occurrence of a Change in Control, the Award will continue to vest in accordance with the
vesting schedule specified in Section II.B.2., subject to earlier vesting or forfeiture pursuant to Section
III.; provided that upon your termination of employment by the Company other than for Cause, or by
you for Good Reason (as defined in Section V.), during the 24-month period following such Change in
Control, all unvested Stock Units that are outstanding as of your termination of employment will remain
outstanding and will be distributed as soon as practicable following the next Scheduled Vesting Date as
described in Section II.B.4.; provided that you have satisfied the conditions described in Section IV.B.
Notwithstanding the foregoing, if the Stock Units are not assumed, converted or replaced in connection
with a Change in Control on an equivalent basis, the Stock Units (to the extent permitted in accordance
with the requirements of Treas. Reg. § 1.409A-3(j)(4)(ix)(B)) will fully vest immediately prior to the
Change in Control and will be distributed as soon as practicable following vesting and in no event later
than 60 days following vesting.
B. In the event of your termination of employment by the Company other than for Cause or by you for Good
Reason during the 24-month period following such Change in Control, you will be required to execute
and not revoke a waiver and release agreement, if provided by the Company at the time of your
termination of employment. Failure to meet these requirements by the date specified by the Company,
which shall be in no event later than 60 days following your termination of employment, or failure to
comply with the waiver and release agreement and be in compliance with the agreement, if applicable,
as of the delivery date as described in II.B.4., will result in the cancellation or forfeiture of any rights,
title and interest in and to the Award.
C. For the avoidance of doubt, in the event of your termination of employment by the Company other than
for Cause or by you for Good Reason during the 24-month period following such Change in Control and,
on or before the date of your termination of employment you satisfy the Age and Service Criteria for
Pro-Rata Vesting or the Age and Service Criteria for Full Vesting as described in Section III.C., any
unvested Stock Units covered by the Award will be treated as described in this Section
11
-- 119 of 156 --
IV.; provided that you have satisfied the conditions described in Section IV.B.
V. DEFINITIONS
As used in these Terms and Conditions:
A. “Age and Service Criteria for Full Vesting” shall mean you are at least age 62 and have a minimum
of five years of service with the Company.
B. “Age and Service Criteria for Pro-Rata Vesting” shall mean you are at least age 55 but are not yet
age 62 and have a minimum of five years of service with the Company.
C. “Cause” shall mean:
1. willful failure to substantially perform the duties consistent with your position which is not
remedied within 30 days after receipt of written notice from the Company specifying such failure;
2. willful violation of any written Company policies, including but not limited to, The Marsh Code of
Conduct, The Greater Good;
3. commission at any time of any act or omission that results in a conviction, plea of no contest, plea
of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral
turpitude;
4. unlawful use (including being under the influence) or possession of illegal drugs;
5. any gross negligence or willful misconduct resulting in a material loss to the Company, or material
damage to the reputation of the Company; or
6. any violation of any statutory or common law duty of loyalty to the Company, including the
commission at any time of any act of fraud, embezzlement, or material breach of fiduciary duty
against the Company.
D. “Change in Control” shall have the meaning set forth in the Plan.
E. “Company” shall mean Marsh or any of its subsidiaries or affiliates.
F. “Employment-Related Action” shall mean the execution and effectiveness of a release of claims and/or
a restrictive covenant.
G. “Good Reason” shall mean any one of the following events without your written consent:
1. material reduction in your base salary;
2. material reduction in your annual incentive opportunity (including a material adverse change in the
method of calculating your annual incentive);
3. material diminution of your duties, responsibilities or authority; or
4. relocation of more than 50 miles from your principal place of employment immediately prior to the
Change in Control; provided that you provide Marsh with written notice of your intent to terminate
your
12
-- 120 of 156 --
employment for Good Reason within 60 days of your becoming aware of any circumstances set forth
above (with such notice indicating the specific termination provision above on which you are relying
and describing in reasonable detail the facts and circumstances claimed to provide a basis for
termination of your employment under the indicated provision) and that you provide Marsh with at
least 30 days following receipt of such notice to remedy such circumstances.
H. “Permanent Disability” will be deemed to occur when it is determined (by Marsh’s disability carrier for
the primary long-term disability plan or program applicable to you because of your employment with the
Company) that you are unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in death or can be expected
to last for a continuous period of not less than 12 months.
I. “Section 409A of the Code” shall mean Section 409A of the U.S. Internal Revenue Code of 1986, as
amended, and the regulations and guidance thereunder (regarding nonqualified deferred
compensation).
J. “Tax-Related Items” shall have the meaning ascribed to such term in the Plan.
VI. ADDITIONAL PROVISIONS
A. Additional Provisions—General
1. Administrative Rules. The Award shall be subject to such additional administrative regulations as
the Committee may, from time to time, adopt. All decisions of the Committee upon any questions
arising under the Award Documentation shall be conclusive and binding. The Committee may
delegate to any other individual or entity the authority to perform any or all of the functions of the
Committee under the Award, and references to the Committee shall be deemed to include any such
delegate.
2. Amendment. The Committee may, in its sole discretion, amend the terms of the Award, including,
without limitation, to impose additional requirements on the Award and on any shares of Common
Stock with respect to the Award; provided, however, that if the Committee concludes, in its sole
discretion, that such amendment is likely to materially impair your rights with respect to the Award,
such amendment shall not be implemented with respect to the Award without your consent, except
to the extent that any such action (a) is made to cause the Award to comply with applicable law,
currency controls, stock market or exchange rules and regulations, or accounting or tax rules and
regulations, (b) is made to obtain or maintain corporate tax deductibility or other favorable tax
treatment with respect to the Award, or (c) is otherwise made in accordance with Section VI.A.4.
3. Limitations. Payment of the Award is not secured by trust, insurance contract or other funding
medium, and you do not have any interest in any fund or specific asset of Marsh by reason of the
Award. Your right
13
-- 121 of 156 --
to payment of the Award is the same as the right of an unsecured general creditor of Marsh.
4. Cancellation or Clawback of Awards.
a. Marsh may, to the extent permitted or required by any applicable law, stock exchange rules,
currency controls, the Company Incentive Compensation Clawback Policy or any other applicable
Company policy or arrangement in effect prior to the vesting of any unvested portion of the
Award, or as specified in the Award Documentation, cancel, reduce or require reimbursement of
the Award in the event of fraud, financial restatements, or other events as may be determined by
the Committee.
b. If you fail to repay any amount due pursuant to this Section VI.A.4., the Company may bring an
action in court to recover the amount due. You acknowledge that, by accepting the Award, you
agree to pay all costs, expenses and attorney’s fees incurred by the Company in any proceeding
for the collection of amounts due pursuant to this Section VI.A.4., provided that the Company
prevails in whole or in part in any such proceeding. The Company may also, to the extent
permitted by applicable law, reduce any amounts owed to you by the Company in an amount up
to the full amount of the repayment due.
5. Governing Law; Choice of Forum. The Award and the Award Documentation applicable to the
Award are governed by, and subject to the laws of the state of Delaware, without regard to the
conflict of law provisions, as set forth in Section 10.K of the Plan. For purposes of any action,
lawsuit, or other proceedings arising out of or relating to this Award, including without limitation, to
enforce the Award Documentation, the Company and you each hereby irrevocably and
unconditionally submits to the exclusive jurisdiction of any New York state court or federal court of
the United States of America sitting in the State of New York, and any appellate court thereof. The
Company and you agree that a final judgment in any such action or proceeding shall be conclusive
and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by law.
6. Severability; Captions. In the event that any provision of this Award is determined to be invalid
or unenforceable, in whole or in part, the remaining provisions of this Award will be unaffected
thereby and will remain in full force and effect to the fullest extent permitted by law. The captions of
this Award are not part of the provisions of this Award and will have no force or effect.
7. Electronic Delivery and Acceptance. Marsh may, in its sole discretion, decide to deliver any
documents related to the Award and/or your current or future participation in the Plan by electronic
means. You hereby consent to receive such documents by electronic delivery and agree to
participate in the Plan through an on-line or electronic system established and maintained by Marsh
or an agent appointed by Marsh.
14
-- 122 of 156 --
8. Waiver. You acknowledge that neither a waiver by Marsh of your breach of any provision of the
Award Documentation nor a prior waiver by Marsh of a breach of any provision of the Award
Documentation by any other participant of the Plan shall operate or be construed as a waiver of any
other provision of the Award Documentation, or of any subsequent breach by you.
9. Eligibility for Award. In order to be granted an Award, you must satisfy the eligibility criteria for
grantees set forth in the Plan as of the grant date.
B. Additional Provisions—Outside of the United States
1. Changes to Delivery. In the event that Marsh considers that due to legal, regulatory or tax issues
the normal delivery of an Award (as described in these Terms and Conditions) to a participant
outside the United States would not be appropriate, then Marsh may, in its sole discretion, determine
how and when the value of the Award will be delivered. Without limitation, this may include making
any payments due under the Award in cash instead of shares of Common Stock or in shares of
Common Stock instead of cash, in an amount equivalent to the value of the Award on the date of
vesting after payment of applicable Tax-Related Items and fees, or, delivering or paying out the
Award as soon as practicable following a termination of employment. If the value of an Award is to
be delivered in cash instead of shares of Common Stock, Marsh may sell any shares of Common
Stock distributable in respect of the Award on your behalf and use the proceeds (after payment of
applicable Tax-Related Items and fees) to satisfy the Award.
2. Amendment and Modification. The Committee may modify the terms of any Award under the
Plan granted to you in any manner deemed by the Committee to be necessary or appropriate in
order for such Award to conform to laws, regulations, and customs of the country (other than the
United States) in which you are then resident or primarily employed or were resident or primarily
employed at the time of grant or during the term of the Award, or so that the value and other
benefits of the Award to you, as affected by non-U.S. tax laws and other restrictions applicable as a
result of your residence or employment outside of the United States, shall be comparable to the
value of such an Award to an individual who is resident or primarily employed in the United States.
15
-- 123 of 156 --
VII. QUESTIONS AND ADDITIONAL INFORMATION
Please retain this document in your permanent records. If you have any questions regarding the Award
Documentation or if you would like an account statement detailing the number of shares of Common Stock
covered by the Award and the vesting date(s) of the Award, or any other information, please contact:
Executive Compensation
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036-2774
United States of America
Telephone Number: +1 212 345-9722
Email: mmc.compensation@mmc.com
16
-- 124 of 156 --
IN WITNESS WHEREOF, Marsh has caused these Terms and Conditions to be duly executed by the facsimile signature
of its Senior Vice President, Chief People Officer as of the day and year first above written. By consenting to these
Terms and Conditions, you agree to the following: (i) you have carefully read, fully understand and agree to all of the
terms and conditions described herein and in the Award Documentation; and (ii) you understand and agree that
these Terms and Conditions and the Award Documentation constitute the entire understanding between you and
Marsh regarding the Award, and that any prior agreements, commitments or negotiations concerning the Award are
replaced and superseded. The grant of the Award is contingent upon your acceptance of these Terms and Conditions,
Country-Specific Notices and Restrictive Covenants Agreement (if applicable) by the date and in the manner specified
in materials provided to you by Executive Compensation and/or the Company’s stock plan service provider. If you
decline the Award or you do not accept the Award and any applicable documents described in the preceding sentence
by the date and in the manner specified, the Award will be cancelled as of the grant date of the Award.
/s/ Carmen Fernandez
Carmen Fernandez
SVP, Chief People Officer
17
2026 Terms and Conditions – RSU
-- 125 of 156 --
MARSH & McLENNAN COMPANIES, INC.
AMENDED AND RESTATED 2020 INCENTIVE AND STOCK AWARD PLAN
TERMS AND CONDITIONS
OF
DEFERRED STOCK UNIT AWARDS
WITH GRANT DATES FROM MARCH 1, 2026 THROUGH FEBRUARY 1, 2027
-- 126 of 156 --
TABLE OF CONTENTS
Page
I. BACKGROUND 1
II. AWARDS 1
III. EMPLOYMENT EVENTS 4
IV. CHANGE IN CONTROL PROVISIONS 7
V. DEFINITIONS 8
VI. ADDITIONAL PROVISIONS 9
VII. QUESTIONS AND ADDITIONAL INFORMATION 11
-- 127 of 156 --
I. BACKGROUND
An award (“Award”) has been granted to you under the Marsh & McLennan Companies, Inc. Amended and
Restated 2020 Incentive and Stock Award Plan (the “Plan”), subject to your acceptance as described in Section
II.A.1. The Award type, the number of shares of Marsh & McLennan Companies, Inc. (“Marsh”) common stock
covered by the Award, instructions on how to accept or decline the Award and the deadline for accepting the
Award will be provided to you by Executive Compensation and/or the stock plan service provider of the
Company (as defined in Section V.). The Award is also subject to the terms and conditions set forth herein (the
“Terms and Conditions”) and to additional terms and conditions as set forth in the country-specific notices (the
“Country-Specific Notices”). The Prospectus dated [DATE] also describes important information about the Plan.
The Terms and Conditions, the Country-Specific Notices, and the Plan will be referred to herein as the “Award
Documentation”. As used herein, “Common Stock” means common stock of Marsh.
Capitalized terms in these Terms and Conditions are defined in Section V.
II. AWARDS
A. General.
1. Award Acceptance. The grant of this Award is contingent upon your acceptance, by the date and
in the manner specified by Executive Compensation and/or the Company’s stock plan service
provider, of these Terms and Conditions, the Country-Specific Notices and Restrictive Covenants
Agreement as described in Section II.A.3. If you decline the Award or if you do not accept the Award
and any applicable documents described in the preceding sentence by the deadline date and in the
manner specified, then the Award will be cancelled as of the grant date of the Award.
2. Rights of Award Holders. Unless and until the vesting conditions of the Award have been
satisfied and cash or shares of Common Stock, as applicable, have been delivered to you in
accordance with the Award Documentation, you have only the rights of a general unsecured creditor
of Marsh. Unless and until shares of Common Stock have been delivered to you, you have none of
the rights of ownership to such shares (e.g., units cannot be used as payment for stock option
exercises; units may not be transferred or assigned; units have no voting rights).
3. Restrictive Covenants Agreement. As described in Section II.A.1., a Restrictive Covenants
Agreement (“Restrictive Covenants Agreement”) in a form determined by Marsh must be in place in
order to accept the Award and you must execute or reaffirm, as determined by Marsh, in its sole
discretion, the Restrictive Covenants Agreement in order for the Award to vest pursuant to certain
employment events as described in Section III. Failure to timely execute the Restrictive Covenants
Agreement by the date specified by the Company or failure to timely execute or reaffirm and comply
with the Restrictive Covenants Agreement as described in Section III.F.1. or 2., as
1
-- 128 of 156 --
applicable, will result in cancellation or forfeiture of any rights, title and interest in and to the Award,
without any liability to the Company.
B. Stock Units.
1. General. A deferred stock unit (“Stock Unit”) represents an unfunded and unsecured promise to
deliver (or cause to be delivered) to you, subject to the terms of the Award Documentation, one
share of Common Stock after vesting.
2. Vesting. Subject to your continued employment, 100% of the Stock Units will vest on the 15th of
the month in which the third anniversary of the grant date of the Award occurs. The date on which a
Stock Unit is scheduled to vest pursuant to this Section II.B.2. is the “Scheduled Vesting Date.” In
the event of your termination of employment or the occurrence of your Permanent Disability (as
defined in Section V.) prior to the Scheduled Vesting Date, your right to any Stock Units that are
unvested immediately prior to your termination of employment or occurrence of your Permanent
Disability, as applicable, will be determined in accordance with Section III. below. For the avoidance
of doubt, the date of your termination of employment for purposes of determining vesting under this
Section II.B.2. will be determined in accordance with Section III.E.
3. Dividend Equivalents. For each outstanding Stock Unit covered by the Award, an amount equal
to the dividend payment (if any) made in respect of one share of Common Stock (a “Dividend
Equivalent”) will accrue in U.S. dollars on each dividend record date that occurs on or after the grant
date of the Award while the Award is outstanding, with no interest paid on such amounts. Accrued
Dividend Equivalents will vest when the Stock Units in respect of which such Dividend Equivalents
were accrued vest. No further Dividend Equivalents will accrue on Stock Units that do not vest or are
cancelled or forfeited. Accrued Dividend Equivalents will not be paid, and no further Dividend
Equivalents will accrue, on Stock Units that do not vest or are cancelled or forfeited as per a
termination of employment event described in Section III.D.
4. Delivery.
a. Shares of Common Stock deliverable in respect of the Stock Units covered by the Award shall be
delivered to you as soon as practicable after vesting, and in no event later than 60 days after
vesting, except as otherwise provided in Section VI.B.
b. The value of vested Dividend Equivalents will be delivered to you in cash as soon as practicable
after vesting and in no event later than 60 days after vesting.
c. The delivery of shares of Common Stock and/or cash or other property that may be deliverable
under these Terms and Conditions, is conditioned on the satisfaction or withholding of any
applicable tax obligations, as described in Section II.C.
d. Any shares of Common Stock and/or cash or other property that may be deliverable following
your death shall be delivered to the
1
-- 129 of 156 --
person or persons to whom your rights pass by will or the law of descent and distribution, and
such delivery shall completely discharge Marsh and any of its subsidiaries’ or affiliates’ obligations
under the Award.
e. Notwithstanding the foregoing, additional delivery rules for certain Award recipients subject to
U.S. federal income tax (whether or not the recipient is a U.S. citizen or employed in the U.S.)
are reflected in Section III.G.
C. Satisfaction of Tax Obligations.
1. Personal Tax Advisor. Neither the Company nor any Company employee is authorized to provide
personal tax advice to you. It is recommended that you consult with your personal tax advisor for
more detailed information regarding the tax treatment of the Award, especially before making any
decisions that rely on that tax treatment.
2. U.S. Employees. Applicable employment taxes are required by law to be withheld when a Stock
Unit or Dividend Equivalent vests. Applicable income taxes are required by law to be withheld when
shares of Common Stock in respect of Stock Units or cash in respect of Dividend Equivalents are
delivered to you. A sufficient number of whole shares of Common Stock, cash or other property, as
applicable, will be retained by Marsh to satisfy the tax withholding obligation.
3. Non-U.S. Employees.
a. Stock Units and Dividend Equivalents. In most countries, the value of a Stock Unit or
Dividend Equivalent is generally not taxable on the grant date. If the value of the Stock Unit or
Dividend Equivalent is not taxable on the grant date, it will, in most countries, be taxed at a later
time, for example, upon delivery of a share of Common Stock in respect of the Stock Unit that
vests, and/or the subsequent sale of the share of Common Stock received in connection with the
vesting of the Stock Unit or upon delivery of cash in respect of a Dividend Equivalent.
b. Withholding. Marsh and/or your employer shall have the power and the right to deduct and
withhold from the Award and other compensation or to require you to remit to Marsh and/or to
your employer, an amount sufficient to satisfy any Tax-Related Items (as defined in Section V.)
that Marsh expects to be payable under the laws of any country, state, province, city or other
jurisdiction. If applicable, Marsh and/or your employer will, to the extent permissible under
applicable law or otherwise agreed between you and Marsh and/or your employer, either (a)
withhold from proceeds of the sale a sufficient number of whole shares of Common Stock issued
to you in settlement of the Award (either through your voluntary sale or through a mandatory
sale arranged by Marsh on your behalf) for purposes of satisfying applicable obligations with
respect to Tax-Related Items and/or (b) withhold a sufficient number of whole shares of Common
Stock distributable to you in in respect of the Award to satisfy applicable obligations with respect
to Tax-Related Items. Further, depending on the withholding
2
-- 130 of 156 --
method, Marsh and/or your employer may withhold or account for obligations for Tax-Related
Items by considering statutory or other withholding rates, including minimum or maximum rates
applicable in your jurisdiction(s).
In the event of over-withholding, you may receive a refund from Marsh and/or your employer of
any over-withheld amount in cash (with no entitlement to the equivalent in shares of Common
Stock), or if not refunded by Marsh and/or your employer, you must seek a refund from the local
tax authorities to the extent you wish to recover the over-withheld amount in the form of a
refund.
III. EMPLOYMENT EVENTS
A. Death. In the event your employment is terminated because of your death, all of the unvested Stock
Units that are outstanding as of the date of your death will fully vest and will be distributed as described
in Section II.B.4.
B. Permanent Disability. Upon the occurrence of your Permanent Disability, the unvested Stock Units will
fully vest and will be distributed as described in Section II.B.4., provided that you satisfy the conditions
to vesting described in Section III.F.1.
C. Termination by the Company Other Than for Cause.
1. General. Except as otherwise provided in Section IV., in the event the Company, in its sole
discretion, determines that your employment is terminated by the Company other than for Cause (as
defined in Section V.), the unvested Stock Units will fully vest at such termination of employment
and will be distributed as described in Section II.B.4., provided that you satisfy the conditions to
vesting described in Section III.F.2.
2. Important Notes.
a. Sale of Business Unit. For purposes of this Award, in the event of a sale or similar transaction
involving the business unit for which you work (“Employing Company”) as a result of which the
Employing Company ceases to be a subsidiary or affiliate of Marsh, your employment will be
deemed terminated by the Company other than for Cause, even if your employment with the
Employing Company continues after the sale or similar transaction.
b. Constructive Discharge. The Award will not vest, whether on a pro-rata or full basis, upon a
constructive discharge, including if any court or regulatory agency retroactively concludes or
interprets events to have constituted a constructive discharge.
D. All Other Terminations. For all other terminations of employment not described in Sections III.A.
through C. or Section IV. (including, but not limited to, a termination by the Company for Cause or a
resignation by you of your employment with the Company), any rights, title and interest in and to any
remaining unvested portion of the Award shall be cancelled
3
-- 131 of 156 --
as of the date your employment is treated as having terminated as described in Section III.E.
E. Date of Termination of Employment.
1. If Section III.E.2. does not apply to you, then for purposes of determining vesting under Section
II.B.2., your employment will be treated as having terminated on your last day of employment with
the Company.
2. If you are obligated (whether by law or contract) to provide the Company advance notice of your
intention to terminate your employment then, in the event you terminate your employment or
service relationship pursuant to Section III.D. (regardless of the reason for such termination and
whether or not later found to be invalid or in breach of employment laws in the jurisdiction where
you are employed or the terms of your employment agreement, if any), for purposes of determining
vesting under Section II.B.2., your employment will be treated as having terminated on your last day
of active service with the Company, as determined by the Company in its sole discretion.
You shall be deemed to have ceased active service with the Company when you are no longer
required by the Company to provide regular services to the Company even if you remain legally
employed by the Company, such as may occur if the Company were to place you on “garden leave”,
a terminal leave of absence or any similar period mandated under employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any (in each
case as determined by the Company in its sole discretion).
F. Conditions to Vesting of Award Prior to the Scheduled Vesting Date.
1. Restrictive Covenants Agreement. In the event of the occurrence of your Permanent Disability
as described in Section III.B., you will be required to execute or reaffirm, as determined by Marsh in
its sole discretion, and return to Marsh (or an agent appointed by Marsh) a Restrictive Covenants
Agreement. Failure to (a) execute or reaffirm such an agreement by the date specified by the
Company, which shall be in no event later than 60 days following the occurrence of your Permanent
Disability as described in Section III.B., or (b) comply with the Restrictive Covenants Agreement, will
result in the cancellation or forfeiture of any rights, title and interest in and to the Award without any
liability to the Company.
2. Waiver and Release and Restrictive Covenants Agreement. In the event of your termination
of employment by the Company other than for Cause as described in Section III.C., you will be
required to (i) execute or reaffirm, as determined by Marsh in its sole discretion, and return to Marsh
(or an agent appointed by Marsh) a Restrictive Covenants Agreement and (ii) execute and not
revoke a waiver and release agreement, if provided to you by the Company at the time of your
termination of employment. Failure to meet these requirements by the date specified by the
Company, which shall be in no event later
4
-- 132 of 156 --
than 60 days following your termination of employment, or failure to comply with the waiver and
release agreement or the Restrictive Covenants Agreement, as applicable, will result in the
cancellation or forfeiture of any rights, title and interest in and to the Award without any liability to
the Company.
G. Section 409A of the Code for Award Recipients Subject to U.S. Federal Income Tax (whether or
not the recipient is a U.S. citizen or employed in the U.S.).
1. For Award recipients subject to U.S. federal income tax, notwithstanding any other provision
herein, the Award may be subject to additional restrictions to ensure compliance with (or continued
exemption from) the requirements of Section 409A of the Code (as defined in Section V.). The
Compensation Committee of the Board of Directors of Marsh (the “Committee”) intends to
administer the Award in accordance with Section 409A of the Code and reserves the right to make
changes in the terms or operations of the Award (including changes that may have retroactive
effect) deemed necessary or desirable to comply with Section 409A of the Code. This means, for
example, that the timing of distributions may be different from those described in the Award
Documentation that do not reflect Section 409A of the Code. If the Award is not in compliance with
Section 409A of the Code, you may be subject to immediate taxation of all unpaid awards under the
Plan that are subject to Section 409A of the Code at your regular federal income tax rate, plus a
20% additional tax, plus interest at the underpayment rate plus 1%, as well as any state and local
taxes, penalties, additional taxes and interest, if applicable, imposed under any state tax law similar
to Section 409A of the Code.
2. Notwithstanding any other provision herein, if any portion of the Award is determined to be
nonqualified deferred compensation subject to Section 409A of the Code, any references to
“termination of employment,” or “when you are no longer employed” in these Terms and Conditions
shall have the following meaning:
Your “termination of employment” (or similar terms) shall occur when you have incurred a
“separation from service” within the meaning of Section 409A of the Code and as further defined
herein. Specifically, you will have incurred a “separation from service” when the level of services you
provide to the Company in any capacity, including as an employee, director, independent contractor
or consultant, does not exceed 20% of the average level of services that you provided to the
Company in the preceding 36 months (or shorter period of service if, for example, your total service
with the Company is less than 36 months), all as determined in accordance with Section 409A of the
Code. In determining whether a “separation from service” has occurred, any period of up to six
months during which you are on a bona fide leave of absence or up to 29 months during which you
are absent from work due to a disability for which you are receiving Marsh long-term disability
benefits will be ignored.
5
-- 133 of 156 --
3. Notwithstanding any other provision herein, if at the time of your termination of employment you
are a “specified employee” (as defined in Section 409A of the Code) no portion of the Award that is
determined to be nonqualified deferred compensation subject to Section 409A of the Code can be
distributed prior to the first day of the seventh month after your termination of employment and any
such distributions to which you would otherwise be entitled during the first six months following your
termination of employment will be accumulated and paid without interest on the first day of the
seventh month after your termination of employment, except to the extent that earlier distribution
would not result in your incurring interest or additional tax under Section 409A of the Code.
4. Nothing in this Section III.G. is intended to, nor does it guarantee, that the Award will not be
subject to “additional tax” or other adverse tax consequences under Section 409A of the Code or any
similar state tax law. In no event will the Company be liable for all or any portion of any taxes,
penalties, interest or other expenses that may be incurred on account of non-compliance with
Section 409A of the Code.
IV. CHANGE IN CONTROL PROVISIONS
A. Upon the occurrence of a “Change in Control”, as defined in the Plan, the Award will continue to vest in
accordance with the vesting schedule specified in Section II.B.2. and subject to earlier vesting or
forfeiture pursuant to Section III., provided that the Award will become fully vested at your termination
of employment by the Company other than for Cause, or by you for Good Reason (as defined in Section
V.), during the 24-month period following such Change in Control and will be distributed as described in
Section II.B.4., provided that you satisfy the conditions to vesting described in Section IV.B.
Notwithstanding the foregoing, if the Award is not assumed, converted or replaced in connection with a
Change in Control on an equivalent basis, the Award will fully vest immediately prior to the Change in
Control and will be distributed as described in Section II.B.4.
B. As a condition to vesting of any unvested portion of the Award, in the event of your termination of
employment by the Company other than for Cause or by you for Good Reason during the 24-month
period following such Change in Control, you will be required to execute and not revoke a waiver and
release agreement, if provided by the Company at the time of your termination of employment. Failure
to meet these requirements by the date specified by the Company, which shall be in no event later than
60 days following your termination of employment, or failure to comply with the waiver and release
agreement, if applicable, will result in the cancellation or forfeiture of any rights, title and interest in and
to the Award.
6
-- 134 of 156 --
V. DEFINITIONS
As used in these Terms and Conditions:
A. “Cause” shall mean:
1. willful failure to substantially perform the duties consistent with your position which is not
remedied within 30 days after receipt of written notice from the Company specifying such failure;
2. willful violation of any written Company policies including, but not limited to, The Marsh Code of
Conduct, The Greater Good;
3. commission at any time of any act or omission that results in a conviction, plea of no contest, plea
of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral
turpitude;
4. unlawful use (including being under the influence) or possession of illegal drugs;
5. any gross negligence or willful misconduct resulting in a material loss to the Company, or material
damage to the reputation of the Company; or
6. any violation of any statutory or common law duty of loyalty to the Company, including the
commission at any time of any act of fraud, embezzlement, or material breach of fiduciary duty
against the Company.
B. “Change in Control” shall have the meaning set forth in the Plan.
C. “Company” shall mean Marsh or any of its subsidiaries or affiliates.
D. “Good Reason” shall mean any one of the following events without your written consent:
1. material reduction in your base salary;
2. material reduction in your annual incentive opportunity (including a material adverse change in the
method of calculating your annual incentive);
3. material diminution of your duties, responsibilities or authority; or
4. relocation of more than 50 miles from your principal place of employment immediately prior to the
Change in Control;
provided that you provide Marsh with written notice of your intent to terminate your employment for
Good Reason within 60 days of your becoming aware of any circumstances set forth above (with
such notice indicating the specific termination provision above on which you are relying and
describing in reasonable detail the facts and circumstances claimed to provide a basis for termination
of your employment under the indicated provision) and that you provide Marsh with at least 30 days
following receipt of such notice to remedy such circumstances.
E. “Permanent Disability” will be deemed to occur when it is determined (by Marsh’s disability carrier for
the primary long-term disability plan or program applicable to you because of your employment with the
7
-- 135 of 156 --
Company) that you are unable to engage in any substantial gainful activity by reason of any medically
determinable physical or mental impairment that can be expected to result in death or can be expected
to last for a continuous period of not less than 12 months.
F. “Section 409A of the Code” shall mean Section 409A of the U.S. Internal Revenue Code of 1986, as
amended, and the regulations and guidance thereunder (regarding nonqualified deferred
compensation).
G. “Tax-Related Items” shall have the meaning ascribed to such term in the Plan.
VI. ADDITIONAL PROVISIONS
A. Additional Provisions—General
1. Administrative Rules. The Award shall be subject to such additional administrative regulations as
the Committee may, from time to time, adopt. All decisions of the Committee upon any questions
arising under the Award Documentation shall be conclusive and binding. The Committee may
delegate to any other individual or entity the authority to perform any or all of the functions of the
Committee under the Award, and references to the Committee shall be deemed to include any such
delegate.
2. Amendment. The Committee may, in its sole discretion, amend the terms of the Award, including,
without limitation, to impose additional requirements on the Award and on any shares of Common
Stock with respect to the Award; provided, however, that if the Committee concludes, in its sole
discretion, that such amendment is likely to materially impair your rights with respect to the Award,
such amendment shall not be implemented with respect to the Award without your consent, except
to the extent that any such action (a) is made to cause the Award to comply with applicable law,
currency controls, stock market or exchange rules and regulations, or accounting or tax rules and
regulations, (b) is made to obtain or maintain corporate tax deductibility or other favorable tax
treatment with respect to the Award, or (c) is otherwise made in accordance with Section VI.A.4.
3. Limitations. Payment of the Award is not secured by trust, insurance contract or other funding
medium, and you do not have any interest in any fund or specific asset of Marsh by reason of the
Award. Your right to payment of the Award is the same as the right of an unsecured general creditor
of Marsh.
4. Cancellation or Clawback of Awards.
a. Marsh may, to the extent permitted or required by any applicable law, stock exchange rules,
currency controls, or the Company Incentive Compensation Clawback Policy or any other
applicable Company policy or arrangement in effect prior to the vesting of any unvested portion
of the Award, or as specified in the Award Documentation, cancel, reduce or require
reimbursement of the Award in the event of fraud, financial restatements, or other events as may
be determined by the Committee.
8
-- 136 of 156 --
b. If you fail to repay any amount due pursuant to this Section VI.A.4., the Company may bring an
action in court to recover the amount due. You acknowledge that, by accepting the Award, you
agree to pay all costs, expenses and attorney’s fees incurred by the Company in any proceeding
for the collection of amounts due pursuant to this Section VI.A.4., provided that the Company
prevails in whole or in part in any such proceeding. The Company may also, to the extent
permitted by applicable law, reduce any amounts owed to you by the Company in an amount up
to the full amount of the repayment due.
5. Governing Law; Choice of Forum. The Award and the Award Documentation applicable to the
Award are governed by, and subject to the laws of the state of Delaware, without regard to the
conflict of law provisions, as set forth in Section 10.K of the Plan. For purposes of any action,
lawsuit, or other proceedings arising out of or relating to this Award, including without limitation, to
enforce the Award Documentation, the Company and you each hereby irrevocably and
unconditionally submits to the exclusive jurisdiction of any New York state court or federal court of
the United States of America sitting in the State of New York, and any appellate court thereof. The
Company and you agree that a final judgment in any such action or proceeding shall be conclusive
and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by law.
6. Severability; Captions. In the event that any provision of this Award is determined to be invalid
or unenforceable, in whole or in part, the remaining provisions of this Award will be unaffected
thereby and will remain in full force and effect to the fullest extent permitted by law. The captions of
this Award are not part of the provisions of this Award and will have no force or effect.
7. Electronic Delivery and Acceptance. Marsh may, in its sole discretion, decide to deliver any
documents related to the Award and/or your current or future participation in the Plan by electronic
means. You hereby consent to receive such documents by electronic delivery and agree to
participate in the Plan through an on-line or electronic system established and maintained by Marsh
or an agent appointed by Marsh.
8. Waiver. You acknowledge that neither a waiver by Marsh of your breach of any provision of the
Award Documentation nor a prior waiver by Marsh of a breach of any provision of the Award
Documentation by any other participant of the Plan shall operate or be construed as a waiver of any
other provision of the Award Documentation, or of any subsequent breach by you.
9. Eligibility for Award. In order to be granted an Award, you must satisfy the eligibility criteria for
grantees set forth in the Plan as of the grant date.
B. Additional Provisions—Outside of the United States
1. Changes to Delivery. In the event that Marsh considers that due to legal, regulatory or tax issues
the normal delivery of an Award (as
9
-- 137 of 156 --
described in these Terms and Conditions) to a participant outside the United States would not be
appropriate, then Marsh may, in its sole discretion, determine how and when the value of the Award
will be delivered. Without limitation, this may include making any payments due under the Award in
cash instead of shares of Common Stock or in shares of Common Stock instead of cash, in an
amount equivalent to the value of the Award on the date of vesting after payment of applicable Tax-
Related Items and fees. If the value of an Award is to be delivered in cash instead of shares of
Common Stock, Marsh may sell any shares of Common Stock distributable in respect of the Award
on your behalf and use the proceeds (after payment of applicable Tax-Related Items and fees) to
satisfy the Award.
2. Amendment and Modification. The Committee may modify the terms of any Award under the
Plan granted to you in any manner deemed by the Committee to be necessary or appropriate in
order for such Award to conform to laws, regulations, and customs of the country (other than the
United States) in which you are then resident or primarily employed or were resident or primarily
employed at the time of grant or during the term of the Award, or so that the value and other
benefits of the Award to you, as affected by non-U.S. tax laws and other restrictions applicable as a
result of your residence or employment outside of the United States, shall be comparable to the
value of such an Award to an individual who is resident or primarily employed in the United States.
VII. QUESTIONS AND ADDITIONAL INFORMATION
Please retain this document in your permanent records. If you have any questions regarding the Award
Documentation or if you would like an account statement detailing the number of shares of Common Stock
covered by the Award and the vesting date(s) of the Award, or any other information, please contact:
Executive Compensation
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036-2774
United States of America
Telephone Number: +1 212 345-9722
Email: mmc.compensation@mmc.com
10
-- 138 of 156 --
IN WITNESS WHEREOF, Marsh has caused these Terms and Conditions to be duly executed by the facsimile
signature of its Senior Vice President, Chief People Officer as of the day and year first above written. By
consenting to these Terms and Conditions, you agree to the following: (i) you have carefully read, fully
understand and agree to all of the terms and conditions described herein and in the Award Documentation; and
(ii) you understand and agree that these Terms and Conditions and the Award Documentation constitute the
entire understanding between you and Marsh regarding the Award, and that any prior agreements, commitments
or negotiations concerning the Award are replaced and superseded. The grant of the Award is contingent upon
your acceptance of these Terms and Conditions, Country-Specific Notices and Restrictive Covenants Agreement (if
applicable) by the date and in the manner specified in materials provided to you by Executive Compensation
and/or the Company’s stock plan service provider. If you decline the Award or you do not accept the Award and
any applicable documents described in the preceding sentence by the date and in the manner specified, the
Award will be cancelled as of the grant date of the Award.
/s/ Carmen Fernandez
Carmen Fernandez
SVP, Chief People Officer
11
-- 139 of 156 --
MARSH & McLENNAN COMPANIES, INC.
AMENDED AND RESTATED 2020 INCENTIVE AND STOCK AWARD PLAN
TERMS AND CONDITIONS
OF
DEFERRED STOCK UNIT AWARDS
WITH GRANT DATES FROM MARCH 1, 2026 THROUGH FEBRUARY 1, 2027
-- 140 of 156 --
TABLE OF CONTENTS
Page
I. BACKGROUND 1
II. AWARDS 1
III. EMPLOYMENT EVENTS 4
IV. CHANGE IN CONTROL PROVISIONS 7
V. DEFINITIONS 8
VI. ADDITIONAL PROVISIONS 9
VII. QUESTIONS AND ADDITIONAL INFORMATION 11
-- 141 of 156 --
I. BACKGROUND
An award (“Award”) has been granted to you under the Marsh & McLennan Companies, Inc. Amended and
Restated 2020 Incentive and Stock Award Plan (the “Plan”), subject to your acceptance as described in Section
II.A.1. The Award type, the number of shares of Marsh & McLennan Companies, Inc. (“Marsh”) common stock
covered by the Award, instructions on how to accept or decline the Award and the deadline for accepting the
Award will be provided to you by Executive Compensation and/or the stock plan service provider of the
Company (as defined in Section V.). The Award is also subject to the terms and conditions set forth herein (the
“Terms and Conditions”) and to additional terms and conditions as set forth in the country-specific notices (the
“Country-Specific Notices”). The Prospectus dated [DATE] also describes important information about the Plan.
The Terms and Conditions, the Country-Specific Notices, and the Plan will be referred to herein as the “Award
Documentation”. As used herein, “Common Stock” means common stock of Marsh.
Capitalized terms in these Terms and Conditions are defined in Section V.
II. AWARDS
A. General.
1. Award Acceptance. The grant of this Award is contingent upon your acceptance, by the date and
in the manner specified by Executive Compensation and/or the Company’s stock plan service
provider, of these Terms and Conditions, the Country-Specific Notices and Restrictive Covenants
Agreement as described in Section II.A.3. If you decline the Award or if you do not accept the Award
and any applicable documents described in the preceding sentence by the deadline date and in the
manner specified, then the Award will be cancelled as of the grant date of the Award.
2. Rights of Award Holders. Unless and until the vesting conditions of the Award have been
satisfied and cash or shares of Common Stock, as applicable, have been delivered to you in
accordance with the Award Documentation, you have only the rights of a general unsecured creditor
of Marsh. Unless and until shares of Common Stock have been delivered to you, you have none of
the rights of ownership to such shares (e.g., units cannot be used as payment for stock option
exercises; units may not be transferred or assigned; units have no voting rights).
3. Restrictive Covenants Agreement. As described in Section II.A.1., a Restrictive Covenants
Agreement (“Restrictive Covenants Agreement”) in a form determined by Marsh must be in place in
order to accept the Award and you must execute or reaffirm, as determined by Marsh, in its sole
discretion, the Restrictive Covenants Agreement in order for the Award to vest pursuant to certain
employment events as described in Section III. Failure to timely execute the Restrictive Covenants
Agreement by the date specified by the Company or failure to timely execute or reaffirm and comply
with the Restrictive Covenants Agreement as described in Section III.F.1. or 2., as
1
-- 142 of 156 --
applicable, will result in cancellation or forfeiture of any rights, title and interest in and to the Award,
without any liability to the Company.
B. Stock Units.
1. General. A deferred stock unit (“Stock Unit”) represents an unfunded and unsecured promise to
deliver (or cause to be delivered) to you, subject to the terms of the Award Documentation, one
share of Common Stock after vesting.
2. Vesting. Subject to your continued employment, 33-1/3% of the Stock Units will vest on the 15th
of the month in which each of the first, second and third anniversaries of the grant date of the Award
occurs. Each date on which a Stock Unit is scheduled to vest pursuant to this Section II.B.2. is a
“Scheduled Vesting Date.” In the event of your termination of employment or the occurrence of your
Permanent Disability (as defined in Section V.) prior to a Scheduled Vesting Date, your right to any
Stock Units that are unvested immediately prior to your termination of employment or occurrence of
your Permanent Disability, as applicable, will be determined in accordance with Section III. below.
For the avoidance of doubt, the date of your termination of employment for purposes of determining
vesting under this Section II.B.2. will be determined in accordance with Section III.E.
3. Dividend Equivalents. For each outstanding Stock Unit covered by the Award, an amount equal
to the dividend payment (if any) made in respect of one share of Common Stock (a “Dividend
Equivalent”) will accrue in U.S. dollars on each dividend record date that occurs on or after the grant
date of the Award while the Award is outstanding, with no interest paid on such amounts. Accrued
Dividend Equivalents will vest when the Stock Units in respect of which such Dividend Equivalents
were accrued vest. No further Dividend Equivalents will accrue on Stock Units that do not vest or are
cancelled or forfeited. Accrued Dividend Equivalents will not be paid, and no further Dividend
Equivalents will accrue, on Stock Units that do not vest or are cancelled or forfeited as per a
termination of employment event described in Section III.D.
4. Delivery.
a. Shares of Common Stock deliverable in respect of the Stock Units covered by the Award shall be
delivered to you as soon as practicable after vesting, and in no event later than 60 days after
vesting, except as otherwise provided in Section VI.B.
b. The value of vested Dividend Equivalents will be delivered to you in cash as soon as practicable
after vesting and in no event later than 60 days after vesting.
c. The delivery of shares of Common Stock and/or cash or other property that may be deliverable
under these Terms and Conditions, is conditioned on the satisfaction or withholding of any
applicable tax obligations, as described in Section II.C.
d. Any shares of Common Stock and/or cash or other property that may be deliverable
following your death shall be
2
-- 143 of 156 --
delivered to the person or persons to whom your rights pass by will or the law of descent and
distribution, and such delivery shall completely discharge Marsh and any of its subsidiaries’ or
affiliates’ obligations under the Award.
e. Notwithstanding the foregoing, additional delivery rules for certain Award recipients subject to
U.S. federal income tax (whether or not the recipient is a U.S. citizen or employed in the U.S.)
are reflected in Section III.G.
C. Satisfaction of Tax Obligations.
1. Personal Tax Advisor. Neither the Company nor any Company employee is authorized to provide
personal tax advice to you. It is recommended that you consult with your personal tax advisor for
more detailed information regarding the tax treatment of the Award, especially before making any
decisions that rely on that tax treatment.
2. U.S. Employees. Applicable employment taxes are required by law to be withheld when a Stock
Unit or Dividend Equivalent vests. Applicable income taxes are required by law to be withheld when
shares of Common Stock in respect of Stock Units or cash in respect of Dividend Equivalents are
delivered to you. A sufficient number of whole shares of Common Stock, cash or other property, as
applicable, will be retained by Marsh to satisfy the tax withholding obligation.
3. Non-U.S. Employees.
a. Stock Units and Dividend Equivalents. In most countries, the value of a Stock Unit or
Dividend Equivalent is generally not taxable on the grant date. If the value of the Stock Unit or
Dividend Equivalent is not taxable on the grant date, it will, in most countries, be taxed at a later
time, for example, upon delivery of a share of Common Stock in respect of the Stock Unit that
vests, and/or the subsequent sale of the share of Common Stock received in connection with the
vesting of the Stock Unit or upon delivery of cash in respect of a Dividend Equivalent.
b. Withholding. Marsh and/or your employer shall have the power and the right to deduct and
withhold from the Award and other compensation or to require you to remit to Marsh and/or to
your employer, an amount sufficient to satisfy any Tax-Related Items (as defined in Section V.)
that Marsh expects to be payable under the laws of any country, state, province, city or other
jurisdiction. If applicable, Marsh and/or your employer will, to the extent permissible under
applicable law or otherwise agreed between you and Marsh and/or your employer, either (a)
withhold from proceeds of the sale a sufficient number of whole shares of Common Stock issued
to you in settlement of the Award (either through your voluntary sale or through a mandatory
sale arranged by Marsh on your behalf) for purposes of satisfying applicable obligations with
respect to Tax-Related Items and/or (b) withhold a sufficient number of whole shares of Common
Stock distributable to you in in respect of the Award to satisfy applicable obligations with respect
to Tax-Related Items. Further, depending on the withholding
3
-- 144 of 156 --
method, Marsh and/or your employer may withhold or account for obligations for Tax-Related
Items by considering statutory or other withholding rates, including minimum or maximum rates
applicable in your jurisdiction(s).
In the event of over-withholding, you may receive a refund from Marsh and/or your employer of
any over-withheld amount in cash (with no entitlement to the equivalent in shares of Common
Stock), or if not refunded by Marsh and/or your employer, you must seek a refund from the local
tax authorities to the extent you wish to recover the over-withheld amount in the form of a
refund.
III. EMPLOYMENT EVENTS
A. Death. In the event your employment is terminated because of your death, all of the unvested Stock
Units that are outstanding as of the date of your death will fully vest and will be distributed as described
in Section II.B.4.
B. Permanent Disability. Upon the occurrence of your Permanent Disability, the unvested Stock Units will
fully vest and will be distributed as described in Section II.B.4., provided that you satisfy the conditions
to vesting described in Section III.F.1.
C. Termination by the Company Other Than for Cause.
1. General. Except as otherwise provided in Section IV., in the event the Company, in its sole
discretion, determines that your employment is terminated by the Company other than for Cause (as
defined in Section V.), the unvested Stock Units will fully vest at such termination of employment
and will be distributed as described in Section II.B.4., provided that you satisfy the conditions to
vesting described in Section III.F.2.
2. Important Notes.
a. Sale of Business Unit. For purposes of this Award, in the event of a sale or similar transaction
involving the business unit for which you work (“Employing Company”) as a result of which the
Employing Company ceases to be a subsidiary or affiliate of Marsh, your employment will be
deemed terminated by the Company other than for Cause, even if your employment with the
Employing Company continues after the sale or similar transaction.
b. Constructive Discharge. The Award will not vest, whether on a pro-rata or full basis, upon a
constructive discharge, including if any court or regulatory agency retroactively concludes or
interprets events to have constituted a constructive discharge.
D. All Other Terminations. For all other terminations of employment not described in Sections III.A.
through C. or Section IV. (including, but not limited to, a termination by the Company for Cause or a
resignation by you of your employment with the Company), any rights, title and interest in and to any
remaining unvested portion of the Award shall be cancelled
4
-- 145 of 156 --
as of the date your employment is treated as having terminated as described in Section III.E.
E. Date of Termination of Employment.
1. If Section III.E.2. does not apply to you, then for purposes of determining vesting under Section
II.B.2., your employment will be treated as having terminated on your last day of employment with
the Company.
2. If you are obligated (whether by law or contract) to provide the Company advance notice of your
intention to terminate your employment then, in the event you terminate your employment or
service relationship pursuant to Section III.D. (regardless of the reason for such termination and
whether or not later found to be invalid or in breach of employment laws in the jurisdiction where
you are employed or the terms of your employment agreement, if any), for purposes of determining
vesting under Section II.B.2. , your employment will be treated as having terminated on your last
day of active service with the Company, as determined by the Company in its sole discretion.
You shall be deemed to have ceased active service with the Company when you are no longer
required by the Company to provide regular services to the Company even if you remain legally
employed by the Company, such as may occur if the Company were to place you on “garden leave”,
a terminal leave of absence or any similar period mandated under employment laws in the
jurisdiction where you are employed or the terms of your employment agreement, if any (in each
case as determined by the Company in its sole discretion).
F. Conditions to Vesting of Award Prior to a Scheduled Vesting Date.
1. Restrictive Covenants Agreement. In the event of the occurrence of your Permanent Disability
as described in Section III.B., you will be required to execute or reaffirm, as determined by Marsh in
its sole discretion, and return to Marsh (or an agent appointed by Marsh) a Restrictive Covenants
Agreement. Failure to (a) execute or reaffirm such an agreement by the date specified by the
Company, which shall be in no event later than 60 days following the occurrence of your Permanent
Disability as described in Section III.B., or (b) comply with the Restrictive Covenants Agreement, will
result in the cancellation or forfeiture of any rights, title and interest in and to the Award without any
liability to the Company.
2. Waiver and Release and Restrictive Covenants Agreement. In the event of your termination
of employment by the Company other than for Cause as described in Section III.C., you will be
required to (i) execute or reaffirm, as determined by Marsh in its sole discretion, and return to Marsh
(or an agent appointed by Marsh) a Restrictive Covenants Agreement and (ii) execute and not
revoke a waiver and release agreement, if provided to you by the Company at the time of your
termination of employment. Failure to meet these requirements by the date specified by the
Company, which shall be in no event later
5
-- 146 of 156 --
than 60 days following your termination of employment, or failure to comply with the waiver and
release agreement or the Restrictive Covenants Agreement, as applicable, will result in the
cancellation or forfeiture of any rights, title and interest in and to the Award without any liability to
the Company.
G. Section 409A of the Code for Award Recipients Subject to U.S. Federal Income Tax (whether or
not the recipient is a U.S. citizen or employed in the U.S.).
1. For Award recipients subject to U.S. federal income tax, notwithstanding any other provision
herein, the Award may be subject to additional restrictions to ensure compliance with (or continued
exemption from) the requirements of Section 409A of the Code (as defined in Section V.). The
Compensation Committee of the Board of Directors of Marsh (the “Committee”) intends to
administer the Award in accordance with Section 409A of the Code and reserves the right to make
changes in the terms or operations of the Award (including changes that may have retroactive
effect) deemed necessary or desirable to comply with Section 409A of the Code. This means, for
example, that the timing of distributions may be different from those described in the Award
Documentation that do not reflect Section 409A of the Code. If the Award is not in compliance with
Section 409A of the Code, you may be subject to immediate taxation of all unpaid awards under the
Plan that are subject to Section 409A of the Code at your regular federal income tax rate, plus a
20% additional tax, plus interest at the underpayment rate plus 1%, as well as any state and local
taxes, penalties, additional taxes and interest, if applicable, imposed under any state tax law similar
to Section 409A of the Code.
2. Notwithstanding any other provision herein, if any portion of the Award is determined to be
nonqualified deferred compensation subject to Section 409A of the Code, any references to
“termination of employment,” or “when you are no longer employed” in these Terms and Conditions
shall have the following meaning:
Your “termination of employment” (or similar terms) shall occur when you have incurred a
“separation from service” within the meaning of Section 409A of the Code and as further defined
herein. Specifically, you will have incurred a “separation from service” when the level of services
you provide to the Company in any capacity, including as an employee, director, independent
contractor or consultant, does not exceed 20% of the average level of services that you provided
to the Company in the preceding 36 months (or shorter period of service if, for example, your
total service with the Company is less than 36 months), all as determined in accordance with
Section 409A of the Code. In determining whether a “separation from service” has occurred, any
period of up to six months during which you are on a bona fide leave of absence or up to 29
months during which you are absent from work due to a disability for which you are receiving
Marsh long-term disability benefits will be ignored.
6
-- 147 of 156 --
3. Notwithstanding any other provision herein, if at the time of your termination of employment you
are a “specified employee” (as defined in Section 409A of the Code) no portion of the Award that is
determined to be nonqualified deferred compensation subject to Section 409A of the Code can be
distributed prior to the first day of the seventh month after your termination of employment and any
such distributions to which you would otherwise be entitled during the first six months following your
termination of employment will be accumulated and paid without interest on the first day of the
seventh month after your termination of employment, except to the extent that earlier distribution would
not result in your incurring interest or additional tax under Section 409A of the Code.
4. Nothing in this Section III.G. is intended to, nor does it guarantee, that the Award will not be
subject to “additional tax” or other adverse tax consequences under Section 409A of the Code or any
similar state tax law. In no event will the Company be liable for all or any portion of any taxes,
penalties, interest or other expenses that may be incurred on account of non-compliance with
Section 409A of the Code.
IV. CHANGE IN CONTROL PROVISIONS
A. Upon the occurrence of a “Change in Control”, as defined in the Plan, the Award will continue to vest in
accordance with the vesting schedule specified in Section II.B.2. and subject to earlier vesting or
forfeiture pursuant to Section III., provided that the Award will become fully vested at your termination
of employment by the Company other than for Cause, or by you for Good Reason (as defined in Section
V.), during the 24-month period following such Change in Control and will be distributed as described in
Section II.B.4., provided that you satisfy the conditions to vesting described in Section IV.B.
Notwithstanding the foregoing, if the Award is not assumed, converted or replaced in connection with a
Change in Control on an equivalent basis, the Award will fully vest immediately prior to the Change in
Control and will be distributed as described in Section II.B.4.
B. As a condition to vesting of any unvested portion of the Award, in the event of your termination of
employment by the Company other than for Cause or by you for Good Reason during the 24-month
period following such Change in Control, you will be required to execute and not revoke a waiver and
release agreement, if provided by the Company at the time of your termination of employment. Failure
to meet these requirements by the date specified by the Company, which shall be in no event later than
60 days following your termination of employment, or failure to comply with the waiver and release
agreement, if applicable, will result in the cancellation or forfeiture of any rights, title and interest in and
to the Award.
7
-- 148 of 156 --
V. DEFINITIONS
As used in these Terms and Conditions:
A. “Cause” shall mean:
1. willful failure to substantially perform the duties consistent with your position which is not
remedied within 30 days after receipt of written notice from the Company specifying such failure;
2. willful violation of any written Company policies including, but not limited to, The Marsh Code of
Conduct, The Greater Good;
3. commission at any time of any act or omission that results in a conviction, plea of no contest, plea
of nolo contendere, or imposition of unadjudicated probation for any felony or crime involving moral
turpitude;
4. unlawful use (including being under the influence) or possession of illegal drugs;
5. any gross negligence or willful misconduct resulting in a material loss to the Company, or material
damage to the reputation of the Company; or
6. any violation of any statutory or common law duty of loyalty to the Company, including the
commission at any time of any act of fraud, embezzlement, or material breach of fiduciary duty
against the Company.
B. “Change in Control” shall have the meaning set forth in the Plan.
C. “Company” shall mean Marsh or any of its subsidiaries or affiliates.
D. “Good Reason” shall mean any one of the following events without your written consent:
1. material reduction in your base salary;
2. material reduction in your annual incentive opportunity (including a material adverse change in the
method of calculating your annual incentive);
3. material diminution of your duties, responsibilities or authority; or
4. relocation of more than 50 miles from your principal place of employment immediately prior to the
Change in Control;
provided that you provide Marsh with written notice of your intent to terminate your employment for
Good Reason within 60 days of your becoming aware of any circumstances set forth above (with
such notice indicating the specific termination provision above on which you are relying and
describing in reasonable detail the facts and circumstances claimed to provide a basis for termination
of your employment under the indicated provision) and that you provide Marsh with at least 30 days
following receipt of such notice to remedy such circumstances.
E. “Permanent Disability” will be deemed to occur when it is determined (by Marsh’s disability carrier for
the primary long-term disability plan or
8
-- 149 of 156 --
program applicable to you because of your employment with the Company) that you are unable to
engage in any substantial gainful activity by reason of any medically determinable physical or mental
impairment that can be expected to result in death or can be expected to last for a continuous period of
not less than 12 months.
F. “Section 409A of the Code” shall mean Section 409A of the U.S. Internal Revenue Code of 1986, as
amended, and the regulations and guidance thereunder (regarding nonqualified deferred
compensation).
G. “Tax-Related Items” shall have the meaning ascribed to such term in the Plan.
VI. ADDITIONAL PROVISIONS
A. Additional Provisions—General
1. Administrative Rules. The Award shall be subject to such additional administrative regulations
as the Committee may, from time to time, adopt. All decisions of the Committee upon any
questions arising under the Award Documentation shall be conclusive and binding. The
Committee may delegate to any other individual or entity the authority to perform any or all of
the functions of the Committee under the Award, and references to the Committee shall be
deemed to include any such delegate.
2. Amendment. The Committee may, in its sole discretion, amend the terms of the Award,
including, without limitation, to impose additional requirements on the Award and on any shares
of Common Stock with respect to the Award; provided, however, that if the Committee concludes,
in its sole discretion, that such amendment is likely to materially impair your rights with respect
to the Award, such amendment shall not be implemented with respect to the Award without your
consent, except to the extent that any such action (a) is made to cause the Award to comply with
applicable law, currency controls, stock market or exchange rules and regulations, or accounting
or tax rules and regulations, (b) is made to obtain or maintain corporate tax deductibility or other
favorable tax treatment with respect to the Award, or (c) is otherwise made in accordance with
Section VI.A.4.
3. Limitations. Payment of the Award is not secured by trust, insurance contract or other funding
medium, and you do not have any interest in any fund or specific asset of Marsh by reason of the
Award. Your right to payment of the Award is the same as the right of an unsecured general
creditor of Marsh.
4. Cancellation or Clawback of Awards.
a. Marsh may, to the extent permitted or required by any applicable law, stock exchange rules,
currency controls, or the Company Incentive Compensation Clawback Policy or any other
applicable Company policy or arrangement in effect prior to the vesting of any unvested portion
of the Award, or as specified in the Award Documentation, cancel, reduce or require
reimbursement of the
9
-- 150 of 156 --
Award in the event of fraud, financial restatements, or other events as may be determined by the
Committee.
b. If you fail to repay any amount due pursuant to this Section VI.A.4., the Company may bring an
action in court to recover the amount due. You acknowledge that, by accepting the Award, you
agree to pay all costs, expenses and attorney’s fees incurred by the Company in any proceeding
for the collection of amounts due pursuant to this Section VI.A.4., provided that the Company
prevails in whole or in part in any such proceeding. The Company may also, to the extent
permitted by applicable law, reduce any amounts owed to you by the Company in an amount up
to the full amount of the repayment due.
5. Governing Law; Choice of Forum. The Award and the Award Documentation applicable to the
Award are governed by, and subject to the laws of the state of Delaware, without regard to the
conflict of law provisions, as set forth in Section 10.K of the Plan. For purposes of any action,
lawsuit, or other proceedings arising out of or relating to this Award, including without limitation, to
enforce the Award Documentation, the Company and you each hereby irrevocably and
unconditionally submits to the exclusive jurisdiction of any New York state court or federal court of
the United States of America sitting in the State of New York, and any appellate court thereof. The
Company and you agree that a final judgment in any such action or proceeding shall be conclusive
and may be enforced in other jurisdictions by suit on the judgment or in any other manner provided
by law.
6. Severability; Captions. In the event that any provision of this Award is determined to be invalid
or unenforceable, in whole or in part, the remaining provisions of this Award will be unaffected
thereby and will remain in full force and effect to the fullest extent permitted by law. The captions of
this Award are not part of the provisions of this Award and will have no force or effect.
7. Electronic Delivery and Acceptance. Marsh may, in its sole discretion, decide to deliver any
documents related to the Award and/or your current or future participation in the Plan by electronic
means. You hereby consent to receive such documents by electronic delivery and agree to
participate in the Plan through an on-line or electronic system established and maintained by Marsh
or an agent appointed by Marsh.
8. Waiver. You acknowledge that neither a waiver by Marsh of your breach of any provision of the
Award Documentation nor a prior waiver by Marsh of a breach of any provision of the Award
Documentation by any other participant of the Plan shall operate or be construed as a
10
-- 151 of 156 --
waiver of any other provision of the Award Documentation, or of any subsequent breach by you.
9. Eligibility for Award. In order to be granted an Award, you must satisfy the eligibility criteria for
grantees set forth in the Plan as of the grant date.
B. Additional Provisions—Outside of the United States
1. Changes to Delivery. In the event that Marsh considers that due to legal, regulatory or tax issues
the normal delivery of an Award (as described in these Terms and Conditions) to a participant
outside the United States would not be appropriate, then Marsh may, in its sole discretion, determine
how and when the value of the Award will be delivered. Without limitation, this may include making
any payments due under the Award in cash instead of shares of Common Stock or in shares of
Common Stock instead of cash, in an amount equivalent to the value of the Award on the date of
vesting after payment of applicable Tax-Related Items and fees. If the value of an Award is to be
delivered in cash instead of shares of Common Stock, Marsh may sell any shares of Common Stock
distributable in respect of the Award on your behalf and use the proceeds (after payment of
applicable Tax-Related Items and fees) to satisfy the Award.
2. Amendment and Modification. The Committee may modify the terms of any Award under the
Plan granted to you in any manner deemed by the Committee to be necessary or appropriate in
order for such Award to conform to laws, regulations, and customs of the country (other than the
United States) in which you are then resident or primarily employed or were resident or primarily
employed at the time of grant or during the term of the Award, or so that the value and other
benefits of the Award to you, as affected by non-U.S. tax laws and other restrictions applicable as a
result of your residence or employment outside of the United States, shall be comparable to the
value of such an Award to an individual who is resident or primarily employed in the United States.
VII. QUESTIONS AND ADDITIONAL INFORMATION
Please retain this document in your permanent records. If you have any questions regarding the Award
Documentation or if you would like an account statement detailing the number of shares of Common Stock
covered by the Award and the vesting date(s) of the Award, or any other information, please contact:
Executive Compensation
Marsh & McLennan Companies, Inc.
1166 Avenue of the Americas
New York, NY 10036-2774
United States of America
Telephone Number: +1 212 345-9722
Email: mmc.compensation@mmc.com
11
-- 152 of 156 --
IN WITNESS WHEREOF, Marsh has caused these Terms and Conditions to be duly executed by the facsimile
signature of its Senior Vice President, Chief People Officer as of the day and year first above written. By
consenting to these Terms and Conditions, you agree to the following: (i) you have carefully read, fully
understand and agree to all of the terms and conditions described herein and in the Award Documentation; and
(ii) you understand and agree that these Terms and Conditions and the Award Documentation constitute the
entire understanding between you and Marsh regarding the Award, and that any prior agreements, commitments
or negotiations concerning the Award are replaced and superseded. The grant of the Award is contingent upon
your acceptance of these Terms and Conditions, Country-Specific Notices and Restrictive Covenants Agreement (if
applicable) by the date and in the manner specified in materials provided to you by Executive Compensation
and/or the Company’s stock plan service provider. If you decline the Award or you do not accept the Award and
any applicable documents described in the preceding sentence by the date and in the manner specified, the
Award will be cancelled as of the grant date of the Award.
/s/ Carmen Fernandez
Carmen Fernandez
SVP, Chief People Officer
12
-- 153 of 156 --
Exhibit 31.1
CERTIFICATIONS
I, John Q. Doyle, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Marsh & McLennan Companies, Inc. (the “registrant”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.
Date: April 16, 2026 /s/ John Q. Doyle
John Q. Doyle
President and Chief Executive Officer
-- 154 of 156 --
Exhibit 31.2
CERTIFICATIONS
I, Mark C. McGivney, certify that:
1. I have reviewed this quarterly report on Form 10-Q of Marsh & McLennan Companies, Inc. (the “registrant”);
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to
make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f)
and 15d-15(f)) for the registrant and have:
a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our
supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being prepared;
b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under
our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for
external purposes in accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about
the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most
recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to
materially affect, the registrant's internal control over financial reporting; and
5. The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's
internal control over financial reporting.
Date: April 16, 2026 /s/ Mark C. McGivney
Mark C. McGivney
Chief Financial Officer
-- 155 of 156 --
Exhibit 32.1
Certification of Chief Executive Officer and Chief Financial Officer
The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q for the fiscal quarter ended March 31,
2026 of Marsh & McLennan Companies, Inc. (the "Report") for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) under the
Securities Exchange Act of 1934, as amended (the "Exchange Act"), and Section 1350 of Chapter 63 of Title 18 of the United States Code.
John Q. Doyle, the President and Chief Executive Officer, and Mark C. McGivney, Chief Financial Officer, of Marsh & McLennan Companies, Inc.
each certifies that, to the best of his knowledge:
1. the Report fully complies with the requirements of Section 13(a) or 15(d) of the Exchange Act; and
2. the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of Marsh &
McLennan Companies, Inc.
Date: April 16, 2026 /s/ John Q. Doyle
John Q. Doyle
President and Chief Executive Officer
Date: April 16, 2026 /s/ Mark C. McGivney
Mark C. McGivney
Chief Financial Officer
-- 156 of 156 --